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Abstract   
Electrogenerated chemiluminescence (ECL) is the process whereby electrochemically 
generated species undergo electron-transfer reactions in solution and emit light. ECL has 
been widely used as a mode of detection due to advantages such as high sensitivity, 
selectivity and wide dynamic range. Tris(2,2′-bipyridine)ruthenium(II) ([Ru(bpy)3]
2+
) and 
various derivatives are the most commonly employed ECL luminophore, but the low 
luminescence quantum yield of [Ru(bpy)3]
2+
 (3.9% in water) limits the sensitivity of its ECL 
system. Therefore, considerable effort has been devoted to developing new ECL 
luminophores such as cyclometalated iridium(III) complexes, which exhibit much higher 
quantum yields (some nearly 99% in acetonitrile). Additionally, iridium(III) complexes 
enable the ECL emission to be tuned to different wavelengths throughout the visible region, 
creating opportunities for ‗mixed-ECL‘ from solutions containing multiple different-
coloured luminophores. 
The research described herein explored the ECL of iridium(III) complexes, from several 
perspectives, including (i) a re-evaluation of complexes previously reported as highly 
promising candidates for ECL, (ii) the development of novel water-soluble iridium(III) 
complexes for ECL detection, (iii) elucidation of the key reaction pathways of ECL with 
iridium(III) complexes, and (iv) the development of new ECL labels containing iridium(III) 
complex luminophores. 
Firstly, the ECL of iridium(III) complexes containing an acetylacetonate (acac) ligand 
with tri-n-propylamine (TPrA) co-reactant in acetonitrile was examined under a range of 
chemical and instrumental conditions. This demonstrated that the ECL intensities of 
iridium(III) complexes are highly dependent on experimental conditions. In some cases, 
exceptional intensities previously reported for iridium(III) complexes may have been 
ii 
 
derived using instrumental or chemical conditions that unintentionally disadvantaged the 
[Ru(bpy)3]
2+
 reference electrochemiluminophore. 
Secondly, a series of new water-soluble iridium(III) complexes containing a 2,2′-
bipyridine (bpy) ligand with one or two tetraethylene glycol (TEG) groups were synthesised 
and their ECL behaviours were studied. The novel [Ir(C^N)2(Me-bpy-TEG)]Cl and 
[Ir(C^N)2(TEG-bpy-TEG)]Cl complexes (where C^N represents a ligand with carbon and 
nitrogen atoms involved in the coordination of the ligand to the metal centre) in aqueous 
solution largely retained the redox potentials and emission spectra of the parent 
[Ir(C^N)2(Me-bpy-Me)]PF6 (where Me-bpy-Me = 4,4′-methyl-2,2′-bipyridine) 
luminophores in acetonitrile, and exhibited ECL intensities similar to those of [Ru(bpy)3]
2+
 
and the analogous [Ir(C^N)2(pt-TEG]Cl complexes (where pt-TEG = 1-(TEG)-4-(2-





, which can both be readily adapted for bioconjugation, reveals a viable 
strategy to create ECL-labels with different emission colours from the same commercial 
[Ir(ppy)2(-Cl)]2 precursor.  
Lastly, a series of new ECL labels with iridium(III) complex luminophores were 
created by adding a suitable functional group to a phenyltriazole ligand, and the potential of 
these labels was examined using two different commonly binding assays. The novel 
[Ir(C^N)2(pt-TEG-Sq)]
+
 labels were obtained through a more convenient and versatile 
synthetic approach and provided superior ECL responses to the commercial 
[Ir(C^N)2(mbpy-COOH)]
+
 analogues in both assays. Comparison of ECL intensities from 
various labels under different assay conditions provided new insight into the reaction 
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Chapter 1: Introduction 
1.1 Electrogenerated chemiluminescence 
Electrogenerated chemiluminescence (ECL) is the phenomenon resulting from 
electrogenerated species undergoing an electron-transfer reaction at the electrode surface, 
resulting in the emission of light.
1
 Compared with chemiluminescence, ECL shows several 
advantages: (1) some luminescence reagents can be regenerated at the electrode surface and 
as a result take part in the reaction more than once.
2
 (2) Due to advantages offered by spatial 
and temporal control, ECL can readily be combined with multiple other technologies such 
as flow injection analysis (FIA),
3





 making it possible to detect the specific targets in 
complicated samples, without the need of adding a chemical oxidant or other 
chemiluminescence reagent. (3) Due to the reaction taking place at the electrode, ECL 
emission can be controlled through the electrochemical potential to improve the sensitivity 
and selectivity of the method.
6
 The details of the current comprehensive understanding of 
ECL processes have been summarized in many reviews in the past few years.
7-11
 Since the 
first detailed ECL studies were reported on the 1960s by Hercules and Bard,
12, 13
 the number 
of publications per year increased to a plateau around 2014 (Figure 1.1). ECL has become a 
major focus of research, encompassing fundamental studies, reagent development, and 
analytical applications. In recent years, ECL biosensors have become an area of intense 
interest (Figure 1.2).
8
 After decades, ECL has evolved as a powerful technique that is 













        


























Figure 1.1. Number of publications related to ECL as a function of year published on the research topic of 
ECL according to SciFinder Scholar. The search was conducted in May, 2018. 
 
 







1.1.1 Annihilation ECL 
Light emission triggered by electrochemical reactions can be produced via a number of 
different mechanisms, among which the ‗annihilation‘ route was the first explored.
17, 18
 
When the potential applied is alternated between positive and negative, electrochemically 
oxidized and reduced species are both generated at electrode. The excited state product is 
generated through electron transfer from the reduced to the oxidized species. The reactions 
in the annihilation ECL route are shown below in Scheme 1.1. 
 
(1)   A－e- → A+           (oxidation at the electrode) 
                  (2)   A＋e- → A-               (reduction at the electrode) 
       (3)   A
-＋A+ → A*＋A    (excited state formation) 
(4)   A* → A＋hν         (light emission) 
Scheme 1.1.  Mechanism of annihilation ECL reaction. 
 
Annihilation ECL is simple, but is limited to reactions in organic solvents, because the 
potential window of aqueous solutions is generally not large enough to both oxidize and 
reduce the luminophore.
19
 Furthermore, not all the oxidized or reduced ECL luminophores 
are stable enough to undergo annihilation ECL, which limits emission intensity.
20
 Finally, 
the annihilation route is more sensitive to quenching by oxygen. Therefore, most ECL 
applications are based on the ‗co-reactant route‘, as described below. 
1.1.2 Co-reactant ECL  
Although the first detailed ECL studies involve annihilation ECL, ‗co-reactant‘ ECL has 
become the dominant approach for analytical applications, including all commercial ECL 
instruments.
21
 There are two pathways for co-reactant ECL systems: ‗oxidative-reduction‘  
or ‗reductive-oxidation‘. Scheme 1.2 shows the general mechanism for oxidative-reduction 
ECL, where the co-reactant forms a highly reducing species after being electrochemically 







followed by light emission. Alternatively, the reduced co-reactant can reduce A, allowing 
the annihilation generation of the excited state species. ECL can be generated as result of 
pulsing the electrode in a single direction in the presence of a co-reactant.
22
 Most co-
reactants are either strong reducing agents or strong oxidizing agents which can be easily 
oxidized or reduced with the luminophore species and undergo a rapid chemical reaction to 
form an intermediate, which then reacts with the ECL luminophore to produce ECL 







 and tri-n-propylamine (TPrA)
26 
have been explored to serve as co-
reactants for ECL emission. TPrA is the most commonly used co-reactant, which is believed 
to produce a strong reduced species.  
(1a)  A－e-→ A+                (oxidation at electrode) 
(1b)  C－e- → C+   (oxidation at electrode) 
(2)  A
+
 + C → A + C
+
  (homogeneous electron transfer) 
(3)  C
+
 → Cred    (co-reactant degradation) 
(4)  Cred + A → A
-
 + Products   (reduction of luminophore) 









 → A*＋A   (excited state formation) 
(5c)  A
+
 + Cred  → A*＋Products    (excited state formation)  
(6)  A*→ A＋hν                     (light emission) 
                 Scheme 1.2. General mechanisms of oxidative-reduction ECL. 
1.2 Main ECL systems 
1.2.1 ECL inorganic luminophores 
The ECL luminophore is the main component of an ECL system and developing and testing 
of efficient and new ECL luminophores is the long-term aim for researchers. According to 
the chemical properties of the luminophores, ECL systems can be simply classified into 











which mainly use organometallic complexes as the luminophore, have been extensively 
studied because they possess unique optical properties, electrochemistry, and excellent ECL. 









have been synthesized and their ECL properties have been investigated. 
1.2.2 ECL from Ru(bpy)3
2+
 and its derivatives 
The first report on ECL of Ru(bpy)3
2+
 was published in 1972 by Bard‘s group, where 
annihilation ECL was generated from ruthenium complexes via electron-transfer reactions 
between oxidized and reduced species.
20
 This was followed by many further studies of the 
ECL behaviour of Ru(bpy)3
2+
 and its derivatives. A considerable number of studies have 
examined the mechanism of Ru(bpy)3
2+
.
7, 9, 11, 33
 Taking the Ru(bpy)3
2+
-TPrA system as an 
example, ECL emission can occur through various routes (Schemes 1.3-1.6), and the 
dominant pathway is dependent on the ratio of the concentration of Ru(bpy)3
2+
 and TPrA. 
When Ru(bpy)3
2+
 is at a high concentration, the excited state is generated by reaction of the 
oxidized Ru(bpy)3
3+
 with either TPrA

 (Scheme 1.3) or Ru(bpy)3
+
 (Scheme 1.4). Under 
these conditions, the oxidation of TPrA by Ru(bpy)3
3+
 (Scheme 1.5) is also an important 
pathway. On the contrary, if the co-reactant TPrA is in large excess, then the TPrA 
oxidation reaction at the electrode plays the dominant role, and the excited state product is 




 (Scheme 1.6). The clear 
understanding of the mechanism of Ru(bpy)3
2+
/TPrA ECL is useful to design highly 
efficient ECL systems and enhance reproducibility of the Ru(bpy)3
2+
 based immunoassay 














Scheme 1.3-1.6. General reaction mechanism of TPrA with Ru(bpy)3
2+
 under different conditions. Adapted 





The photoluminescence quantum yield of Ru(bpy)3
2+
 in aqueous solutions is only 
2.8%,
34
 and thus limits the sensitivity of Ru(bpy)3
2+
-based analytical methods. Therefore, 
many attempts have been made to explore ruthenium complexes with higher efficiency than 
that of Ru(bpy)3
2+
. For example, Ciana et al.
35
 investigated a family of Ru(II) complexes 
bearing mixed 2,2‘-bipyridine (bpy) and bathophenanthroline disulfonate (BPS) ligands 
([Ru(BPS)n(bpy)3-n]
(2n-2)-)
, where n decreases from 3 to 1. The electrochemistry of these 
species in acetonitrile showed reversible or partially reversible oxidation processes and fully 
reversible reductions, indicating that these species could generate ECL through cation-anion 
annihilation. As shown in Figure 1.3a, in the case of [Ru(BPS)2(bpy)]2, the electrochemical 
behaviour is very similar to that of Ru(bpy)3
2+ 
with three reduction peaks and a single 
oxidation. The oxidation peak was a reversible one-electron processes, which was attributed 
to the Ru(II) metallic centre. Therefore, the ECL spectra of the complexes could be 
produced by ion annihilation reactions or co-reactant pathways. As the net charge changed 
from -4 to 0, the ECL intensity dramatically increased, with the neutral complex 
[Ru(BPS)(bpy)2] approximately 26 times greater than Ru(bpy)3
2+
. This was ascribed to the 
highly negative charge that promoted the formation of a filming product at the electrode 
during oxidation, resulting in the increased ECL intensity.  
Besides improving luminescence yield of ECL luminophores to amplify the sensitivity 
of ECL assays, in recent years, several researchers have focused on making self-enhanced 
ECL reagents by linking co-reactants to a ruthenium complex. The efficiency can be 
improved significantly by introducing a co-reactant into the ligand structure of complexes 
due to more efficient intramolecular electron transfer between complexes and co-reactants 
than when in solution individually. A series of self-enhancing ECL co-reactant based on the 
complex Ru(bpy)3
2+
 have been developed and successfully used in amplified assays.
36, 37







Figure 1.3. Cyclic voltammetric curves of 0.5 mM [Ru(BPS)(bpy)2] in solution. Working electrode: Pt disk 
(diameter 3 mm).Scan rate: (a) 0.5 and (b) 0.2 V/s. Cyclic voltammogram under the same experimental 
conditions including the third (black line), fourth (red line), and fifth (blue line) reduction process occurring at 
the edge of the solvent window. Figure from reference 35. 
   Most of the ruthenium complexes are limited to emission wavelengths of around 600-
650 nm, due to the highest occupied molecular orbital (HOMO) energy level based on the 
ruthenium metal centre being reasonably constant, thus reducing the possibility of 
developing multicolour ECL analytical techniques. Therefore, a family of ruthenium 
complex derivatives were designed and synthesized to broaden the emission wavelength 
range. Puodziukynaite and co-workers
38
 successfully tuned the emission wavelength from 
640 to 700 nm by introducing acrylate on the bipyridine ligand (Figure 1.4). 
Electrochemiluminescent devices based on the complexes exhibited colours from red-
orange to deep red. The main reason for the color change is that their ligand-based lowest 
unoccupied molecular orbital (LUMO) value decreased and this resulted in lower energy 
triplet metal-to-ligand charge-transfer excited state transitions. The complexes were utilized 
as cross-linked electrochromic films and electrochemiluminescent layers in light-emitting 






Figure 1.4. Acrylate-containing Ru(bpy)3
2+
-based coordination complexes. Figure from reference 38. 
1.3 Iridium complexes  
Over the last decade, iridium complexes have emerged as promising alternative ECL 
luminophores for ECL due to their versatile synthesis and excellent spectroscopic and 
electrochemical properties. Unlike ruthenium complexes, which are limited to the ligand-
field splitting energies of ruthenium, iridium complexes could be easily tuned to desirable 
emission wavelengths (even near-infrared) through the introduction of substituents on the 
ligands, enabling manipulation of both HOMO and LUMO levels. Moreover, iridium 
complexes have high luminescence quantum yields, some approaching 100%, which 
facilitates the development of more sensitive and multiplexed ECL assays.
39, 40
 In this regard, 
many groups have been focusing on the development of ECL active iridium luminophores 
with highly efficient luminescence and large emission wavelength ranges. Kim and co-
workers
41
 have reported that (pq)2Ir(acac) and (pq)2Ir(tmd) (pq = 2-phenylquinoline anion, 
acac = acetylacetonate anion, tmd = 2,2′,6,6′-tetramethylhepta-3,5-dione anion; see 
structures in Figure 1.5) with the co-reactant TPrA gave higher ECL intensities than the 
[Ru(bpy)3]
2+
-TPrA system. Particularly Ir(pq)2acac, which has a low enough oxidation 
potential (expected to accelerate generation of the radical ion TPrA
•
) and well-matched 
reduction potential to accept electron efficiently from TPrA
•
, which means that the 





the ECL efficiency of luminescent metal complex molecules could be tuned through 
controlling energetics between the electron donor-acceptor pair (HOMO and LUMO levels) 
based on the electrochemical properties of complexes and available co-reactants. The 
significantly improved ECL efficiencies showcased the potential of iridium complexes 
becoming an alternative to ruthenium complexes for ECL sensing applications. However, 
this type of iridium complex with pq ligand has a similar emission wavelength to ruthenium 
complexes. 
 
Figure 1.5. Intense ECL-emitting iridium complexes with 2-phenylpyridine or 2-phenylquinoline 
cyclometallating ligands and a variety of ancillary ligands reported by Kim et al., (a) [Ir(ppy)2(bpy)]
+
, (b) 
Ir(pq)2(3-iq), (c) Ir(pq)2(pic), (d) Ir(pq)2(quin), (e) [Ir(ppy)2(phen)]
+
, (f) Ir(pq)2(dbm), (g) Ir(pq)2(tmd), (h) 
Ir(pq)2(acac).  Figure from reference 41. 
Recently, many iridium(III) complexes exhibiting blue/green luminescence have been 
reported. The common strategy to tune their emission colour is by controlling the energetic 
gap between HOMO and LUMO levels by attaching electron-withdrawing or electron-
donating groups to different ligands. Swanick et al.
42
 reported four bright 
electrochemiluminescent iridium(III) complexes containing aryltriazole cyclometallating 
ligands, with emissions down to the blue-cyan region at 503 nm.
42
 This was achieved by 





HOMO–LUMO energy gap and resulted in a large hypsochromic shift in the emission. 
Inspired by the study, Ladouceur et al.
43
 explored two strongly blue luminescent cationic 
heteroleptic iridium complexes containing an 4,4′-bis(dimethylamino)-2,2′-bipyridine 
(dmabpy) ancillary ligand and either 1-benzyl-4-(2,4-difluorophenyl)-1H-1,2,3-triazole 
(dFphtl) or 2-(2,4-di-fluorophenyl)-5-methylpyridine (dFMeppyH) cyclometalated ligands 
(Figure 1.6). These complexes showed efficient blue-shifted ECL emission, which further 
demonstrated that the feasibility of hypsochromically shifting the emission could be 
accomplished by anchoring the fluorine groups to the phenyl moiety of the ligands to 
stabilise the HOMO. After comparison of the electrochemical and ECL properties of these 
complexes which had the same fluorine group but with minor changes on the neutral 
ancillary ligand, we can understand the idea that the LUMO could be destabilised by 
attaching electron-donating groups to the bipyridine groups of the ligands while ensuring 
favourable energetic conditions for the ECL reaction. Other electron-withdrawing groups on 
the cyclometalating ligand (C^N) that result in a blue-shift of the phosphorescence of Ir(III) 
complexes are trifluoromethyl, sulfonyl,
44
 and cyclometalated heterocycles.
45
  
Green-emitting complexes have also received attention. Ir(ppy)3
2+
 was the first 
complex that showed green emission in 2002, explored by Bruce and Richter.
46
 However, 
the ECL efficiency was only 0.33 compared with the standard ruthenium complex. 
Shavaleev et al.
47 
used stronger electron-withdrawing sulfur pentafluoride groups (SF5) to 
modify 1-phenylpyrazole and 2-phenylpyridine cyclometalating (C^N) ligands, the resulting 
complexes exhibited green to yellow-green ECL emission with wavelength maxima ranging 
from 501 nm to 520 nm. Besides modifying the ligand of metal complexes, multi-color ECL 
systems can also be achieved by tuning the applied potential to the system, which will be 







Figure 1.6. Complexes from the literature. Image from reference 43. 
1.4 Synthesis of water-soluble iridium complex 
Iridium complexes have many advantages such as high ECL efficiency and the ability to be 
easily tuned over a wider color range. However, the hydrophobic properties of iridium 
complexes limit their analytical applications, so it is still a significant challenge to develop 
practical approaches to make them more water soluble and biocompatible. Various 
strategies have been reported to overcome this problem. The basic protocol is that the 





 or polyethylene glycol chains (Figure 1.7).
50
 For example, Li‘s 
group
48 
made a water-soluble iridium complex with a hydrophilic appended sugar, and the 
ECL intensity of the complex was higher than the conventional ruthenium complex under 
certain conditions, the iridium complex was successfully applied to test antibiotics with a 





 reported an intense chemiluminescence of bis(2-phenylpyridine-
C
2






(Ir(fppy)2DSBPNa) which had a hydrophilic diimine ligand, DSBP
2-
. These complexes 
normally showed red shifted emission after addition of the hydrophilic ligand. To obtain 
water-soluble green or blue emitting iridium complexes, Kerr et al.
52
 made a series of 
complexes with an ancillary 1,2,3-triazol-4-ylpyridine ligand containing sulfonate 
substituents or tetraethylene glycol (TEG) groups which allowed for higher aqueous 
solubility, as shown in Figure 1.7, the results showed that Ir(df-ppy)2(pt-TEG)]
+
 (df-ppy = 
2-(2,4-difluorophenyl)pyridine, pt-TEG = 1-(2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)-
ethyl)-4-(2-pyridyl)-1,2,3-triazole) produced higher ECL intensity over the orange-red 
emitter [Ru(bpy)3]
2+
, making it a highly effective blue emitter . 
 
 
Figure 1.7. Various water-soluble Ir(III) complexes previously examined for photoluminescence, 





The second method to improve the water-solubility or aqueous applicability is the 
practice of doping the complex into nanoparticles, which can then be dispersed in water. 
The nanoparticle can not only can dissolve in water but also avoid quenching from oxygen. 
Moreover, the nanoparticles exhibit low toxicity, and are cheap and simple to prepare. Xue 
and co-workers
53
 developed an iridium-complex loaded polypyrrole nanoparticle for 
photodynamic therapy. However, this kind of nanoparticle could not be used as an ECL 
reagent, due to the polymer most likely blocking and quenching the ECL properties of the 
iridium complex. To overcome this problem, silica nanoparticles have been the most 
commonly used nano-size material to encapsulate the metal complex. The hydrophobic 
iridium complex Ir(pq)2(acac) (acac = acetylacetonato; pq = 2-phenylquinolinato), 
Ir(iqbt)2(dpm) or fac-Ir(iqbt)3 (dpm = 2,2,6,6-tetramethyl-3,5-heptanedione; iqbt = 1-
(benzo[b]thiophen-2-yl)-isoquinoline), which showed intense ECL emission, was doped into 
silica nanoparticles with a hydrophilic polyethylene glycol outer shell in aqueous media 
(Figure 1.8).
54 
The ECL characterization and photoluminescence experiments confirmed that 
even though the complexes are defined in a silica insulating matrix, electron-transfer still 
occurred and resulted in ECL emission. Additionally, after the Ir(pq)2acac was doped into 
silica nanoparticles (SiNPs), the resulting nanoparticle was used to develop a nanoparticle-









1.5 Factors contributing to ECL comparison for metal complexes  
In recent decades, efforts have been made to explore alternative metal complexes to replace 
Ru(bpy)3
2+
. Therefore, the comparison between other metal complexes and the standard 
Ru(bpy)3
2+
 complex plays a very important role when evaluating relative ECL intensity. 
Kim et al.
41
 reported that for Ir(pq)2(acac) and Ir(pq)2(tmd) ECL intensities were 77-fold 
and 49-fold greater than that of [Ru(bpy)3]
2+ 
in the presence of the co-reactant TPrA in 
acetonitrile solution. But for Ir(pq)2(acac), Zhou et al.
56 
recorded a much lower value of 10 
(vs [Ru(bpy)3]
2+ 
= 1) under the experimental conditions.  
There are many factors that may contribute to the variation in the ECL efficiency for the 
same metal complex. The first factor is the method: several types of electrochemical 





 Depending on which species are oxidized and 
reduced, the methods can involve different reaction pathways for the complexes and could 
result in the difference in ECL intensities often reported.  
The second factor is the choice of light detector. Currently, the photomultiplier tube 
(PMT)
59
 and charged coupled device (CCD) spectrometer
11
 and are two of the most 
commonly used optical detectors for ECL. PMT‘s with different peak spectral responses can 
be used to optimize the response from different luminophores. CCD spectrometers provide 
significant advantages over PMTs due to the ability to provide spectral information but are 
considerably less sensitive. An alternative photodetector, which can also provide 
discrimination between different coloured emitters is a digital camera. Doeven et al.
60
 
successfully captured ECL at an electrode surface from three different emitters using a 
digital camera, the RGB colour channels of the photographs could be separated and 
analysed using ImageJ software, which allowing sensitive detection of the red, green and 





concept of using cameras as photodetectors opens a now door for developing low cost, 
portable and sensitive multiplexed ECL detection systems. 
   The third factor is the concentration of co-reactant, as mentioned previously, different 
ratios of concentrations between TPrA and Ru(bpy)3
2+
 can lead to different ECL generation 
pathways, and further affect the ECL intensity. Additionally, the factors such as solvent, 
electrolyte, and reaction time all could contribute to changes in ECL intensity. These will be 
discussed in Chapter 2.  
1.6 Multi-colour ECL from metal chelates 
Iridium complexes can be tuned in to a wide range of emission wavelengths, (i.e. from blue 
to red), which makes them important ECL reagents, as it opens the possibility of developing 
multicolor ECL systems for multiplex analysis. The first demonstration of multi-colour ECL 




 was combined with green emissive 
Ir(ppy)3 (ppy = 2-phenylpyridine). As shown in Figure 1.9, the wavelength of peak emission 
for Ir(ppy)3 was distinguishable from Ru(bpy)3
2+
, which made it possible to get separate 
signals in a solution with both complexes present with the co-reactant TPrA.  
 
Figure 1.9. ECL spectra of (A) a 10 uM Ir(ppy)3 and 10 uM Ru(bpy)3
2+
 solution in CH3CN containing 0.05 M 
TPrA (0.1 M Bu4NPF6 as electrolyte, (B) 10 uM Ir(ppy)2 (0.05 M TPrA ) in CH3CN (0.1 M Bu4NPF6) , and (c) 





After that, many attempts had been made to develop efficient spectrally resolved ECL 
systems by combining metal chelates with different emission colours.
60, 62
 However, only a 
small number of iridium complexes with high ECL efficiency were suitable for this 
approach, and the mixture can result in considerable overlap of the emission maxima. 
Doeven et al.
62
proposed that ECL of metal complex could be selectively detected from the 
mixed metal chelate system by the modulation of the applied potential. Solutions of 
[Ru(bpy)2(L)]
2+
] (ppy = 2-phenylpyridine; L is a derivative of 2,2‘-bipyridine) and either 
Ir(df-ppy)2(BPS)]
- 
(df-ppy = 2-(2,4-difluorophenyl)pyridine) or Ir(ppy) were selected to test 
the concept. The emission of ECL intensity vs electrode potential and emission wavelength 
could be simplified by automated acquisition of ECL spectra using a CCD or camera 
synchronised with the cyclic voltammetry or chronoamperometry experiments. This 
provided new avenues for multianalyte ECL detection. Following this work, they extended 
the concept to three-component ECL systems.
60
 For the mixture of [Ru(bpy)2(dm-bpy-dc)]
2+
 
(dm-bpy-dc = dimethyl 2,2‘-bipyridine-4,4‘-dicarboxylate), Ir(ppy)3 and Ir(df-ppy)3, the 
colour of the system could be switched between green, blue and red using the applied 
potential. However, the mechanism of the multi-component system was more complicated 
than single emitter systems because the multi-colour phenomenon was also related to the 
concentration of co-reactant and electrochemiluminophores. More recently, the ability to 










Figure 1.10. 3D-ECL excitation−emission matrices for red−green−blue electrogenerated chemiluminescence 
(RGB-ECL) system. Figure from reference
 
60. 
1.7 Metal chelate-based ECL labels 
A number of metal chelate-based ECL luminophores possess excellent ECL emission, and 
some of them have been found to emit more intensive ECL than Ru(bpy)3
2+
 in organic 
solvents.
42, 65, 66
 Among these metal chelates, ruthenium and iridium complexes have 
become the most commonly used ECL labels for the development of various assays for 
DNA (deoxyribonucleic acid), proteins, small molecules and so on. However, the practical 
applications have been limited due to their poor solubility in aqueous solution and the lack 
of straight forward bioconjugation. For use as labels in immunoassay or other binding 
assays, a bioconjugation group such as carboxylic acid, N-succimidyloxycarbonylpropyl, 
biotin or amino are required to link the metal complex to the biologically active species. 
Additionally, the electrochemical reaction occurs within the diffusion layer close to the 





weight or long strand nucleic acid molecule, this could keep the metal complex far away 
from working electrode surface, reducing or inhibiting the direct oxidation of the metal 
complex and reducing the ECL emission due to the different ECL reaction pathway which 
occurs.
67
 Based on the above consideration, only a small amount of metal complex would be 
used for ECL detection. The ECL labels in commercial ECL systems are limited to 
derivatives of the classic [Ru(bpy)3]
2+
 luminophore. Therefore, it is important to explore 
new metal-complex based ECL labels for possible application in the immunoassay market. 
Yu et al.
68
 synthesized two new ECL labels based on ruthenium complexes shown in Figure 
1.11 (Label 1 and Label 2)
68
 with carboxylic acid as the bioconjugation group, which were 
compared with one used in commercial systems (Label 3). In this study, mouse IgG was 
used as the analyte (antigen), while goat anti-mouse IgG(H+L) and biotinylated rabbit anti-
Mouse IgG(H+L) were labelled with metal complexes and used as capture antibodies, 
respectively. The results demonstrated that ECL immunoassay performance could be 
improved by taking advantage of the more intense emission of new ruthenium complexes 
for the development of ECL-based clinical immunoassays. Besides ruthenium labels, five 
novel cationic iridium labels and one control ruthenium label, each bearing a carboxylic 
group, were prepared,
69
 and the BSA-labelled iridium complex displayed an ECL signal that 
was 1.9 times higher than the same amount labelled by the traditional ruthenium-based label 
in Procell buffer solution. These novel iridium labels, exhibiting various emission colors, 
shed light on the further development of ECL-based analytical technology.   
In addition to ruthenium and iridium complexes, several other transition metal chelates 
(La, Os, Cr, Re) have been reported as potential labels. For example, osmium polypyridine 
complexes
70
 showed better photostability and lower oxidation potentials than their 
ruthenium analogues, and therefore they could be useful in the design of DNA-labelling 






Figure 1.11. Molecular structures of ruthenium(II) diimine labels. Figure adapted from reference 68. 
                             
1.8 Iridium complex-based ECL for bio-application 
During the last few decades, iridium complex-based ECL systems have been successfully 




 and various other small 
molecules.
73






 hydroxide and ethoxide 
ions,
75
 have been detected as alternative co-reactants to TPrA. Based on the study by Qi et 
al. that showed the iridium complex (pq)2Ir(N-phMA) (pq is 2-phenylquinoline anion, N-
phMA is N-phenylmethacrylamide) could be immobilized onto a glassy carbon electrode 
and respond sensitively to TPrA,
74
 Song et al.
40
 developed a solid-state ECL sensor for the 
detection of NH4
+ 
using a (pq)2Ir(N-phMA) modified electrode. In order to more clearly 
understand the electrochemical process and the ligand effect on ECL efficiency, they 
studied the ECL response to ammonia using four iridium complexes (ppy)2Ir(acetylaniline), 
(ppy)2Ir(N-phMA), Ir(ppy)3 and (pq)2Ir(acac)
72
 with minor changes to the ligand with each 
complex. It was found that (pq)2Ir(acac) showed greater ECL efficiency than the other 
complexes when ammonia was employed as co-reactant. This is because the lowest LUMO 
energy level made the complex more easily accept the electron from the radical NH2 species 





be detected at concentrations as low as 4 ×10
-8
 M, and the sensor was applied to quickly 
determine NH3 in the atmosphere with recovery of 92.5–101.9%. 
Based on the intercalation of the metal complex and DNA, another kind of ECL sensor 
has been fabricated for the determination of DNA. It was reported that certain iridium 
complexes could be employed as efficient binders for G-quadruplex, including telomeric 
DNA.
76, 77
 This group of iridium complexes normally must have an ancillary ligand that can 
be specifically interacted into G-quadruplex DNA but has no response to double-stranded or 
single-stranded DNA. Based on these studies, a number of luminescent iridium complexes 
have been employed as probes for the development of G-quadruplex assay for the detection 







extend the concept for ECL application, a new class of cyclometalated iridium(III) 
complexes bearing π-extended phenylimidazole phenanthroline ligands (shown in Figure 
1.12) were described by Sleiman‘s group.
71
 Complex 2 and 5 showed a ―switch-on‖ effect in 
the presence of G-guadruplex DNA and the ECL signal was greatly enhanced. These 
promising results demonstrated that iridium complexes could be used as ECL reagents to 







Figure 1.12. Synthesis of Complexes 1−7.  Figure adapted from reference 71. 
Iridium complexes are also used as ECL labels to detect a variety of biomolecules. 
Iridium complexes with functional groups (e.g. amino, carboxyl) can also be loaded onto a 
nanoparticle surface to serve as a nanoprobe. For example, a simple gold nanoparticle 
(AuNP) driven ECL aptasensor was fabricated by Zhao‘s group (Figure 1.13).
81
 Using 
AuNPs decorated with iridium complexes as an ECL label, Fumonisin B1 was successfully 






Figure 1.13. Illustration of AuNPs driven ECL aptasensors for FB1 detection. Figure from reference 81. 
Magnetic bead technology is another potential amplification method employed in the 
construction of ECL bioassays, which allows the metal-complex based ECL label to be 
separated from unbound labels without a complex separation step. Commercial instruments 
based on magnetic bead technology have been available for the detection of a wide range of 
biomolecules. For example, in the operation of the commercial ECL instrument, BioVerris 
M-Series analyzers, the Ru(bpy)3
2+
-tagged species are immobilized on magnetic beads that 
are brought to an electrode surface magnetically for analysis. This provides much more 
sensitive ECL detection than the immunoassay without beads. Many other magnetic beads 
based ECL assays have been explored due to the success of these instruments. As shown in 
Figure 1.14,
82
 sequences of ssDNA or antibody can be loaded on the surface of magnetic 
beads, the ECL-label tagged species are attached by hybridizing with the probe ssDNA or 
forming sandwich immunoassay, the beads are then brought to the electrode surface by the 
application of a magnetic field. This approach can result in improvement in sensitivity of 
almost 100 times compared to a previously reported surface-immobilized ECL method. The 
high sensitivity showed that most of the Ru(bpy)3
2+
 attached to the bead via the attached 
recognition element was involved in the ECL reaction and contributed to the ECL intensity. 
However, only small amount of Ru(bpy)3
2+





on the electrode due to the beads blocking on the surface. This concept is also suitable for 
developing bioassays based on iridium complexes. 
 
 
Figure 1.14. Schematic diagrams of (a) DNA hybridization and (b) sandwich type immunoassay using a 
polystyrene bead as the ECL label carrier and a magnetic bead for the separation of analyte-containing ECL 






1.9 Linking Statement 
The papers presented in this thesis focus on a series of novel iridium complexes and the 
study of their ECL properties, encompassing detailed electrochemical, structural and 
photophysical investigations. This includes exploration of the effects of reaction conditions 
and electrochemical methods used to initiate ECL, the design and evaluation of new water-
soluble iridium complexes for ECL detection, examination of the influence of ligand 
structure on ECL intensity and reaction mechanism, and the application of novel ECL labels 
in real-world assays for the detection of ssRNA and protein targets.  
Chapter 2 is a re-evaluation of a set of heteroleptic iridium(III) complexes containing 
an acetylacetonate ligand (acac) that were previously reported to exhibit high ECL 
intensities, to understand the influence of instrumental and chemical conditions on relative 
ECL intensities, and elucidate source of some conflicting prior findings.  
Chapter 3 describes the synthesis and evaluation of new water-soluble iridium(III) 
complexes containing a 2,2′-bipyridine (bpy) ligand with one or two tetraethylene glycol 
(TEG) groups, as potential ECL luminophores with different emission colours and a 
convenient point of attachment for bioconjugation. 
Chapter 4 examines the limitations of contemporary iridium(III) complex ECL labels, 
and introduces a convenient and versatile synthetic approach to prepare iridium(III) labels 
incorporating a phenyltriazole derivative designed for bioconjugation. The ECL intensities 
from the labels under two different assay conditions is exploited to derive a new 
understanding of the mechanisms of ECL reactions with iridium(III) complexes.  
As outlined in the Conclusions and Future Work (Chapter 5), this research makes 
significant contribution to the understanding and application of iridium complexes in ECL 
detection systems, and reveals several important new strategies for the development of 
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Chapter 2: Co-reactant electrogenerated chemiluminescence of 
iridium(III) complexes containing an acetylacetonate ligand 
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 We examine the electrogenerated chemiluminescence (ECL) of three Ir(C^N)2(acac) 
complexes, where acac = acetylacetonate anion and C^N = 2-phenylpyridine (ppy), 
2-phenylbenzothiazole (bt) or 2-phenylquinoline (pq) anions, with tri-n-propylamine 
co-reactant in acetonitrile, under a range of chemical and instrumental conditions, following 
somewhat conflicting recent claims of the ECL intensities from complexes of this type. 
Relevant electrochemical, spectroscopic and ECL properties are evaluated in direct 
comparison with those of Ir(ppy)3 and [Ru(bpy)3](PF6)2, and data from previous 
publications. DFT calculations on the Ir(C^N)2(acac) complexes show the HOMOs to be 
composed of both the metal and C^N ligand, and LUMOs almost exclusively on the C^N 
ligand. The ECL intensities of the Ir(C^N)2(acac) complexes (relative to [Ru(bpy)3](PF6)2) 
were dependent on experimental conditions, and in some cases, the ECL intensities reported 
for iridium complexes may have been derived using conditions that unintentionally 
disadvantaged the reference electrochemiluminophore. 
2.2 introduction 
After the success of ruthenium(II) bipyridine complexes as electrogenerated 
chemiluminescence (ECL) reagents,
[1]
 researchers began to examine a range of 
cyclometalated iridium(III) complexes exhibiting high photoluminescence efficiencies and a 
wide range of emission wavelengths, seeking advances in detection sensitivity
[2]
 and multi-
colour (multiplexed) detection systems.
[3]
 
Initial demonstrations of ECL reactions involving homoleptic Ir(ppy)3 (ppy = 2-
phenylpyridine anion) were promising.
[3a, 4]
 Kapturkiewicz and co-workers then examined a 
series of heteroleptic iridium(III) complexes containing an acetylacetonate anion (acac) 
ligand, such as Ir(ppy)2(acac) and Ir(bt)2(acac), where bt = 2-phenylbenzothiazole anion 
(Figure 2.1).
[5]










Figure 2.1. Ir(ppy)2(acac): bis(2-phenylpyridine)(acetylacetonato)iridium(III); Ir(bt)2(acac): bis(2-
phenylbenzo[d]thiazole)(acetylacetonato)iridium(III); Ir(pq)2(acac): bis(2-phenylquinoline)(acetylacetonato)-




Kapturkiewicz et al. observed impressive ECL efficiencies (ECL up to 0.55) when 
using the triple-potential-step technique to generate the oxidised [Ir(C^N)2(acac)]
+
 complex 
and the reduced radical anions of aromatic nitriles in 1:1 acetonitrile-dioxane,
[5]
 compared to 
the self-annihilation of tris(2,2′-bipyridine)ruthenium(II) ([Ru(bpy)3]
2+
) in acetonitrile (ECL 
= 0.05).
[7]
 Around the same time, Kim et al.
[2a]
 identified Ir(pq)2(acac) and Ir(pq)2(tmd) (pq 
= 2-phenylquinoline anion, tmd = 2,2′,6,6′-tetramethylhepta-3,5-dione anion) as fulfilling 
two parameters essential for efficient co-reactant ECL with tri-n-propylamine (TPrA), 
considering the detailed ECL mechanism for [Ru(bpy)3]
2+





 is the corresponding aminium radical cation (Pr3N
•+
) 
of TPrA, and TPrA
•
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 recorded relative co-reactant ECL efficiencies
§
 for Ir(pq)2(acac) and 
Ir(pq)2(tmd) (with TPrA in acetonitrile) that were 77-fold and 49-fold greater than that of 
[Ru(bpy)3]
2+
, respectively. They attributed the enhancement to the suitability of their 
respective redox potentials for fast generation of TPrA
+•
 via Eqn 3, and the efficient 
acceptance of electrons from TPrA

 in Eqn 6. In a closely related subsequent investigation, 
Zhou et al.
[9]
 reported that the ECL signals for Ir(pq)2(acac) and Ir(pq)2(dm-acac) with TPrA 





 An even greater relative co-reactant ECL intensity (214-fold of that of 
[Ru(bpy)3]
2+
) was observed for Ir(bt)2(acac) with TPrA in dichloromethane,
[10]
 but unlike 
the previous studies,
[2a, 9]
 their relative ECL intensities in acetonitrile were not reported.  
These extraordinary ECL intensities with TPrA as co-reactant (relative to the 
conventional ruthenium(II) complex luminophore that is employed in commercial ECL-
based immunodiagnostics systems) promise superior detection sensitivity and multi-colour 
detection techniques. However, Kapturkiewicz
[2f]
 has questioned the validity of the prior, 





Moreover, Fernandez-Hernandez et al.
[11]
 recently reported a much lower relative co-
reactant ECL for Ir(pq)2(acac) of 0.11 (vs [Ru(bpy)3]
2+
 = 1) under aqueous conditions. 
With these considerations in mind, we have re-examined several promising 
electrochemiluminophores (Ir(ppy)2(acac), Ir(bt)2(acac) and Ir(pq)2(acac)),
[5, 9-10]
 in direct 
comparison with the archetypal [Ru(bpy)3]
2+
 and Ir(ppy)3 complexes. We evaluate the 
relative ECL intensities of these complexes with TPrA co-reactant in acetonitrile across a 
range of complex and co-reactant concentrations, and instrument configurations. These 
experiments not only reconcile some wide discrepancies between previously reported data, 
but also reveal several major shortcomings of conventional approaches to evaluate ECL 
luminophore candidates. 
2.3 Results and Discussion 
2.3.1 Spectroscopic properties 
The UV-visible absorption spectra of the Ir(C^N)2(acac) complexes (Figure 2.2a) were in 
good agreement with previous reports,
[10, 12]
 in which the intense absorption bands between 
250 nm and 350 nm were assigned to spin-allowed singlet intra-ligand (
1
LC) transitions 
(*, ppy/bt/pq) and the weaker bands above 400 nm to mixed singlet and triplet metal-
to-ligand charge-transfer (MLCT) transitions (d(Ir) *(ppy/bt/pq)) and intra-ligand 
transitions.
[12a, 12b] 
The photoluminescence emission spectra of the Ir(C^N)2(acac) complexes in 
acetonitrile each exhibited a broad band (Figure 2.3a) with a maximum intensity at 525, 565 
and 611 nm for Ir(ppy)2(acac), Ir(bt)2(acac) and Ir(pq)2(acac), respectively. The 
luminescence of these complexes has previously been attributed to mixed 
3
LC (π → π*) and 
3
MLCT (dπ(Ir) → π*(ppy/bt/pq)) transitions.
[12a]





with a pronounced shoulder at ~600 nm, suggests a significant ligand 
3
(π → π*) 
contribution in that case. 
 
 
Figure 2.2. Absorption spectra of (a) Ir(ppy)2(acac) (green line), Ir(bt)2(acac) (yellow line), Ir(pq)2(acac) (red 
line), and (b) Ir(ppy)3 (green line), and [Ru(bpy)3]
2+
 (red line), at 10 M in acetonitrile. 
As shown in Table 2.1, the luminescence properties of Ir(bt)2(acac) are somewhat 
intermediate to those of Ir(ppy)2(acac) and Ir(pq)2(acac), and also to those of Ir(ppy)3 and 
[Ru(bpy)3]
2+
. The maximum emission wavelengths of these complexes increase in the order: 
Ir(ppy)3 < Ir(ppy)2(acac) << Ir(bt)2(acac) << Ir(pq)2(acac) < [Ru(bpy)3]
2+
, which is seen in 
their application as luminophores in green (Ir(ppy)3 and Ir(ppy)2(acac)), yellow 





There is considerable variation in the wavelengths of maximum photoluminescence 















































exhibiting widths at half peak height (W½) of 77-119 nm, and thus the maxima are 
vulnerable to error from small changes arising from solvent effects
[3a, 14]
 and instrumental 
noise and intensity fluctuations. Moreover, significant error is introduced by the difference 
in the sensitivity of the instrument across the wavelength range (Figures S2.1-S2.5 in ESI), 
which is commonly left uncorrected. As the sensitivity of typical photomultiplier tubes 
decreases sharply into near-infrared region, this effect is most pronounced on luminophores 
with intensity maxima at the red end of the visible region, such as Ir(pq)2(acac) and 
[Ru(bpy)3]
2+
. With our spectrometer, correction for this artefact resulted in changes in max 
of up to 11 nm, and our corrected values were in good agreement with previously reported 




Figure 2.3. Corrected room-temperature photoluminescence emission spectra of (a) Ir(ppy)2(acac) (green line), 
Ir(bt)2(acac) (yellow line), Ir(pq)2(acac) (red line), and (b) Ir(ppy)3 (green line), and [Ru(bpy)3]
2+

















































10 M in acetonitrile. An excitation wavelength of 350 nm was used for all complexes except [Ru(bpy)3]
2+
, for 
which 450 nm was used. See also: Figures S2.1-S2.5. 
Correction of spectra obtained at 77 K in 4:1 (v/v) ethanol:methanol had a much smaller 
effect on their max, because the emission bands were narrower, although the intensity ratio 
of the multiple bands within each spectrum was significantly altered (Figure 2.4 and S2.1-
S2.5). Our measurements of max for Ir(ppy)3 were within 2 nm of those previously reported 
by Dedeian et al.,
[16]
 Nakamaru et al.,
[17]
 and Djurovich et al.
[18]
 (Table 2.1), despite 
differences in solvent and/or counter ion, with the exception of Ir(pq)2(acac), for which we 
obtained 581 nm in 4:1 (v/v) ethanol:methanol, whereas Djurovich et al. reported 575 nm in 
2-methyltetrahydrofuran (2-MeTHF). Frey et al.
[12c]
 recently observed the max of 
Ir(ppy)2(acac) in 2-MeTHF at 77 K as 506 nm, but our result (501 nm) was in better 
agreement with that of Djurovich et al.
[18]
 (500 nm) in the same solvent. 
The reported photoluminescence quantum efficiencies (PL) of the Ir(C^N)2(acac) 
complexes in deaerated solutions vary widely (Table 2.1), but when compared under the 
same conditions within a single study,
[12a]
 they decrease in the order Ir(ppy)2(acac) > 
Ir(bt)2(acac) > Ir(pq)2(acac). In general, the PL of the Ir(C^N)2(acac) complexes are lower 
than that of Ir(ppy)3, but much higher than that of [Ru(bpy)3]
2+
. However, in air-equilibrated 
solutions, the difference is off-set by the greater susceptibility of the electronically excited 
iridium complexes to oxygen quenching.
[18]
 The PL of Ir(bt)2(acac) in aerated acetonitrile at 
room temperature (0.016),
[12b]




















Figure 2.4. Corrected low-temperature (77 K) photoluminescence emission spectra of (a) Ir(ppy)2(acac) (green 
line), Ir(bt)2(acac) (yellow line), Ir(pq)2(acac) (red line), and (b) Ir(ppy)3 (green line), and [Ru(bpy)3]
2+
 (red 





































Table 2.1. Selected spectroscopic and electrochemical data for the Ir(C^N)2(acac) complexes in comparison with those of fac-Ir(ppy)3 and 
[Ru(bpy)3](PF6)2 




Emission colour Green Green Yellow Orange-Red Orange-Red 



























557, 590 sh (DCM) 
[12b]
 








































































































































max/nm (77 K) 494 (EtOH-MeOH) 
[16]








 575 (2-MeTHF) 
[18]







 /sec (77 K) 5.0 (EtOH-MeOH) 
[26]
 3.2 (DCM) 
[12a]
 4.4 (2-MeTHF) 
[12a]

















Eºox /V vs Fc
0/+














































































































































- - 0.16 (ACN) 
[28]
 0.050 (ACN) 
[7]
 










































 214 (DCM) 
[10]

















The PL is an important consideration in the exploration of new ECL luminophores. The 
ECL is the product of the efficiencies of excitation to the excited state (ex) and the 
subsequent luminescence (em), the latter being equivalent to the PL. Thus, in an ECL 
system where the excitation efficiency is very high, the ECL will approach the PL limit. 
This can be seen in the ECL of systems in which these complexes are oxidised in 
conjunction with the reduction of certain aromatic nitriles and ketones (see Table 2.1, 
second last row).
[4c, 5b, 31]
 Considering that the upper estimate of the PL of Ir(bt)2(acac) 
[5a]
 is 




 and if we assume that under identical conditions, 
the relative ECL intensity is approximately equal to the co-reactant ECL efficiency,
§
 then 





require more than 40-fold greater efficiency in the co-reactant excitation process (ex) for 




In their examination of the co-reactant ECL of Ir(bt)2(acac), Zhou et al.
[10]
 initially 
attempted to characterise the electrochemical potentials of the complexes in 
dichloromethane with 0.1 M TBAPF6 as the supporting electrolyte. Under these conditions, 
a reversible oxidation (0.50 V vs Fc
0/+
) was observed, but an alternative solvent 
(tetrahydrofuran) with a more negative working potential range was required to detect the 
reduction peak (-2.63 vs Fc
0/+
). However, this potential gap (E = 3.13 V) is much larger 





 (Table 2.1). Using acetonitrile as a solvent 
(with 0.1 M TBAPF6 as the supporting electrolyte), we observed reversible oxidation and 
reduction peaks at 0.58 V and -2.24 V vs Fc
0/+
 (Figure 2.5). These values are similar those 
reported by Chen et al.
[27]
 and provide a more reasonable E of 2.82 V. The oxidation peaks 





attributed to ligand-centered reduction processes. In our study, all of the complexes are 
under diffusional controlled conditions, as they are dissolved species in solution. The 
complexes had varying degrees of reversibility. Ruthenium-based complexes were highly 
reversible in aqueous and organic solutions, while the iridium complexes studied showed 
good reversibility in organic solutions, and generally poor reversibility in aqueous media. 
According to the Figure 2.5 and Table 2.2, the ratios of oxidation peak current ipa/ipc (ox) 
and reduction peak current ipa/ipc (red) for all the complexes were equal to 1, which further 
demonstrated that these specific CV‘s show a high degree of reversibility under these 
particular conditions. Potentials quoted in text are formal potentials for reversible redox 
couples, or peak potentials for irreversible reactions. The reversibility of processes was not 
studied in detail. 
 
Figure 2.5. Cyclic voltammetry of the five complexes at 0.25 mM in acetonitrile with 0.1 M TBAPF6, using a 
scan rate of 0.1 V s
-1
. The voltammograms have been off-set on the y-axis for clarity only. 
Our potentials for Ir(ppy)3 and Ir(ppy)2(acac) were also in good agreement with those 
reported.
[27]
 Our data for Ir(pq)2(acac) and [Ru(bpy)3]
2+
 (Table 2.2) were within the range of 
previously reported values, with the exception of the Eºox for Ir(pq)2(acac) of 0.46 V vs Fc
0/+
, 
although this value was similar to the report of Fernandez-Hernandez et al. (0.47 V vs 
-3 -2 -1 0 1 2
















 (Table 2.1). The difference in their first reduction and oxidation potentials (E) 
increased in the order: Ir(ppy)3  Ir(ppy)2(acac) << Ir(bt)2(acac) << Ir(pq)2(acac)  
[Ru(bpy)3]
2+
 (Tables 2. 1 and 2. 2). 
2.3.3 Theoretical Calculations 
The electronic structure and nature of each complex was investigated with DFT calculations. 
A range of density functionals were considered, including pure and hybrid functionals; in 
each case the characteristics of the calculated MOs were qualitatively similar and calculated 
trends were consistent, but the orbital energies (and HOMO-LUMO gaps) were found to be 
strongly dependent on the proportion of Hartree-Fock exchange in the functional. As a result, 
only BP86 results (pure exchange-correlation functional without Hartree-Fock exchange) 
are presented. Having no Hartree-Fock exchange, the calculated HOMO-LUMO gaps 
represent a lower bound of DFT calculated values. The BP86 results also yield the smallest 
degree of spin contamination in the oxidized and reduced forms of the complexes (see 
below). 
For the complexes considered here, plots of the frontier MOs are given in Figure 2.6 
and S2.6. The MOs of [Ru(bpy)3]
2+
 are already well characterised, with a metal-centred 
HOMO and ligand-based LUMO.
[2e, 29, 32]
 The triplet-state spin density (Figure 2.7 and 2.S7) 
shares the same spatial extent as the singlet HOMO and LUMO, for which the lowest 
singlet-triplet transition may be described as metal-to-ligand charge-transfer (MLCT).
[32]
 
For each of the iridium complexes, there is very little spatial overlap between the singlet-
state HOMO and LUMO (i.e., they are largely orthogonal), which indicates that the HOMO 
and LUMO energies might be independently ‗tuned‘ by appropriate substitution of 











Figure 2.6. BP86/def2-TZVP ground-state singlet MO surfaces of [Ru(bpy)3]
2+
 (top) and Ir(ppy)2(acac) 


























Table 2.2.  Selected spectroscopic, electrochemical and ECL data (obtained in acetonitrile unless otherwise stated). 
 
Ir(ppy)3 Ir(ppy)2(acac) Ir(bt)2(acac) Ir(pq)2(acac) [Ru(bpy)3]
2+
 





 525 (523) 565, 605 (564, 600) 611 (602) 621 (610) 
PL (77 K) max/nm
[a],[c]
 494, 532 501, 537 546, 592, 645 581, 624 580, 628 
E0-0/eV
[d]
 2.51 2.47 2.27 2.13 2.14 
ECL, max/nm
[a]
 520 530 567, 602 613 620 
Electrochemistry      
Eºox /V (vs Fc
0/+
) 0.33 0.42 0.58 0.46 0.89 
Eºred/V (vs Fc
0/+
) -2.67 -2.59 -2.24 -2.15 -1.73, -1.92, -2.16 
E/V 3.00 3.01 2.82 2.61 2.62 
ipa/ipc (ox) 1.05 1.06 1.02 1.01 1.02 














 -0.16 -0.12 0.03 -0.02 0.41 
Relative ECL Intensity with 
TPrA co-reactant (Is/Iref) 
     
Conditions A 0.016 (0.018)
[b],[j]
 0.033 (0.036) 1.15 (1.19) 3.08 (3.09) 1
[h]
 
Conditions B <0.001 (0.001) 0.011 (0.012) 0.51 (0.52) 1.13 (1.13) 1 
Conditions C <0.01
 
2.63 (2.95) 25.1 (26.1) 79.1 (79.5) 1 
Conditions D
[i]
 (0.190) (51.8) (243.1) (80.4) 1 
[a]Luminescence spectra were corrected for the change in instrument sensitivity across the examined wavelength range. The correction 
factor was established using a light source with standard spectral irradiance. [b]Values in parentheses were obtained prior to correction. 
[c]Obtained in 4:1 ethanol:methanol. [d]Calculated from PL max at 77 K. 
[e]Calculated: Eºox - E0-0. 
[f]Calculated: Eºred + E0-0. 
[g]For Conditions 
A-C, the detection response was fairly uniform across the wavelengths of emission and therefore correction had very little influence on the 
relative ECL intensities. For Conditions D, the detector response was much poorer towards the red end of the visible spectrum and the ECL 
intensities were artificially raised (relative to [Ru(bpy)3]
2+), which is more pronounced for the metal complexes with lower wavelengths of 
emission. [h]By definition, the ECL intensity of [Ru(bpy)3]
2+ = 1 under each set of conditions. [i]Obtained using a PMT as the photodetector 







Figure 2.7. BP86/def2-TZVP calculated triplet spin density surfaces of [Ru(bpy)3]
2+
 (left) and Ir(ppy)2(acac) 
(right). The triplet spin density surfaces of all complexes investigated in this study are shown in ESI (Figure 
S2.2). 
Löwdin population analysis of fragment contributions to the HOMO and LUMO is 
plotted in Figure 2.8 and S2.8. Iridium octahedral complexes differ from [Ru(bpy)3]
2+
 in that 
the HOMO has a reduced metal d-orbital contribution (typically 50% or less) compared to 
that of [Ru(bpy)3]
2+
 (~80%). The frontier MO characteristics of Ir(ppy)3 lie between those of 
the Ir(C^N)2(acac) complexes and [Ru(bpy)3]
2+
, with a greater HOMO metal contribution 
(58%) than the Ir(C^N)2(acac) complexes. There are noticeable similarities in the 
Ir(C^N)2(acac) compounds: Ir contributes 43-47% of the HOMO while the C^N ligand 
contributes 46-51%. The LUMO is almost exclusively composed of the C^N ligand (95%). 
It is important to note that the LUMO has little density on the acac ligand, which results in 
the LUMO energies being dependent on the nature of the C^N ligand. This observation 
suggests a simpler strategy of tuning photophysical properties of acac-containing iridium 
complexes via a straight-forward variation of the C^N ligand. For example, the energies of 
the C^N centred LUMOs of Ir(ppy)3 and Ir(ppy)2(acac) are very similar (-1.60 and -1.64 
eV), but differ from the Ir(pq)2(acac) and Ir(bt)2(acac) LUMO energies of -2.12 and -1.99 
eV, respectively. In contrast, the HOMO energies of each of the Ir(III) complexes are 
similar (-5.21 to -5.43 eV). The net effect is that the HOMO-LUMO gap is greatest for the 





For the Ir complexes, the triplet spin density surface (Figure 2.7 and S2.7) shares the 
same spatial extent as the singlet HOMO and LUMO, which in this case leads to a 
description of the lowest energy excited state as having a mixed MLCT and metal–ligand-
to-ligand charge-transfer (MLLCT) character. The trends in HOMO and LUMO energies 
are in good agreement with the electrochemical results (Figure 2.9), and the trends in the 
HOMO-LUMO gaps are consistent with the spectroscopic results (Figure S2.9), where the 
energies increase in the order: [Ru(bpy)3]
2+
 < Ir(pq)2(acac) << Ir(bt)2(acac) << 
Ir(ppy)2(acac) ≤ Ir(ppy)3. 
 
Figure 2.8. Contribution to (a) LUMO and (b) HOMO of metal centre and ligands in: (1) Ir(ppy)3; (2) 
Ir(ppy)2(acac); (3) Ir(bt)2(acac); (4) Ir(pq)2(acac); and (5) [Ru(bpy)3]
2+
. A comparison of the contribution of the 


























































2.3.4 Electrogenerated chemiluminescence 
We sought to compare the relative ECL intensities of the complexes under oxidative 
potential with TPrA as co-reactant. Initially, we employed chemical and instrumental 
conditions (hereafter referred to as ‗Conditions A‘) that were similar to that of our previous 
comparisons of ECL intensities of various ruthenium and iridium complexes with TPrA co-
reactant in acetonitrile.
[2e, 33]
 In these previous studies, the electrochemiluminophores were 
typically compared at a concentration of 0.1 mM with a large excess of the TPrA co-reactant, 
applying an oxidative overpotential with a glassy carbon working electrode. The ECL 
intensities were measured by integrating emission spectra obtained with a spectrometer with 
a CCD detector. One of the most promising iridium complexes identified in these studies
[2e]
 
was [Ir(df-ppy)2(ptb)](PF6) (where df-ppy = 2-(2,4-difluorophenyl)pyridine anion, ptb = 
1-benzyl-1,2,3-triazol-4-ylpyridine) (PL max = 454, 484 nm; PL = 0.21), which exhibited a 
co-reactant ECL intensity that was much greater than a range of other iridium complexes, 
but still only 0.24 compared to the [Ru(bpy)3](PF6)2 reference intensity of 1. 
 
Figure 2.9. Comparison of MO energies (left axis) and electrochemical properties (right axis) of: (1) Ir(ppy)3; 
(2) Ir(ppy)2(acac); (3) Ir(bt)2(acac); (4) Ir(pq)2(acac); and (5) [Ru(bpy)3]
2+
. 
Under Conditions A, the co-reactant ECL intensities of Ir(bt)2(acac) and Ir(pq)2(acac) 












































previously reported [Ir(df-ppy)2(ptb)](PF6) complex (nb: the additional Is/Iref values shown 
in parentheses in Table 2.2 were obtained without correction for the sensitivity of the 
instrumentation across the wavelength range; the similarity with those obtained after 
correction show the reasonable consistency of the CCD spectrometer response across the 
investigated range). However, these values were well below the reported 214 for 
Ir(bt)2(acac),
[10]




 for Ir(pq)2(acac) (Table 2.1). The relative ECL 
intensity for Ir(ppy)2(acac) (0.036) was also more than an order of magnitude lower than 
that previously reported (0.96).
[10]
 In an attempt to understand the large discrepancies 
between the observed and reported values, we considered numerous factors that could 
influence these ratios:  
(1) Decomposition. The Ir(C^N)2(acac) complexes can decompose by exchange of the 
acac ligand with solvent molecules.
[34]
 However, the presence of acid is required for this to 
occur at an appreciable rate, and none of the characteristic changes in the absorption or 
emission spectra associated with this decomposition
[34]
 were observed under the chemical 
conditions used in this study.  
(2) Solvent. Bruce and Richter reported co-reactant ECL efficiencies for Ir(ppy)3 of 0.33 
in ACN, 0.0044 in mixed ACN and aqueous solution (1:1 v/v) and 0.00092 in aqueous 




 It is therefore likely that even traces of water in the 
solvent will affect the relative ECL intensity for Ir(ppy)3 and possibly also for the 
Ir(C^N)2(acac) complexes. In our study, the ACN was freshly distilled over calcium hydride 
under nitrogen and we are confident that it would be at least as dry as that used in the 
previous reports of relative ECL intensities. In one of the previous studies,
[10]
 Zhou et al. 
compared the ECL intensities of the Ir(ppy)2(acac) and Ir(bt)2(acac) complexes in 
dichloromethane (DCM) rather than ACN. Although both are organic, aprotic solvents, they 
provide a different electrochemical potential window, and Zhou et al. could not measure the 
reduction peaks of the complexes in DCM.
[10]





of certain reactive intermediates of the multiple possible ECL reaction pathways.
[8]
 This is 
elaborated in item 5 below. 
(3) Deaeration. The longer excited-state lifetimes of the iridium(III) complexes than 
[Ru(bpy)3]
2+
 (Table 2.1) make them more susceptible to quenching by dissolved molecular 
oxygen, thus reducing their relative ECL intensity in its presence. With our experimental 
approach, which includes purging each solution in the electrochemical cell with argon for 15 
min, we do not believe that the presence of any remaining oxygen was responsible for the 
much lower relative ECL intensities found under these conditions that those previously 
reported.
[2a, 3a, 9-10]
 Moreover, the presence of oxygen is easily seen by cyclic voltammetry, 
and was not observed in our experiments. 
(4) Electrode materials and applied potentials. The instrumental conditions for the 
evaluation of relative co-reactant ECL intensities are not standardised, and a survey of the 
literature shows a variety of different electrode materials and applied potentials that include 
the use of a single voltage for a set of complexes (e.g., 1.2 V
[9]
 or 1.4 V vs Fc
0/+[2e, 33b]
) and 





 or 0.5 V
[2a]
). In their study in which they reported a relative co-reactant ECL intensity 
of 77 for Ir(pq)2(acac), Kim et al.
[2a]
 used the same reactant and electrolyte concentrations as 
our Conditions A, but they used a platinum disk working electrode and a higher 
overpotential (Eox + 0.5 V), which was applied at 10 Hz for 10 s (total of 100 pulses). We 
attempted to replicate these experimental parameters (Conditions B), but observed a further 
decrease in the relative co-reactant ECL intensities of the iridium complexes compared to 
[Ru(bpy)3]
2+
 (Table 2.2). However, during these experiments it became evident that the 
decrease in ECL intensity with each subsequent applied potential pulse (of a single 
experiment) was less prominent for the Ir(C^N)2(acac) complexes than for [Ru(bpy)3]
2+
. 





of the Ir(C^N)2(acac) complexes relative to that of [Ru(bpy)3]
2+
, because the ECL intensity 
is integrated over the time period of the experiment (all pulses). 
(5) Reactant concentration. The mechanism of co-reactant ECL with TPrA comprises 
several reaction pathways to the electronically excited state species that is responsible for 
the emission of light.
[8]
 TPrA can be oxidised at the electrode (Eqn 2) or by the oxidised 
metal complex (Eqn 3) to form the corresponding aminium radical cation, denoted TPrA
•+
, 
which rapidly deprotonates to generate a highly reductive neutral α-amino alkyl radical, 
denoted TPrA
•
 (Eqn 4). The emitting species can then be generated by direct reaction 
between the oxidised metal complex and TPrA
•
 (Eqn 5), or via reduction of the metal 
complex by TPrA
•
 (Eqn 6), followed by annihilation of the oxidised and reduced metal 
complex (Eqn 7), or reaction of the reduced metal complex with TPrA
•+
 (Eqn 8). When 
comparing the potentials of the Ir complexes under investigation with those of TPrA (for 
which a peak potential was obtained at 0.43 V vs Fc
0/+





 (estimated at -2.1 V vs Fc
0/+[36]
), we find that Eqn 1-9 are not all energetically 
feasible for the Ir(III) complexes. Kim et al. attributed the intense ECL for Ir(pq)2(acac) 
with TPrA in acetonitrile in part to an efficient transfer of electrons in Eqn 3 and 6,
[2a]
 but 
Eqn 3 is not feasible for Ir(ppy)2(acac) and Ir(ppy)3, and Eqn 6 (and therefore also Eqn 7 
and 8) is not feasible for Ir(bt)2(acac), Ir(ppy)2(acac) and Ir(ppy)3. This, however, does not 
rule out the generation of ECL for these complexes, which can still occur via Eqns 1, 2, 4, 5 
and 9. 
For each feasible reaction pathway, the intensity of the ECL at any particular moment 
will be dependent on the rate that the emitting species is generated, which is dependent in 
part on the concentration of the reactants required for each step. The initial concentration of 
the metal complex and the co-reactant, and any experimental condition that influences the 
formation or stability of the intermediates, will influence the rate and relative contribution of 





configuration and dimensions, the solvent and electrolyte, and the magnitude and sequence 
of the applied potentials. For example, Zhou et al.
[9]
 found that the co-reactant ECL 
intensity of Ir(pq)2(acac) (relative to [Ru(bpy)3]
2+
 = 1) was 10.3 when the applied potential 
was stepped to 1.2 V (vs Fc
0/+
), but increased to 42.5 when the potential was instead scanned 
at 0.1 V s
-1
 from 0.4 V to 1.2 V, which would have generated different concentrations of the 
key intermediates of the reaction pathways. Although many of the above parameters are 
difficult to examine, we can manipulate the rate and contribution of the distinct reaction 
pathways by changing the concentrations of the two starting reactants (the metal complex 
and the co-reactant), which achieves similar outcomes in terms of the relative ECL 
intensities. 
Decreasing the concentration of the metal complex by two orders of magnitude (whilst 
also increasing the number of applied potential pulses to compensate for the reduced 
intensity) produced an increase in the relative intensity for Ir(bt)2(acac), but a decrease for 
the other iridium complexes. In contrast, decreasing the concentration of TPrA instead by 
two orders of magnitude gave a large increase for each Ir(C^N)2(acac) complex relative to 
that of [Ru(bpy)3]
2+
. Surprisingly, an even greater increase in the relative intensities of the 
Ir(C^N)2(acac) complexes was observed when decreasing the concentrations of both starting 
reactants (Conditions C in Table 2.2). Under these conditions, the relative intensity for 
Ir(pq)2(acac) (Is/Iref = 81.9) was now well above that reported by Zhou et al. (Is/Iref = 10) and 
similar to that reported by Kim et al. (Is/Iref = 77).
[2a]
 The intensities for Ir(bt)2(acac) (Is/Iref = 
26.8) and Ir(ppy)2(acac) (Is/Iref = 0.50) were also greatly increased compared to those 
obtained using Conditions A, but still below those reported by Zhou et al.
[10]
 (Is/Iref = 214 
and 0.96, respectively; Table 2.1). It should be noted that the concentrations of metal 
complex and TPrA used in the comparisons of ECL intensities by Kim et al.
[2a]
 and Zhou et 
al.
[9-10]
 were the same or similar to those that we used in Conditions A and B, and that we 





reaction intermediates to represent the possible effects of a range of other parameters as 
described above. 
(6) Spectral sensitivity. For complexes that have a similar spectral distribution, such as 
the orange-red light emitters: Ir(pq)2(acac) and [Ru(bpy)3]
2+
 (Figure 2.3), changes in the 
sensitivity of the photodetector over the wavelength range will have only minor effects on 
the relative intensity of the two complexes. In their evaluation of the Ir(pq)2(acac) complex, 
Kim et al.
[2a]
 obtained spectra with a Princeton Instruments charge-coupled device (CCD) 
camera and used the integrated area of the spectrum, whereas Zhou et al.
[9]
 used an 
unspecified PMT and integrated the signal over time. Although it could be expected that the 
CCD-based approach would provide a more consistent response over the wavelengths of the 
emission bands, this would be unlikely to explain the difference in their reported relative 
ECL intensities (Is/Iref of 77 and 10, respectively), due to the similarity of the emission 
wavelengths of the evaluated and reference complexes.  
However, the other three iridium complexes (which emit yellow or green light; Figure 
2.3) have a very different spectral distribution to that of [Ru(bpy)3]
2+
, and photodetectors 
that have much lower sensitivity in the red region of the spectrum (such as typical 
photomultiplier tubes) will give artificially high ECL intensities for these complexes relative 
to the [Ru(bpy)3]
2+
 reference. In their evaluation of the Ir(bt)2(acac) and Ir(ppy)2(acac) 
complexes, Zhou et al.
[10]
 used a MPI-A detector (Xi‘an Remax Electronics, China) for ECL 
measurement, and a Cary Eclipse fluorescence spectrophotometer to collect ECL spectra 
(without spectral correction). It is unclear which of these instruments was used to obtain the 
relative ECL intensities, but both contain a photomultiplier tube that will significantly less 
sensitive to the longer wavelengths of the reference complex. In the evaluation of Ir(ppy)3 
by Bruce et al.,
[3a]
 they refer to previous papers for the details of the instrumentation, which 
include a photomultiplier tube (Hamamatsu HC 135) for the measurement of ECL,
[37]
 and a 







 They do state, however, that the ECL efficiencies were obtained by the literature 
methods using [Ru(bpy)3]
2+
 (ECL = 1) as the standard, and cite a paper in which a charge-
coupled device (CCD) camera system was employed,
[38]
 but it is unclear which 
instrumentation was utilised for the evaluation of Ir(ppy)3. 
For our Conditions A-C, we used an Ocean Optics spectrometer that exhibits a much 
flatter spectral response of the region of interest than a PMT. This is seen in the similar max 
of the ECL spectra collected with the CCD spectrometer using a emission slit that provided 
a 6.5 nm resolution, with the respective photoluminescence spectra obtained with a Cary 
Eclipse with a emission bandpass of 5 nm, but only after correction of the 
photoluminescence spectra for the relative spectral sensitivity of the Eclipse (Table 2.2). 
The artificial hypsochromic shift of the uncorrected photoluminescence emission spectra 
(particularly Ir(pq)2(acac) and [Ru(bpy)3]
2+
) results from the poorer sensitivity of the 
instrument in the red end of the visible range. The Eclipse contains an extended-range multi-
alkali PMT (model R928; Hamamatsu), whereas typical bialkali PMTs are even less 
sensitive in that region.  
Conditions D were a repeat of Conditions C, except that we replaced the CCD 
spectrometer with a bialkali PMT (and the acquisition time was reduced). The relative ECL 
intensity of Ir(pq)2(acac) was similar, due to the similarity of its spectrum with that of the 
reference complex (Figure 2.3). However, the other three complexes emit light at shorter 
wavelengths, where the PMT is considerably more sensitive, resulting in an artificial 
increase in their measured ECL intensities relative to the [Ru(bpy)3]
2+
. Under these 
conditions, our Is/Iref value for Ir(bt)2(acac) was similar to that reported by Zhou et al.,
[10]
 but 








The evaluation of ECL Is/Iref is vulnerable to influence from a range of experimental 
parameters and in some cases, exceptional intensities reported for new complexes may have 
been derived using instrumental or chemical conditions that unintentionally disadvantaged 
the [Ru(bpy)3]
2+
 reference electrochemiluminophore, such as the electrochemical pulse 
sequence or the use of photodetectors that are less sensitive towards the red end of the 
spectrum where the reference complex emits light. However, although the wavelength 
sensitivity of typical photomultiplier tubes may bias the relative ECL intensities towards 
electrochemiluminophores that emit light near the blue-end of the spectrum, this comparison 
may be more practical if the final analytical instrumentation for which the detection system 
is used exhibits a similar bias. The light-producing reaction pathways identified for the 
classic [Ru(bpy)3]
2+
-TPrA co-reactant ECL system are not necessarily all feasible for novel 
electrochemiluminophores, which is an important consideration for the intended application. 
For example, in ECL-based immunodiagnostic systems in which the metal-complex labels 
are immobilised on magnetic microbeads held at an electrode surface, generation of ECL 
relies predominantly on the diffusion of oxidised TPrA radicals from the electrode to the 
bound electrochemiluminophores (i.e., Eqn 2, 4, 6 and 8).
[8]
 Eqn 6 and 8 are not feasible for 
most of the iridium complexes examined in this study. Conversely, in systems in which the 
metal complex is used for the ECL detection of an amine analyte,
[1b, 39]
 both species can be 
oxidised at the electrode surface and pathways analogous to Eqns 1-5 become more 
important. When comparing relative ECL intensities, it is therefore also important to 
consider the influence of experimental conditions on the relative contribution of multiple 







2.5 Experimental Section 
2.5.1 Chemicals 
 [Ru(bpy)3](PF6)2, Ir(ppy)3 and tetrabutylammonium hexafluorophosphate (TBAPF6) were 
purchased from Sigma-Aldrich (NSW, Australia). Ir(ppy)2(acac), Ir(bt)2(acac) and 
Ir(pq)2(acac) were purchased from SunaTech (Jiangsu, China). Acetonitrile was from 
Scharlau (Barcelona, Spain) and was distilled over calcium hydride under nitrogen. 
Bis(cyclopentadienyl)iron (ferrocene) was purchased from Strem Chemicals (MA, USA). 
2.5.2 Absorption and photoluminescence emission spectra 
 Absorption spectra were obtained using 1 cm pathlength quartz cells with a Cary 300 Bio 
UV/Vis spectrophotometer (Varian Australia, Vic., Australia). Photoluminescence spectra 
were collected using a 1cm quartz cuvette with a Cary Eclipse spectrofluorimeter (Varian 
Australia; 5 nm band pass, 1 nm data interval, PMT voltage: 800 V). Low temperature (77 
K) photoluminescence were obtained using an OptistatDN Variable Temperature Liquid 
Nitrogen Cryostat, with custom-made quartz sample holder. Room temperature and low 
temperature emission spectra were corrected for the change in instrument sensitivity across 
the wavelength range under examination, using a correction factor that was established 
using a quartz-halogen tungsten lamp of standard spectral irradiance (OL 245M, Optronic 
Laboratories, FL, USA), operated at 6.5A dc from a programmable current source (OL 65A, 
Optronic Laboratories). 
2.5.3 Electrochemistry and ECL 
 Cyclic voltammetry experiments were performed using an Autolab PGSTAT204 
potentiostat (Metrohm Autolab B.V., Netherlands). The electrochemical cell consisted of a 
cylindrical glass cell with a quartz base and Teflon cover with spill tray.
[40]





accessories were encased in a custom-built light-tight faraday cage. A conventional three-
electrode configuration was employed, consisting of a glassy carbon (3 mm diameter) 
working electrode shrouded in Teflon (CH Instruments, Austin, TX, USA), silver wire 
reference electrode and platinum wire counter electrode. The metal complexes were 
prepared at a concentration of 0.25 mM (with 0.1 M TBAPF6 as the supporting electrolyte) 
in freshly distilled acetonitrile. Prior to each experiment, the working electrode was polished 
using 0.3 mm and then 0.05 mm alumina with water on a felt pad, sonicated in MilliQ water 
(1 min), rinsed in freshly distilled acetonitrile and dried with a stream of N2. The solutions 
were degassed within the electrochemical cell for 15 min. CVs were collected at a scan rate 
of 0.1 V s
-1
. Electrochemical potentials were referenced to the ferrocene/ferrocenium (Fc
0/+
) 
couple measured in situ (1 mM) at the end of each experiment. ECL experiments were 
performed with an Autolab PGSTAT128N potentiostat. The light was detected using an 
Ocean Optics QE65Pro spectrometer with HC-1 (300 l/mm) grating and Hamamatsu S7031-
1006 back-thinned CCD (Quark Photonics, Vic., Australia) via optical fibre (1.0 m length, 
1.0 mm core diameter) and collimating lens (Ocean Optics 74-UV, 200-2000 nm), 
positioned under the transparent base of the electrochemical cell described above, and 
vertically aligned with the face of the working electrode that was 2 mm above the base of 
the cell. The spectrometer was fitted with a 200 μm entrance slit, which provided a spectral 
resolution of 6.5 nm (FWHM). Acquisition was triggered using a HR 4000 Break-Out box 
in conjunction with the potentiostat. The spectra were corrected for the change in instrument 
sensitivity across the wavelength range (including absorption from the optical fibre and the 
lens, features in the grating response and the CCD detector response) using correction 
factors (one for each slit width setting) that were established using an HL-2000 Ocean 
Optics light source directed onto a WS-1-SL diffuse white reflectance standard. The spectra 
were integrated to determine the relative ECL intensities. Prior to each experiment, solutions 





ECL Conditions A: Electrodes: glassy carbon working (3 mm diameter), Ag/AgCl 
low-leakage reference (Innovative Instruments, FL, USA), and platinum counter. 
Concentrations: 0.1 mM metal complex, 10 mM TPrA, and 0.1 M TBAPF6 supporting 
electrolyte. Applied potential: {Eox + 0.15 V} for 0.05 s at 10 Hz, 2 s acquisition time (total 
of 20 pulses). The entrance slit of the spectrometer was removed and replaced with a round 
SMA with no slit installed, to increase the proportion of light reaching the CCD detector, 
resulting in an effective spectral resolution of 30 nm (FWHM). 
ECL Conditions B: Electrodes: platinum working (2 mm diameter), silver wire reference, 
and platinum counter. Concentrations: 0.1 mM complex, 10 mM TPrA, and 0.1 M TBAPF6. 
Applied potential: {Eox + 0.50 V} for 0.05 s at 10 Hz, 10 s acquisition time (100 pulses). 
The spectrometer was fitted with a 200 μm entrance slit. 
ECL Conditions C: Electrodes: glassy carbon working (3 mm diameter), Ag/AgCl 
low-leakage reference, and platinum counter. Concentrations: 0.001 mM complex, 0.1 mM 
TPA, and 0.1 M TBAPF6. Applied potential: {Eox + 0.15 V} for 0.05 s at 10 Hz, 30 s 
acquisition time (300 pulses). The entrance slit of the spectrometer was removed and 
replaced with a round SMA as described above. 
ECL Conditions D: Electrodes: glassy carbon working (3 mm diameter), Ag/AgCl 
low-leakage reference, and platinum counter. Concentrations: 0.001 mM complex, 0.1 mM 
TPA, and 0.1 M TBAPF6. Applied potential: {Eox + 0.15 V} for 0.05 s at 10 Hz, 1 s 
acquisition time (10 pulses). The CCD spectrometer and fibre optic assembly were replaced 
with a bialkali photomultiplier tube (ET Enterprises model 9125SB; ETP, NSW, Australia), 
positioned directly under the transparent base of the electrochemical cell. The PMT was set 
at a constant voltage of 800 V from a stable power supply (PM20D, ETP) via a voltage 
divider (E637-09, ETP). The output from the PMT was connected to the auxiliary channel 





Computational methods. DFT calculations were carried out within the Gaussian 09 suite of 
programs.
[41]
 Ground and triplet state geometries were optimised in the absence of solvent 
with the mPW1PW91 functional
[42]
 in conjunction with the def2-SVP basis set and 
associated effective core potential.
[43]
 The mPW1PW91 functional has previously been 
demonstrated to yield reliable results for such systems.
[29, 33b, 44]
 Stationary points were 
characterised as minima by calculating the Hessian matrix analytically at the same level of 
theory. All structures are minima with no imaginary frequencies. Due to difficulties with the 
D3 symmetry triplet state of [Ru(bpy)3]
2+
, a previously reported
[45]
 B3PW91/LANL2DZ 
calculated structure was used. Single-point energy calculations (including molecular orbital 
(MO) energies) were carried out with the def2-TZVP basis set and core potential
[43]
 together 
















 Solvent effects were 
included for all single-point energy calculations with acetonitrile for consistency with the 
experimental system. The polarisable continuum model (PCM)
[52]
 self-consistent reaction 
field (SCRF) was used together with Truhlar‘s SMD solvent model.
[53]
 TD-DFT calculations 
of absorption and emission were calculated at the CAM-B3LYP/def2-SVP level of theory. 
Absorbance bands were calculated at the singlet-state optimised geometry; 20 singlet and 
triplet states were calculated with TD-DFT. An SCF convergence criterion of 10-8 a.u. was 
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The ECL efficiency (ECL; the photons emitted per charge transfer event, but often 
estimated as the coulometric efficiency, which is the photons generated per charge transfer 
event in the first potential step) is frequently reported for annihilation ECL systems 
relative to the absolute value for [Ru(bpy)3]
2+
 in acetonitrile of 0.050.
[7, 56]
 In the case of 
ECL under solely oxidative conditions with TPrA as co-reactant, the Faradaic charge 
transfer from the metal complex cannot be distinguished from that of the co-reactant, 
which is generally present in large excess. Moreover, the oxidised [Ru(bpy)3]
3+
 also reacts 
with the TPrA co-reactant, which regenerates [Ru(bpy)3]
3+
 in the ground electronic state 
(Eqn 3).
[57]
 Therefore, comparisons of co-reactant ECL are generally made by relative 
ECL intensities under identical conditions, using the [Ru(bpy)3]
2+
/TPrA system = 1 as an 
arbitrary reference. In some cases (e.g., 
[2a]
), this is still referred to as ECL efficiency 
(ECL), but it is more appropriate to use the term ‗relative co-reactant ECL intensity‘ (Is/Iref). 
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Four cationic heteroleptic iridium(III) complexes containing a 2,2′-bipyridine (bpy) ligand 
with one or two tetraethylene glycol (TEG) groups attached in the 4 or 4,4′ positions, were 
synthesized to create new water-soluble electrogenerated chemiluminescence (ECL) 
luminophores bearing a convenient point of attachment for the development of ECL-labels. 
The novel TEG-derivatised bipyridines were incorporated into [Ir(C^N)2(R-bpy-R′)]Cl 
complexes, where C^N = 2-phenylpyridine anion (ppy) or 2-phenylbenzo[d]thiazole anion 
(bt), through reaction with commercially available ([Ir(C^N)2(-Cl)]2 dimers. The novel 
[Ir(C^N)2(Me-bpy-TEG)]Cl and [Ir(C^N)2(TEG-bpy-TEG)]Cl complexes in aqueous 
solution largely retained the redox potentials and emission spectra of the parent 
[Ir(C^N)2(Me-bpy-Me)]PF6 (where Me-bpy-Me = 4,4′methyl-2,2′-bipyridine) luminophores 
in acetonitrile, and exhibited ECL intensities similar to those of [Ru(bpy)3]
2+
 and the 
analogous [Ir(C^N)2(pt-TEG]Cl complexes (where pt-TEG = 1-(TEG)-4-(2-pyridyl)-1,2,3-





, which can both be readily adapted for bioconjugation, reveals a viable strategy to 
create ECL-labels with different emission colours from the same commercial [Ir(ppy)2(-
Cl)]2 precursor. 
3.2 Introduction 
Electrogenerated chemiluminescence (ECL) is the process whereby electrochemically 
oxidised and reduced species undergo subsequent electron transfer reactions to produce 
electronically excited products that emit light.
1,2
 To date, the wide use of ECL across 
various fields
3,4
 has predominantly focused on ruthenium(II) complexes (particularly 
[Ru(bpy)3]
2+
, where bpy = 2,2′-bipyridine) as the luminophores.
5,6
 These complexes are 
highly soluble in buffered aqueous solution and generally produce ECL in the red/orange 





attracted enormous interest as alternative ECL luminophores to the conventional 
ruthenium(II) complexes due to their high luminescence efficiencies and wide range of 
emission colours,
7-10
 which not only enables the emission to be shifted into the region where 
commonly used photomultiplier tubes are most sensitive, but also creates new opportunities 
for tuneable light-emitting devices and simultaneous multi-analyte detection with spectrally 
distinct species. 
A great number of cyclometalated iridium(III) complexes have been synthesised and 
many have shown impressive annihilation and/or co-reactant ECL intensities in organic 
media.
9,11,12
 For example, we recently re-examined a promising series of heteroleptic 
iridium(III) complexes containing an acetylacetonate anion (acac) ligand, with several 
exhibiting much greater ECL intensities than [Ru(bpy)3]
2+
 (with tri-n-propylamine (TPrA) 




Nevertheless, very few of the iridium(III) complexes examined as ECL luminophores to 





As previously reported, the solubility can be improved by incorporating polar functional 




 on one or more ligands of the complex. Li 
et al.,
18
 for example, reported intense ECL from a water-soluble bis-cyclometalated 
iridium(III) complex incorporating a bpy ligand appended with two sugar moieties. 
Similarly, we utilised bathophenanthroline-disulfonate (BPS) as an ancillary ligand in to 
increase the solubility of the complexes in aqueous solution.
23,24
 However, in most cases, the 
dissolution of the complexes at relatively high concentrations often still required the 
addition of some acetonitrile to the aqueous solution, and these approaches do not provide a 
convenient means to incorporate the luminophores into ECL labels. We recently examined 





phenyl)pyridine anion (ppy) or 2-(2,4-difluorophenyl)pyridine anion (df-ppy), and pt = 4-(2-
pyridyl)-1,2,3-triazole) with either a tetraethylene glycol (TEG) or benzyl group attached to 
the triazole and/or methanesulfonate substituents on the ppy/df-ppy ligands.
25
 Although the 
TEG and methanesulfonate groups improved the solubility of the complexes in water, the 
complexes with the pt-TEG ligand (Figure 3.1) gave greater co-reactant ECL intensities 
with TPrA and provide a convenient point of attachment of functional groups for 
bioconjugation
26







Herein, we prepare four novel [Ir(C^N)2(N^N)]Cl complexes (Figure 3.2), where N^N is 
bpy with either one or two TEG groups attached in the 4 and 4′ positions (referred to 
hereafter as Me-bpy-TEG and TEG-bpy-TEG). Through the introduction of the TEG 
group(s) onto the commonly used bpy ligand, iridium(III) complexes previously studied in 
organic solvents can be examined in buffered aqueous solution. We incorporate the Me-bpy-
TEG and TEG-bpy-TEG ligands into heteroleptic iridium(III) complexes with ppy or 2-
phenylbenzo[d]thiazole anion (bt) ligands by reacting the bipyridine derivatives with 
commercially available ([Ir(C^N)2(-Cl)]2 dimers. We evaluate the influence of the TEG 
group(s) on the parent luminophore by comparing their spectroscopic and electrochemical 
properties with the corresponding [Ir(C^N)2(Me-bpy-Me)]
+
 complexes, and compare their 











Figure 3.2. Novel iridium(III) complexes containing a 2,2′-bipyridine ligand with one or two tetraethylene 
glycol groups. 
3.3 Results and Discussion 
To prepare the complexes shown in Figure 3.2, the chloro-bridged iridium(III) dimers 
([Ir(C^N)2(-Cl)]2, where C^N = ppy or bt) were initially reacted with bpy derivatives 
furnished with either one or two TEG groups (Me-bpy-TEG (L
1
) and TEG-bpy-TEG (L
2
)). 
The bipyridine ligands were prepared using TEG mono protected with a trityl group and 
functionalised using tosyl chloride to afford a suitable leaving group to react with hydroxyl 











Trifluoroacetic acid was used to deprotect L
1





 proved difficult to isolate by this method, so L
2
Trt2 was used directly to form 
iridium(III) dimers. The trityl groups were then removed from the bis-TEGTrt2 complexes 
to give [Ir(C^N2)(TEG-bpy-TEG)]Cl by stirring in methanolic hydrochloric acid afforded 
by addition of acetyl chloride to methanol. Precipitation of complexes from 
dichloromethane occurred upon addition of diethyl ether allowing isolation by 
centrifugation. The [Ir(C^N2)(Me-bpy-TEG)]Cl and [Ir(C^N2)(TEG-bpy-TEG)]Cl 
complexes were sufficiently soluble for the preparation of aqueous stock solutions at 1 mM. 
3.3.1 UV-Vis absorption and photoluminescence spectra 
UV-vis absorption spectra of the four novel iridium(III) complexes and [Ru(bpy)3]
2+
 were 
examined at 10 µM in water (Figure 3.3) and the peak maxima were compared to the 
[Ir(C^N)2(Me-bpy-Me)]
+
 analogues at the same concentration in acetonitrile (Table 3.1). 
The two [Ir(C^N)2(TEG-bpy-TEG)]
+







 counterparts in water, although the absorbances for the 
[Ir(C^N)2(TEG-bpy-TEG)]
+
 species were higher. In general, complexes with the ppy ligands 
exhibited strong ππ* LC transitions ( = 240–300 nm), while the complexes with bt 
ligands exhibited more prominent charge-transfer ( = 300 nm and above).
27
 The peak 
maxima were somewhat similar to those of corresponding [Ir(C^N)2(Me-bpy-Me)]
+
 
complexes in acetonitrile (Table 3.1).  
 
Figure 3.3. UV-vis absorbance spectra obtained for [Ir(bt)2(TEG-bpy-TEG)]
+
 (grey line), [Ir(bt)2(Me-bpy-
TEG)]
+
 (blue line), [Ir(ppy)2(TEG-bpy-TEG)]
+
 (orange line), [Ir(ppy)2(Me-bpy-TEG)]
+
 (yellow line) and 
[Ru(bpy)3]
2+
 (green line), at a concentration of 10 µM in water at ambient temperature. 
The photoluminescence spectra of the four novel complexes ([Ir(ppy)2(TEG-bpy-TEG)]Cl, 
[Ir(bt)2(TEG-bpy-TEG)]Cl, [Ir(ppy)2(Me-bpy-TEG)]Cl and [Ir(bt)2(Me-bpy-TEG)]Cl) and 
the archetype ECL metal complex [Ru(bpy)3]
2+
 were initially examined at room temperature 
at 10 µM in aqueous solution (Figure 3.4). The peak maxima were also compared to those 
of the previously reported Ir(ppy)2(Me-bpy-Me)]PF6 and [Ir(bt)2(Me-bpy-Me)]PF6 
complexes
28-30























Table 3.1. UV-Vis absorbance and luminescence peak maxima of the metal complexes at room temperature 
and low temperature. 
Complex abs (nm) em (r.t.)
a
 / nm em (85 K)
b
 / nm 
[Ir(bt)2(TEG-bpy-TEG)]Cl 258, 310, ~360(br) 531, 568, 619 517, 557, 599 
[Ir(bt)2(Me-bpy-TEG)]Cl 214, 258, 307, ~400(br) 531, 567, 613  
[Ir(bt)2(Me-bpy-Me)]PF6 256, 408(br), 468(br) 528, 568, 615 516, 558, 606 
[Ir(ppy)2(TEG-bpy-TEG)]Cl 213, 316, ~420(br) 628 471, 511(sh), 533 
[Ir(ppy)2(Me-bpy-TEG)]Cl 213, 318, ~420(br) 623  
[Ir(ppy)2(Me-bpy-Me)]PF6 208, 269, 321, 411(br) 590 473, 511, 533 
[Ru(bpy)3]Cl2 215, 290, 445 629  
a
10 M in water, except for the two [Ir(C^N)2(Me-bpy-Me)]PF6 complexes where were prepared at 10 M in 
acetonitrile. 
b
5 M in 4:1 (v/v) ethanol:methanol. sh = shoulder. br = broad. 
 
Figure 3.4. Normalised luminescence emission spectra obtained for [Ir(bt)2(TEG-bpy-TEG)]
+
 (grey line), 
[Ir(bt)2(Me-bpy-TEG)]
+
 (blue line), [Ir(ppy)2(TEG-bpy-TEG)]
+
 (orange line), and [Ir(ppy)2(Me-bpy-TEG)]
+
 
(yellow line), at 10 µM in water at ambient temperature. 
The three [Ir(bt)2(N^N)]
+
 complexes exhibited similar peak maxima (Table 3.1). There were 
differences in the relatively intensity of the three major emission bands (Figure 3.4), but the 
























in acetonitrile were visually a similar green (Figure 3.5, second, fourth and seventh cuvette 
from the left). The luminescence of heteroleptic iridium(III) complexes has previously been 
attributed to mixed ligand-centred (
3





 The vibronic fine structure observed in the emission 
spectra of the bt complexes are consistent with a significant * contribution to the 
luminescence. 
The two novel [Ir(ppy)2(N^N)]
+
 complexes in water exhibited single broad emission 
peaks (Figure 3.4) that were red-shifted from that of [Ir(ppy)2(Me-bpy-Me)]
+
 in acetonitrile 
by over 30 nm (Table 3.1). The closely related [Ir(ppy)2(bpy)]
+
 complex has previously 
been shown to exhibit solvatochromic shifts
32,33 34
 due to an unusually high barrier for 
relaxation to the lowest energy excited state (
3
MLCT(bpy)), where contributions from higher 
energy bands are promoted in less polar solvents. The absence of a red-shift in the 
[Ir(bt)2(N^N)]
+
 complexes and the similar peak maxima for the two [Ir(ppy)2(N^N)]
+
 
complexes with either one or two TEG groups, indicates that the red-shift in these 
complexes can be attributed to a similar solvatochromic effect. It is possible that some 
aggregation of the complexes occurs, considering they possess a hydrophilic core with 
highly polar side chain, which may enhance this effect.
33







 complexes in 
water (Figure 3.5) compared to the [Ir(ppy)2(Me-bpy-Me)]
+
 in acetonitrile, under a UV lamp, 
are in part due to the lower sensitivity of the camera (and eye) at 623-629 nm compared to 
590 nm. Quantitative comparisons of photoluminescence intensities or quantum yields were 








Figure 3.5. Left: [Ir(ppy)2(TEG-bpy-TEG)]Cl, [Ir(bt)2(TEG-bpy-TEG)]Cl, [Ir(ppy)2(Me-bpy-TEG)]Cl, 
[Ir(bt)2(Me-bpy-TEG)]Cl and [Ru(bpy)3]Cl2, in water at a concentration of 0.1 mM. Right: Ir(ppy)2(Me-bpy-
Me)]PF6 and [Ir(bt)2(Me-bpy-Me)]PF6 at 0.1 mM in acetonitrile. 
The photoluminescence spectra of the two [Ir(C^N)2(TEG-bpy-TEG)]
+
 complexes (where 
C^N is bt or ppy) were examined at 85 K (Figure 3.6). The solutions were prepared in 4:1 




Figure 3.6. Normalised photoluminescence emission spectra obtained for [Ir(bt)2(TEG-bpy-TEG)]
+
 (grey line), 
and [Ir(ppy)2(TEG-bpy-TEG)]
+
 (orange line), at 5 µM in 4:1 (v/v) ethanol:methanol at low-temperature (85 K). 
Low-temperature spectra generally show greater detail of vibrational energy levels, and 
allow for a more accurate estimation of the energy gap (E0-0) between the lowest vibrational 
levels of the ground and lowest excited state.
35
 The low temperature spectrum for 
[Ir(bt)2(TEG-bpy-TEG)]
+
 is highly structured (Figure 3.6), even more than at room 
temperature (Figure 3.4), and was in close agreement with that of [Ir(bt)2(Me-bpy-Me)]
+
 
























broad emission spectrum produced by [Ir(ppy)2(TEG-bpy-TEG)]
+
 at low temperature is 
unusual for an iridium(III) complex, but the peak maxima are nearly identical to those of 
[Ir(ppy)2(Me-bpy-Me)]
+
, and the highest energy band at 471/473 nm is well over 100 nm 
blue-shifted from the room-temperature maxima. This is further confirmation that, like 
[Ir(ppy)2(bpy)]
+
, these complexes exhibit simultaneous emissions from multiple bands. 
Although this complicates the approximation of the E0-0, comparison with previous 




 enables it to be also estimated as 
2.4 eV. 
3.3.2 Voltammetry 
Cyclic voltammetry (CV) experiments were initially conducted using buffered aqueous 
solutions to mimic the analytical conditions for which they were designed (Figure 3.7, black 
lines). No reverse peaks are seen as the oxidation of the four novel complexes appears 
irreversible in an aqueous environment, which is most likely due to the tendency of iridium 
complexes to generate electrochemically unstable oxidised or reduced species, in addition 
the poor solubility of the complexes and/or reaction products in aqueous solution that can 
cause electrode fouling. This behavior has been observed for various iridium complexes in 
aqueous solutions in the literature, thus was not investigated in detail. The electrochemical 
reversibility of the luminophore is important for intense and efficient ECL, as the 
luminophore can participate in the light emitting process many times in a single potential 
pulse or CV scan (under conditions of excess co-reactant). The electrochemical 
irreversibility of the iridium complexes studied is most likely a factor in the relatively weak 
light emission observed, with respect to the complexes QY and the standard Ru(bpy)3
2+
 
complex. In the Chapter 4, Ru(bpy)3
2+ 
based assays and iridium-complex based ECL assays 
were compared, and the experiments further demonstrated that the irreversibility of iridium 





voltammetry (CV) experiments and square wave voltammetry (swv) were both conducted to 
get the positions of the oxidation peaks. The shape of the cyclic voltammograms made 
assigning peak potentials difficult, so squarewave voltammetry (Figure 3.7, orange lines) 
was also conducted to inform the positions of the oxidation peaks (Table 3.3). 
 
Figure 3.7. Squarewave voltammetry,and cyclic voltammetry traces obtained for the four novel iridium(III) 
complexes at a concentration of 1 mM. 0.005 V step, 0.02 V amplitude, 25 Hz, scan rate: 0.1 V/s. The 
electrochemical parameters were determined by using a three-electrode system. All solutions were prepared in 
either deionised water with a 0.1 M phosphate buffer electrolyte adjusted to pH 7.5, or dry acetonitrile with 0.1 
M TBAPF6 electrolyte, and were degassed with nitrogen for 5 min. Glass carbon electrode was used as 
working electrode, Pt wire and either a ‗leakless‘ Ag/AgCl reference or Ag wire pseudo-reference were used 
as counter electrode, and reference electrode.  
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Table 3.3. Oxidation and reduction potentials of the complexes.  
Complex  Ep
ox















[Ir(bt)2(TEG-bpy-TEG)]Cl 1.25 1.02 -1.73 
[Ir(bt)2(Me-bpy-TEG)]Cl 1.22 1.00 -1.79 
[Ir(bt)2(Me-bpy-Me)]PF6 - 1.03 -1.79 
[Ir(ppy)2(TEG-bpy-TEG)]Cl 0.84, 1.18 0.86 -1.79 
[Ir(ppy)2(Me-bpy-TEG)]Cl 0.73, 1.04 0.86 -1.81 
[Ir(ppy)2(Me-bpy-Me)]PF6 - 0.85 -1.86 
[Ru(bpy)3](PF6)2 - 0.89 -1.73 
a
1 mM in buffered aqueous solution. 
b
0.1 mM in acetonitrile with 0.1 M TBAPF6 electrolyte. 
The mechanism of co-reactant ECL depends on both the oxidation and reduction of the 
metal complex, so it is important that both are characterised. The reduction of the complexes, 
however, is obscured in voltammetric experiments due to the reduction of solvent, so these 
potentials were determined in acetonitrile and referenced to the ferrocenium/ferrocene 
couple (Figure 3.8). This internal electrochemical reference is more reliable that the 
reference electrode potential and provides a more accurate comparison to the previously 
reported potentials of related iridium complexes that were not sufficiently soluble in an 
aqueous buffer (Table 3.3). The additional oxidation peak at ~0.6 V (vs Fc
+/0
) in the traces 
in Figure 3.8 arises from the chloride counter ion of these complexes. This peak could be 
removed by converting the compounds to their hexafluorophosphate salts, but this was 
deemed unnecessary for the project. 
The values obtained for the three [Ir(bt)2(N^N)]
+
 complexes were very similar 
(oxidation potentials within 30 mV and reduction potentials within 60 mV). Those obtained 
for the three [Ir(ppy)2(N^N)]
+





10 mV and reduction potentials within 70 mV). The oxidation peaks can be attributed to the 
metal-centered oxidation process, and the reduction peaks can be attributed to ligand-
centered reduction processes. The similarity of these potentials indicates that the presence of 
TEG moieties on the bpy ligand has little effect on the electrochemical properties of the 
complex. 
 
Figure 3.8. Cyclic voltammetry traces for the four novel iridium(III) complexes at 1 mM in acetonitrile with 
0.1 M TBAPF6 electrolyte. 
3.3.3 Electrogenerated chemiluminescence 
The ECL intensities of the [Ir(C^N)2(N^N)]
+
 complexes containing a Me-bpy-TEG or TEG-
bpy-TEG ligand in buffered aqueous solution using TPrA as a co-reactant were compared 
with those of the analogous complexes with pt-TEG ligand (Note: the synthesis and 




 complex is included in the 
following chapter of this thesis). To remove the bias of the large differences in sensitivity of 
typical photomultiplier tubes towards the emission wavelengths of these complexes, we 
used the integrated area of ECL spectra collected using a CCD spectrometer for these 
comparisons. Figure 3.9 shows the ECL intensities relative to that of the [Ru(bpy)3]
2+
 
complex under the same conditions.  
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The co-reactant ECL intensities of iridium(III) complexes relative to [Ru(bpy)3]
2+
 can 
be highly dependent on instrumental and chemical conditions.
13,25
 Using an applied potential 
pulse 0.1 s, the co-reactant ECL intensities of most of the [Ir(C^N)2(N^N)]
+
 complexes were 
greater than that of [Ru(bpy)3]
2+
 (Figure 3.9a), but when the pulse time was increased to 0.5 
s (Figure 3.9b) the intensities were below that of [Ru(bpy)3]
2+
. Nevertheless, the trend in 
intensities between the [Ir(C^N)2(N^N)]
+
 complexes was similar at the two pulse times. The 
intensities of the [Ir(C^N)2(Me-bpy-TEG)]
+
 complexes were between 1.2- and 2.2-fold 






Figure 3.9. Relative ECL intensities (integrated area of ECL spectra obtained using a CCD spectrometer) of 
water-soluble [Ir(C^N)2(N^N)]
+
 complexes at 10 M in a 0.1 M phosphate buffer with 10 mM TPrA, using an 
applied potential of Ep
ox
 + 0.1 V for each complex for (a) 0.1 s or (b) 0.5 s. 











































































spectra (Figure 3.4), taking into account the lower resolution of the CCD spectrometer used 
to collect the ECL spectra. The spectral distribution of [Ir(bt)2(pt-TEG)]
+





, but emission of [Ir(ppy)2(pt-TEG)]
+
 





(Figure 3.10). One practical outcome of this shift is that much greater ECL intensities will 
be measured with [Ir(ppy)2(pt-TEG)]
+





 when using photomultiplier tubes that are much more sensitive 
towards shorter wavelengths of light within the visible region. On the other hand, as both 
the Me-bpy-TEG and pt-TEG ligands can be readily adapted for bioconjugation, this shows 
a viable strategy to create two ECL-labels with distinctly different emission colours from 
the same commercial [Ir(ppy)2(-Cl)]2 dimer that provide similar ECL intensities using a 
CCD spectrometer to distinguish their emissions. 
 
Figure 3.10. Normalised ECL spectra obtained for [Ir(bt)2(TEG-bpy-TEG)]
+
 (grey line), [Ir(bt)2(Me-bpy-
TEG)]
+
 (blue line), [Ir(bt)2(pt-TEG)]
+
 (purple line), [Ir(ppy)2(TEG-bpy-TEG)]
+
 (orange line), and 
[Ir(ppy)2(Me-bpy-TEG)]
+
 (yellow line) and [Ir(ppy)2(pt-TEG)]
+
 (green line) at 10 µM in 0.1 M phosphate 
buffer with 10 mM TPrA co-reactant, using an applied potential of Ep
ox







Four [Ir(C^N)2(N^N)]Cl complexes in which C^N = ppy or bt, and C^N = bpy with either 
one or two TEG groups attached in the 4 and 4′ positions, were successfully synthesised 
with acceptable yields for all reaction steps. Characterisation of the complexes showed that 
the introduction of one or two the TEG groups to the bpy ligand of iridium(III) complexes is 
a viable strategy to enhance their solubility in aqueous solution while retaining the 
electrochemical and spectroscopic properties of the parent luminophore, and providing a 
convenient attachment point for the future development of ECL labels for bioconjugation in 
affinity based assays. 
3.5 Experimental 
3.5.1 Chemicals 
Tris(2,2′-bipyridine)ruthenium(II) hexafluorophosphate ([Ru(bpy)3](PF6)2), 
tetrabutylammonium hexafluorophosphate (TBAPF6; electrochemical grade) was purchased 
from Sigma-Aldrich (NSW, Australia). Bis(cyclopentadienyl)iron (ferrocene; Fc) was 
purchased from Strem Chemicals (MA, USA). Reagents and solvents were purchased from 
various commercial sources and used without further purification. The iridium(III) dimer 
precursors were purchased from SunaTech (China). NMR spectra were acquired on a 
Bruker Biospin AV400 spectrometer or a Bruker Biospin AV500 spectrometer. 
1
H NMR 




H} NMR spectra were acquired at 
100 MHz or 126 MHz. All NMR spectra were recorded at 298 K. Chemical shifts were 










Trityl chloride (4.85 g, 17.4 mmol) in dichloromethane (80 mL) was added dropwise to a 
mixture of tetraethylene glycol (33.1 g, 170.6 mmol) and triethylamine (8 mL, 57.4 mmol) 
in dichloromethane (200 mL). After the addition was complete, the reaction mixture was 
stirred for 2 days at ambient temperature. The mixture was washed with saturated sodium 
carbonate (200 mL), dH2O (3 × 200 mL) then brine (200 mL) before being dried (MgSO4). 
The solvent was removed under reduced pressure to afford a yellow oil (6.95 g, 15.9 mmol, 
91%). 
1
H NMR (500 MHz; CD3CN):  7.47-7.44 (m, 6H), 7.34-7.31 (m, 6H), 7.28-7.24 (m, 




H} NMR (101 
MHz, CD3CN)  145.27, 129.55, 128.82, 128.05, 87.35, 73.30, 71.43, 71.27, 71.24, 71.12, 
71.09, 64.39, 61.95. 
1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-methylbenzenesulfonate 
 
A mixture of 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-ol (3.51 g, 8.1 mmol) in 
tetrahydrofuran (100 mL) was cooled to 0°C. Sodium hydroxide (8 M, 25 mL) was added 
followed by dropwise addition of tosylchloride (1.85 g, 9.7 mmol) in tetrahydrofuran 
(80mL). The reaction was left to warm to ambient temperature and stirred overnight. Brine 
(100 mL) was added to the mixture which was then extracted with dichloromethane (3 × 75 
mL). The combined organic extracts were dried (MgSO4) and the solvent was removed 
under reduced pressure to afford a yellow oil (4.58 g, 7.6 mmol, 91%). 
1
H NMR (500 MHz; 





7.27-7.23 (m, 3H), 4.08-4.06 (m, 2H), 3.61-3.54 (m, 8H), 3.53-3.51 (m, 2H), 3.49-3.47 (m, 




H} NMR (101 MHz, CD3CN)  146.34, 145.26, 
133.79, 131.00, 129.54, 128.82, 128.77, 128.05, 87.34, 71.42, 71.25, 71.20, 71.11, 70.94, 





A mixture of 4-(hydroxymethyl)-4′-methyl-2,2′-bipyridine (458 mg, 2.3 mmol) and sodium 
hydride (60% oil dispersion, 190 mg, 4.8 mmol) was heated at reflux in tetrahydrofuran (dry, 
50 mL). After 1.5 h, 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-
methylbenzenesulfonate (1662 mg, 2.8 mmol) was added and the reaction mixture was 
stirred at reflux for 20 h. The reaction mixture was cooled to ambient temperature before 
methanol was added to quench excess sodium hydride. A solid was observed and remove by 
filtration then the solvent was removed from the filtrate under reduced pressure. The residue 
was purified by flash chromatography (SiO2, 050% ethyl acetate in dichloromethane) to 
afford the product as a viscous yellow oil after removal of the solvent under reduced 
pressure (940 mg, 1.5 mmol, 65%).
1
H NMR (400 MHz; CD3CN):  8.57 (d, J = 4.9, 1H), 
8.49 (d, J = 5.0, 1H), 8.36 (s, 1H), 8.26 (s, 1H), 7.44 (m, 6H), 7.31 (m, 7H), 7.30 (m, 4H), 




H} NMR (101 MHz, 
CD3CN)  156.97, 156.57, 150.10, 150.02, 149.95, 149.27, 145.20, 129.47, 128.74, 127.97, 










A mixture of 4-methyl-4′-(15,15,15-triphenyl-2,5,8,11,14-pentaoxapentadecyl)-2,2′-
bipyridine (940 mg, 1.52 mmol) and trifluoroacetic acid (2 mL) was set stirring in 
dichloromethane (20 mL) at ambient temperature. After 1 h the mixture was extracted with 
1 M hydrochloric acid (3 × 30 mL) and the combined aqueous extracts were adjusted to pH 
9 by careful addition of solid potassium carbonate. The aqueous phase was then extracted 
with ethyl acetate (3 × 30 mL) and the combined organic extracts were dried and the solvent 
removed under reduced pressure to afford a yellow oil (229 mg, 0.61 mmol, 40%). 
1
H NMR 
(400 MHz, CD3CN)  8.61 (dd, J = 5.0, 0.7 Hz, 1H), 8.51 (dd, J = 5.0, 0.5 Hz, 1H), 8.35 (dd, 
J = 1.6, 0.8 Hz, 1H), 8.28 – 8.24 (m, 1H), 7.34 (ddd, J = 7.3, 4.0, 3.2 Hz, 1H), 7.26 – 7.21 




H} NMR (101 MHz, CD3CN)  157.01, 156.57, 150.19, 149.93, 149.80, 149.43, 
128.65, 125.78, 122.95, 122.45, 119.71, 73.10, 72.04, 70.97, 70.91, 70.88, 70.84, 70.74, 
61.69, 21.20. 
Synthesis of 4,4′-bis(ethoxycarbonyl)-2,2′-bipyridine 
 
A mixture of 2,2′-bipyridine-4,4′-dicarboxylic acid (5.08 g, 20.8 mmol) and sulphuric acid 
(10 mL) was heated at reflux in ethanol (200 mL). After 24 h the reaction mixture was 
cooled to ambient temperature then poured into ice water (100 mL) and adjusting to pH 7 by 
addition of solid potassium carbonate. The solvent volume was lessened under reduced 





was washed with dH2O (3 × 100 mL) then brine (100 mL) before drying (MgSO4) and 
removal of the solvent a under reduced pressure to afford a colourless solid (4.85 g, 16.1 
mmol, 77%). 1H NMR (400 MHz, CDCl3)  8.95 (s, 1H), 8.86 (s, 1H), 7.91 (d, J = 4.2 Hz, 




H} NMR (101 MHz, CDCl3)  
165.24, 156.46, 150.15, 139.22, 123.47, 120.79, 62.09, 14.42. 
Synthesis of 4,4′-bis(hydroxymethyl)-2,2′-bipyridine 
 
A mixture of 4,4′-bis(ethoxycarbonyl)-2,2′-bipyridine (2.80 g, 9.3 mmol) in ethanol (150 
mL) was set stirring and sodium borohydride (3.83 g, 85 mmol) was added portion-wise. 
After stirring for 16 h at ambient temperature excess sodium borohydride was quenched by 
addition of an aqueous solution of saturated ammonium chloride. The reaction mixture was 
filtered to remove solids and the solvent volume was lessened under reduced pressure. The 
mixture was washed with ethyl acetate (6 × 100 mL) and the combined organic extracts 
were washed with brine. The organic phase was dried (MgSO4) and the solvent removed 
under reduced pressure to afford a colourless solid (1.51 g, 7.0 mmol, 75%). 
1
H NMR (400 
MHz, DMSO)  8.60 (d, J = 5.0 Hz, 1H), 8.39 (s, 1H), 7.37 (d, J = 4.9 Hz, 1H), 5.52 (t, J = 
5.8 Hz, 1H), 4.63 (d, J = 5.7 Hz, 2H). 
13
C NMR (101 MHz, DMSO)  155.21, 152.83, 









A mixture of 4,4′-bis(hydroxymethyl)-2,2′-bipyridine (254 mg, 1.2 mmol) and sodium 
hydride (60% oil dispersion, 70 mg, 1.8 mmol) was heated at reflux in tetrahydrofuran (dry, 
50 mL). After 1.5 h, 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-yl 4-
methylbenzenesulfonate (1693 mg, 2.9 mmol) was added and the reaction mixture was 
stirred at reflux for 20 h. The reaction mixture was cooled to ambient temperature before 
methanol was added to quench residual sodium hydride. The reaction mixture was filtered to 
remove any solids and the solvent was removed under reduced pressure. The resultant 
residue was taken up in ethyl acetate (100 mL) and washed with dH2O (3 × 100 mL) then 
brine (100 mL). The organic phase was dried (MgSO4) and the solvent was removed under 
reduced pressure then the residue was purified by column chromatography (SiO2, 010% 
methanol in ethyl acetate) to afford a yellow oil (939 mg, 0.89 mmol, 74%). 
1
H NMR (400 
MHz, CD3CN)  8.57 (d, 2H), 8.37 (d, 2H), 7.49 – 7.40 (m, 12H), 7.32 (s, 2H), 7.32 – 7.27 




H} NMR (126 MHz, CD3CN)  156.83, 150.16, 145.23, 129.51, 128.79, 128.01, 
122.92, 119.60, 87.29, 70.99, 64.36, 60.95. 
General method for synthesis of iridium complexes  
Approximately one molar equivalent of chloro-bridged iridium dimer and two equivalents 
of ligand were added to a flask. A solvent mixture of dichloromethane and methanol (1:1 
v/v) was added and the mixture was sparged with N2 for 20 min then sealed, shielded from 
light and heated at 50°C for 20 h. Any solid that remained in the reaction mixture was 
removed by centrifuge and the supernatant was filtered through filter aid (celite). The 
solvent was removed under reduced pressure and the residue was taken up in a minimum of 
dichloromethane and a precipitate was formed after addition of diethyl ether. The precipitate 







The dimer [Ir(bt)2(-Cl)]2 (239 mg, 0.18 mmol) and L
1
 (132 mg, 0.35 mmol) were reacted 
according to the general method. The product was isolated as an orange powder (250 mg, 
0.24 mmol, 69%). 
1
H NMR (500 MHz, CD3CN)  8.52 (s, 1H), 8.44 (s, 1H), 8.03 (t, J = 7.1 
Hz, 3H), 7.92 (dd, J = 8.5, 7.0 Hz, 3H), 7.52 (d, J = 5.6 Hz, 1H), 7.38 (t, J = 7.4 Hz, 3H), 
7.12 (dt, J = 21.1, 7.6 Hz, 4H), 6.87 (t, J = 7.5 Hz, 2H), 6.40 (dd, J = 7.5, 4.9 Hz, 2H), 6.24 
(dd, J = 8.4, 4.2 Hz, 2H), 4.77 (s, 2H), 3.65 (ddd, J = 8.4, 6.4, 3.5 Hz, 4H), 3.55 – 3.44 (m, 




H} NMR (126 MHz, CD3CN)  182.47, 
182.44, 157.42, 156.99, 154.26, 153.66, 151.66, 151.64, 151.57, 151.10, 150.13, 150.11, 
141.47, 141.43, 134.19, 134.15, 132.84, 132.67, 132.63, 130.38, 129.05, 129.00, 127.75, 
127.20, 127.04, 127.02, 126.39, 124.94, 124.12, 122.93, 73.28, 71.35, 71.15, 71.11, 71.07, 
71.05, 70.99, 70.96, 61.76, 21.49. 
[Ir(ppy)2(Me-bpy-TEG)]Cl 
 
The dimer [Ir(ppy)2(-Cl)]2 (193 mg, 0.18 mmol) and L
1
 (128 mg, 0.34 mmol) were reacted 
according to the general method. The product was isolated as a yellow powder (243 mg, 
0.27 mmol, 79%). 
1
H NMR (500 MHz, CD3CN)  8.58 (s, 1H), 8.50 (s, 1H), 8.06 (d, J = 8.1 
Hz, 2H), 7.89 (d, J = 5.6 Hz, 1H), 7.86 – 7.76 (m, J = 11.7, 6.1 Hz, 5H), 7.61 (dd, J = 12.2, 





(t, J = 7.4 Hz, 2H), 6.27 (dd, J = 7.5, 4.4 Hz, 2H), 4.75 (s, 2H), 3.72 – 3.63 (m, 4H), 3.59 – 
3.45 (m, J = 29.1, 5.3 Hz, 10H), 3.41 (t, J = 4.9 Hz, 2H), 2.53 (s, 3H). 13C NMR (126 MHz, 
CD3CN)  168.44, 168.41, 156.82, 156.39, 153.53, 152.98, 151.65, 151.61, 151.18, 150.73, 
150.13, 150.05, 145.07, 145.03, 139.43, 132.53, 132.50, 131.29, 131.28, 129.98, 126.87, 
126.52, 125.83, 125.81, 124.44, 124.43, 123.38, 123.37, 123.17, 120.80, 120.77, 73.29, 





The dimer [Ir(ppy)2(-Cl)]2 (71.7 mg, 0.0.067 mmol) and L
2
Trt2 (118 mg, 0.112 mmol) 
were reacted according to the general method. The product was isolated as a yellow powder 
(106 mg, 0.067 mmol, 60%). 
1
H NMR (400 MHz, CD3CN)  8.56 – 8.42 (m, 4H), 8.03 (dd, 
6H), 7.97 – 7.73 (m, 8H), 7.60 – 7.52 (m, 12H), 7.41 – 7.18 (m, 12H), 7.08 – 6.85 (m, 6H), 




H} NMR (126 MHz, CD3CN)  151.21, 





The dimer [Ir(bt)2(-Cl)]2 (111 mg, 0.086 mmol) and L
2
Trt2 (162 mg, 0.15 mmol) were 
reacted as per the general method. The product was isolated as an orange powder (168 mg, 
0.099 mmol, 66%). 
1
H NMR (400 MHz, CD3CN)  8.48 (s, 2H), 8.04 (dd, 4H), 7.92 (d, 2H), 









H} NMR (126 MHz, CD3
156.81, 153.84, 151.16, 149.68, 141.01, 133.74, 132.44, 132.22, 128.62, 127.34, 126.86, 
126.61, 124.50, 123.74, 122.64, 72.81, 70.43, 61.41. 
General procedure for trityl deprotection of [Ir(C^N)2(L
2
Trt2)]Cl complexes  
The trityl protected complex was set stirring in methanol (15 mL) and the mixture was 
cooled to 0°C before acetyl chloride (0.4 mL) was added. The mixture stirred and allowed to 
warm to ambient temperature for a total of 10 h. The solvent was removed under reduced 
pressure and the residue was taken up a in a minimum of dichloromethane. A precipitate 
was formed upon addition of diethyl ether which was isolated by centrifugation and washed 





Trt2)]Cl (90 mg, 0.057 mmol) was reacted according to the general 
procedure for trityl deprotection to afford a yellow solid (51 mg, 0.046 mmol, 81%). 
1
H 
NMR (400 MHz, CD3CN)  8.52 (s, 2H), 8.03 (dd, 2H), 7.97 – 7.77 (m, 6H), 7.62 (d, 2H), 





H} NMR (126 MHz, CD3







The complex [Ir(bt)2(bpy-(TEG-Trt)2)]Cl (101 mg, 0.059 mmol) was reacted according to 
the general procedure for trityl deprotection to afford an orange solid (53 mg, .043 mmol, 
73%). 
1
H NMR (400 MHz, CD3CN)  8.47 (s, 2H), 8.16 – 8.00 (m, 4H), 7.92 (d, 2H), 7.56 
(t, 2H), 7.39 (t, 1H), 7.12 (dd, 4H), 6.88 (t, 2H), 6.40 (d, 2H), 6.24 (d, 2H), 4.76 (d, 4H), 




H} NMR (126 MHz, CD3
153.84, 151.16, 149.68, 141.01, 133.74, 132.33, 128.62, 127.34, 126.74, 124.50, 123.74, 
122.64, 72.81, 70.87, 61.41. 
3.5.3 Absorbance and emission spectra 
Absorbance spectra were obtained using a Cary 300 Bio UV/Vis spectrophotometer 
(Agilent, USA). Quartz cuvettes with a path length of 1 cm were used for all measurements. 
All room temperature photoluminescence spectra were collected using a Cary Eclipse 
spectrofluorometer (5 nm band pass, 1 nm data interval, PMT: 600 V). Quartz cuvettes with 
a path length of 1 cm were used for all measurements. Low temperature spectra were 
obtained using an OptistatDN Variable Temperature Liquid Nitrogen Cryostat (Oxford 
Instruments) with custom-made quartz sample holder, placed within the Eclipse sample 
chamber. Low temperature spectra were collected at 85 K to avoid damage to the 
spectroscopic cuvettes near 77 K.
35
 No difference was observed in the max at 77 K and 85 K 
for complexes such as [Ru(bpy)3]
2+
 under these conditions.
35
 
In both the low temperature and room temperature data, there is a wavelength dependence 





halogen tungsten lamp of standard spectral irradiance) was applied to both room 
temperature and low temperature emission spectra. All room temperature experiments were 
performed with deionised water or acetonitrile, and all low temperature experiments 
performed in an ethanol:methanol (4:1) glass. 
3.5.4 Electrochemistry and ECL 
An Autolab PGSTAT204 or PGSTAT128N potentiostat (Metrohm Autolab B.V., 
Netherlands) was used to perform cyclic voltammetry, squarewave voltammetry (0.005 V 
step, 0.02 V amplitude, 25 Hz), and chronoamperometry (CA). The system comprised of a 
flat-bottomed glass electrochemical cell with a Teflon custom-built lid designed for a three-
electrode system. The electrodes were a glassy carbon working (CH instruments), Pt wire 
counter, and either a ‗leakless‘ Ag/AgCl reference or Ag wire pseudo-reference. This 
configuration positioned the working electrode 2 mm from the bottom of the cell. 
Experiments were conducted with the electrochemical cell housed in a Faraday cage. All 
experiments were referenced to Fc
+/0
 in situ (at equimolar concentration to the analyte). The 
working electrode was polished on a felt pad with 0.05 μm alumina powder prior to use. A 
small blowtorch was used to polish the platinum and silver electrodes prior to use. All 
solutions were prepared in either deionised water with a 0.1 M phosphate buffer adjusted to 
pH 7.5, or dry acetonitrile with 0.1 M TBAPF6 electrolyte, and were degassed with nitrogen 
for 5 min. ECL spectra were collected using a QE65pro Ocean Optics CCD via optical fibre 
and collimating lens positioned below the base of the electrochemical cell. Each acquisition 
was triggered by the potentiostat in conjunction with a HR4000 Break-Out box. Relative 
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Translation of the highly promising electrogenerated chemiluminescence (ECL) properties 
of Ir(III) complexes (with tri-n-propylamine (TPrA) as a co-reactant) into a new generation 
of ECL labels for ligand binding assays necessitates the introduction of functionality 
suitable for bioconjugation. Modification of the ligands, however, can affect not only the 
photophysical and electrochemical properties of the complex, but also the reaction pathways 
available to generate light. Through a combined theoretical and experimental study, we 
reveal the limitations of conventional approaches to the design of electrochemiluminophores 
and introduce a new class of ECL label, [Ir(C^N)2(pt-TOxT-Sq)]
+
 (where C^N is a range of 
possible cyclometalating ligands, and pt-TOxT-Sq is a pyridyltriazole ligand with 
trioxatridecane chain and squarate amide ethyl ester), which outperformed commercial Ir(III) 
complex labels in two commonly used assay formats. Predicted limits on the redox 
potentials and emission wavelengths of Ir(III) complexes capable of generating ECL via the 
dominant pathway applicable in microbead supported ECL assays were experimentally 
verified by measuring the ECL intensities of the parent luminophores at different applied 
potentials, and comparing the ECL responses for the corresponding labels under assay 
conditions. This study provides a framework to tailor ECL labels for specific assay 
conditions and a fundamental understanding of the ECL pathways that will underpin 
exploration of new luminophores and co-reactants. 
4.2 Introduction 
Electrogenerated chemiluminescence (ECL) has been widely adopted over the past few 
decades for affinity/ligand binding assays,
1
 with ~2 billion tests now performed each year 
on commercial ECL instrumentation for clinical diagnostics, life science research, food 
testing and biodefense applications.
2
 Remarkably, despite the extensive on-going research 











The underlying principles of this detection chemistry were established through an 
extensive series of investigations that included the inception of ‗co-reactant‘ ECL,
3
 in which 
the oxidation of a sacrificial species such as tri-n-propylamine (TPrA) forms the chemi-
excitation source (Scheme 4.1a), and the elucidation of an alternative pathway to the excited 
luminophore (Scheme 4.1b)
4
 that has been shown to be the dominant light-producing 
mechanism within typical ECL-based assays immobilized on microbeads.
5
 ECL labels for 
bioconjugation were created by adding suitable functional groups to both or one pyridine 
rings of a single ligand (see Fig. 4.1), which exert only minor influence on the 




Scheme 4.1. Co-reactant ECL mechanisms involving (a) electrochemical oxidation the tri-n-propylamine 
co-reactant (TPrA) and metal complex (M; [Ru(bpy)3]
2+









 is an aminium radical cation, TPrA

 is a neural -amino alkyl radical, and P is its oxidation products. 
The additional ‗catalytic route‘ involving oxidation of TPrA by M
+
, and an ‗annihilation‘ pathway, in which 
the excited state is generated from the reaction of M
+
 (from Scheme 1a) with M

 (from Scheme 1b), are shown 
in Scheme 4.S1 in the Supporting Information. 
 
Fig. 4.1. (a) The parent luminophore, tris(2,2 ′ -bipyridine)ruthenium(II); (b,c) Examples of derivatives 
containing (b) two
8
 or (c) one
5a, 6, 9
 functional group for bioconjugation. The single binding group separated 
from the luminophore by an alkyl chain is the approach that has been adopted in commercial ECL systems. 
Carboxylic acid functionality is common, but other groups, such as amines, maleimides, hydrazides, and 
phosphoramidites have also been used.
10
 (d,e) The carboxylic acids are converted to more reactive 
N-hydroxysuccinimide (NHS) esters for binding to amines (such as lysine units of proteins).
9a
 
Cyclometalated iridium(III) complexes (e.g., Fig. 4.2a,b,c) have emerged as promising 
candidates for a new generation of ECL labels.
1c, 11
 Compared to the traditional Ru(II) 
polypyridine chelates, the Ir(III) complexes exhibit much greater quantum yields (offering 
enhanced analytical performance) and their emission wavelengths and electrochemical 







exciting opportunities for multi-color and/or potential-resolved multiplexed ECL systems.
13
 
However, despite over a decade of exploration of the co-reactant ECL of Ir(III) complexes 
with these goals in mind, the properties of the most promising luminophores have not been 
effectively translated into ECL labels for the extensive range of possible bioassays, which 
we attribute to several major limitations:  
(1) The available Ir(III) complexes are generally far less soluble in water than [Ru(bpy)3]
2+
, 
and so their ECL properties have almost exclusively been evaluated under conditions that 
are not compatible with those of the bioassays.
11a, 14
 
(2) Most ligands utilized in Ir(III) complexes do not have readily available derivatives with 
functional groups suitable for bioconjugation and consequently, very few of the promising 
Ir(III) complexes have been adapted into labels. Of the few that have been created, the 
predominant approach has been to replace one ligand with the same bipyridine derivatives 
that have been used in the [Ru(bpy)3]
2+
-based labels (e.g., Fig. 4.2d).
13i, 15
 However, this 
appears to limit the range of electrochemical potentials, emission wavelengths and ECL 
intensities of the complexes. 
(3) The two dominant ECL reaction pathways (Schemes 4. 1a and 1b) elucidated for 
[Ru(bpy)3]
2+
 (with TPrA as co-reactant)
4
 are not necessarily both feasible for all Ir(III) 
complexes,
16
 which has implications for their effectiveness under assay conditions. This has 
not been considered in the previous development of Ir(III)-based ECL labels. 
We sought to devise a framework for the development of ECL labels from Ir(III) 
complex luminophores in which each of the above challenges are addressed. With this in 
mind, we selected a pyridyltriazole ancillary ligand (Fig. 4.2c) as the scaffold for the novel 







 including simple ‗click chemistry‘ preparation
18
 that provides a versatile point 
for derivatization or attachment.
19
 
De Cola and co-workers explored various [Ir(C^N)2(pt-R)]
+
 complexes (Fig. 4.2c; 
where C^N = ppy or df-ppy, and R = methyl, phenyl, benzyl, adamantyl, -cyclodextrin and 
other groups) for photoluminescence,
20







 species exhibited a deeper blue emission than most 
charged Ir(III) complexes, and intense co-reactant ECL under aprotic and aqueous 
conditions. Similarly, we have shown that [Ir(df-ppy)2(ptb)]
+
 (Fig. 4.2c; C^N = df-ppy; R = 
Bn) exhibits more intense co-reactant ECL than related blue luminophores Ir(df-ppy)3 and 
[Ir(df-ppy)2(ptp)]
+
 (where ptp = 3-phenyl-1,2,4-triazol-5-ylpyridinato) in acetonitrile,
17b
 
which we exploited in foundational investigations of multicolor annihilation ECL.
22
 Using 
an analogous synthetic strategy, we prepared a highly water-soluble derivative [Ir(df-
ppy)2(pt-TEG)]
+
 (Fig. 4.2c; C^N = df-ppy; R = tetraethylene glycol (TEG)) that provided 




 than related Ir(III) complexes 






Fig. 4.2. The conceptual development of [Ir(C^N)2(L)]
+
 complex ECL labels from the early promising 
examinations of (a) neutral heteroleptic iridium(III) complexes such as Ir(C^N)2(acac), where C^N = 2-
phenylpyridine (ppy), 2-phenylbenzo[d]thiazole (bt), 2-phenylisoquinoline (piq) or various other ligands.
11a, 14
 
(b) A representative example of the wider class of cationic [Ir(C^N)2(N^N)]
+
 complexes, the co-reactant ECL 
of many of which has also been examined.
25
 (c) More recently reported analogues incorporating various 1-
substituted-4-(2-pyridyl)-1,2,3-triazole ligand, which show promising properties for ECL.
17a, b, 22a
 (d) The most 
common approach to convert neutral and cationic Ir(III) complexes into ECL labels has been to substitute one 
ligand for the same carboxylic acid bipyridine derivative as that used in Ru(II) labels (see Fig. 4.1).
13i, 15
 (e) As 
with the Ru(II)-based labels shown in Fig. 4.1, the carboxylic acids are converted to the corresponding NHS 
esters for binding to amines. (f) The alternative design for ECL labels described herein. 
Although most prior studies of the ECL of [Ir(C^N)2(pt-R)]
+
 complexes have focused 
on developing efficient blue luminophores (such as [Ir(df-ppy)2(ptb)]
+
; em = 453, 481 
nm),
17
 we have previously observed efficient red photoluminescence (em = 592, 632 nm) 
from [Ir(piq)2(ptb)]
+
 (where piq = 1-phenylisoquinoline),
26
 indicating that the emission of 
these complexes can be tuned over a wide range via simple modifications to the C^N 
ligands. Moreover, in our previous development of luminescent Ir(III) complexes for live 
cell imaging,
27
 we explored several strategies for their covalent attachment to biomolecules, 
involving the introduction of maleimide, N-hydroxysuccinimide activated ester, or squarate 
ethyl ester (Fig. 4.2f; C^N = ppy or 2-phenylquinoline (pq)) functional groups. 
We now draw together these advances to overcome several barriers to the adoption of 
promising iridium-complex electrochemiluminophores to labeling in bioassay. This includes 
an in-depth examination of the influence of bioconjugation ligands on Ir(III) complex 
luminophores, a simple synthetic approach to prepare analogues suitable for organic 
solvents or aqueous conditions, the creation of novel ECL labels, and the evaluation of the 






4.3 Results and Discussion 
4.3.1 Comparison of luminophores 
The electrochemical properties in acetonitrile solution were investigated by cyclic 
voltammetry using ferrocene/ferrocenium as an internal standard, as shown in Table 4.1. 
Peak positions were determined using the peak picking algorithm in the Nova software 
package, or, under some conditions, by drawing a manual baseline (where automatic picking 
was difficult or inaccurate). Unless otherwise specified, the potential specified is the formal 
potential (E1/2), calculated from the average of the oxidation and reduction peaks of the 
specified couple. Electrochemiluminophore efficiency is fundamentally dependent on both 
its redox potentials and excited state character. In the case of heteroleptic iridium(III) 
complexes, these parameters can be readily tuned through even subtle modifications of 
ligand structure, to stabilize or destabilize the frontier molecular orbitals with some degree 
of selectivity.
11, 28
 Early exploration of Ir(C^N)2(acac) complexes showed high ECL 
efficiencies with a wide range of emission colors, in reactions with radical anions of 
aromatic nitriles.
29
 Efficient co-reactant ECL from Ir(C^N)2(acac) complexes with TPrA as 
a co-reactant has also been demonstrated,
25a, 30
 but little attention has been paid to the 
influence of their different redox potentials on the competing light-producing reaction 
pathways (Scheme 4.1). Moreover, the effects of replacing ancillary ligands such as acac 
with those suitable for bioconjugation (ECL-labeling) must also be considered. To 
understand these effects, we initially conducted an experimental and theoretical study of the 
relevant properties of twelve iridium(II) complexes. This included: (i) four commercially 
available Ir(C^N)2(acac) complexes (Fig. 4.2a), where C^N = piq, bt, ppy and df-ppy, which 
exhibit red, yellow, green and blue luminescence, respectively; (ii) four [Ir(C^N)2(dm-
bpy)]
+
 complexes (Fig. 4.2b; R and R′ = Me), with the same C^N ligands, as the parent 
luminophores of complexes with bpy-based ligands for bioconjugation (Fig.4.2e), and (iii) 
four [Ir(C^N)2(ptb)]
+







 labeling complexes. The model luminophores were 
employed because they were commercially available or readily synthesized and they 
avoided complications from the reactive peripheral functionality of their labelling 
derivatives
6





 complexes containing piq, ppy and df-ppy ligands have previously been 
reported,
17b, 21, 26, 31
 but the two bt analogues were prepared in this study for the first time. 
The properties of the Ir(C^N)2(acac) complexes (Table 4.1 and Fig. 4.3, S4.1-S4.6) 
were in good agreement with those reported across prior studies.
14b, 32
 DFT calculations on 
Ir(C^N)2(acac) complexes indicate that the HOMO is predominantly localized on the phenyl 
ring of the C^N ligands and the metal center, the LUMO is on the C^N ligand (Fig. S4.7), 
and the observed luminescence (Fig. 4.4) originates from mixed metal-to-ligand and intra-






 As the acac ligand has minimal 
direct involvement in the frontier molecular orbitals, trends in spectroscopic and 














Table 4.1. Selected spectroscopic and electrochemical properties of Ir(C^N)2(acac), [Ir(C^N)2(dm-bpy)]+, and 
[Ir(C^N)2(ptb)]+ complexes in acetonitrile. 
aMetal complexes at 10 M in acetonitrile at ambient temperature. bCorrected for the change in instrument sensitivity over the 
wavelength range. cMetal complexes at 5 M in ethanol:methanol (4:1) at 85 K (sh = shoulder). dEnergy gap between the zeroth 
vibrational levels of the ground and excited states, estimated from the highest energy peak of the low-temperature emission 
spectrum. eMetal complexes at 0.25 mM in acetonitrile with 0.1 TBAPF6 supporting electrolyte; scan rate: 0.1 V/s. 
fExcited state 
potentials based on the ground state potentials and E0-0.
35 gECL intensities relative to [Ru(bpy)3]
2+ (10 M metal complex, 10 mM 
TPrA, 0.1 M TBAPF6 supporting electrolyte; 10 s pulse, 10 Hz). 
hShoulder arising from the characteristic rigidochromic blueshift of 
[Ir(ppy)2(N^N)]
+ complexes (where N^N = bpy or a derivative) involving contribution to the emission from a higher energy excited 
state.36  
Ir(ppy)2(acac) exhibits green luminescence (Fig. 4.4a) and the highest LUMO energy of the 
four complexes, which is seen in its most negative reduction potential (Fig. 4.3). The 
electron-withdrawing fluoro substituents of Ir(df-ppy)2(acac) strongly stabilize the HOMO 















2+ 620 581, 629, 685(sh) 2.13 0.89 1.73, 
1.92, 
2.15 
1.24 0.40 1 
Ir(piq)2(acac) 633 604, 655, 716 2.05 0.43 2.12, 
2.34 
1.62 0.07 2.05 
Ir(bt)2(acac) 565, 605  546, 592, 645 2.27 0.58 2.24 1.69 0.03 0.81 
Ir(ppy)2(acac) 525 501, 537 2.48 0.42 2.59 2.06 0.11 0.015 
Ir(df-ppy)2(acac) 491 471, 504, 542(sh) 2.63 0.73 2.44, 
2.68 
1.90 0.19 0.17 
[Ir(piq)2(dm-bpy)]
+ 595, 631 581, 594(sh), 631, 
687, 758(sh) 
2.13 0.84 1.85, 
2.14, 
2.36 
1.29 0.28 0.76 
[Ir(bt)2(dm-bpy)]
+ 526, 566 515, 529, 557, 
573(sh), 605, 
626(sh), 661 
2.41 0.99 1.83, 
2.26 
1.42 0.58 0.66 
[Ir(ppy)2(dm-
bpy)]+ 
592 475(sh),h 509, 531 2.44 0.85 1.86, 
2.46 
1.59 0.58 0.27 
[Ir(df-ppy)2(dm-
bpy)]+ 
524 450, 482, 508, 518, 
549(sh), 564(sh) 
2.76 1.16 1.80, 
2.48 
1.60 0.96 0.89 
[Ir(piq)2(ptb)]
+ 594, 633 581, 594(sh), 631, 
687, 758(sh) 
2.13 0.86 1.98, 
2.19, 
2.51 
1.27 0.15 0.43 
[Ir(bt)2(ptb)]
+ 526, 565 515, 528(sh), 556, 
572(sh), 604, 659 
2.41 1.02 2.06, 
2.27 
1.39 0.35 0.34 
[Ir(ppy)2(ptb)]
+ 477, 509 471, 487, 495(sh), 
506, 536, 549(sh), 
585(sh) 
2.63 0.87 2.18 1.74 0.43 0.10 
[Ir(df-ppy)2(ptb)]





and to a lesser extent the LUMO, with corresponding positive shifts in associated 
electrochemical potentials and a hypsochromic shift to give its characteristic blue emission. 
The bt ligand also lowers the energy of the frontier orbitals compared to ppy, but with a 
slightly lesser effect on the HOMO, resulting in a yellow emission. The structure in this 
emission can be attributed to the greater proportion of the LUMO on the phenyl ring of the 
C^N ligands. The extended aromaticity of the piq ligand greatly stabilizes the LUMO 
through its low lying * orbital, but the HOMO energy is relatively unchanged, resulting in 
a large bathochromic shift into the red region 
 
Fig. 4.3. Effects of ligand structure on electrochemical properties (solid diamonds; left axes) and calculated 
MO energies (open circles; right axes; BP86/def2-TZVP calculations), for Ir(C^N)2(acac) (grey symbols), 
[Ir(C^N)2(dm-bpy)]
+
 (red symbols), and [Ir(C^N)2(ptb)]
+
 (blue symbols) complexes, where C^N = piq, bt, ppy, 
or df-ppy. The upper graph shows reduction potentials and LUMO energies, and the lower graph shows 
oxidation potentials and HOMO energies. 
 






































































 complexes, where C^N = df-ppy (blue lines), ppy (green lines), bt (yellow lines), or piq 
(red lines), at a concentration of 10
 
M in acetonitrile. The inset photos show the emissions under UV light, 
with the complexes (0.1 mM in acetonitrile) containing df-ppy, ppy, bt, and then piq ligands in cuvettes from 
left to right. 
If the ancillary acac ligand is replaced by dm-bpy, the HOMO is stabilized by ~0.4 eV 
(observed as commensurate increases in the oxidation potentials; Fig. 4.3b) but remains on 
the metal and C^N ligands (Fig. S4.7 and Table S4.5). The low-lying * orbital of the dm-
bpy ligand, however, is now the dominant contributor to the LUMO level of the df-ppy, ppy, 
and bt complexes, although both the dm-bpy and two piq ligands contribute to the LUMO of 
the [Ir(piq)2(dm-bpy)]
+
 complex. This results in a similar reduction potential for all four 
[Ir(C^N)2(dm-bpy)]
+
 complexes at ~1.83 ±0.03 V vs Fc
+/0
 (Fig. 4.3a). As Ir(ppy)2(acac) has 
the highest energy LUMO, the influence of the dm-bpy ligand on the emission spectra is 
most prominent for [Ir(ppy)2(dm-bpy)]
+
. This changes the order of emission energy from df-
ppy > ppy > bt > piq in Ir(C^N)2(acac) complexes (Fig. 4.4a) to df-ppy > bt > ppy > piq in 









































































 complexes (Fig. 4.4b). Moreover, the near identical LUMO energies 
narrows the difference in emission wavelengths between the four complexes, reducing the 
possible selectivity of multi-color ECL systems. 
The HOMOs calculated for the [Ir(C^N)2(ptb)]
+
 complexes had similar energies to 
those of their [Ir(C^N)2(dm-bpy)]
+
 counterparts (Fig. 4.3b), and were again distributed on 
the metal center and C^N ligands. The LUMOs, however, were intermediate in energy 
between those of the Ir(C^N)2(acac) and [Ir(C^N)2(dm-bpy)]
+
 complexes. The order of 
emission energies matched that of the Ir(C^N)2(acac) complexes (Fig. 4.4c). The difference 
in the max between the blue and red emitters is 151 nm (or 140 nm if the highest energy 
peaks are compared), which is much greater than that of the [Ir(C^N)2(ptb)]
+
 complexes (71 
nm), and similar to that of the Ir(C^N)2(acac) complexes (142 nm). 
The co-reactant ECL intensities of iridium complexes relative to [Ru(bpy)3]
2+
 are highly 
dependent on instrumental and chemical conditions, such as co-reactant concentration, the 
applied potential pulse time, and sensitivity of the photodetector in different regions of the 
spectrum.
14b
 The conditions used to obtain the ECL intensities in Table 4. 1 (shown relative 
to [Ru(bpy)3]
2+
) were based on those previously employed, which provide a conservative 
evaluation.
14b
 In the case of the Ir(C^N)2(acac) complexes, the red and yellow emitters 
exhibited greater intensities (2.05 and 0.81) than the green and blue emitters (0.015 and 
0.17), but it should be noted that the CCD detector provides a fairly even response across 
the wavelength range and other commonly used photodetectors (such as photomultiplier 





 complexes were distributed over narrower 
ranges (0.27-0.89 and 0.10-0.43, respectively). 
The above characterizations allow us to assess the feasibility of the ECL reaction 





studies of the ECL of [Ru(bpy)3]
2+
 with TPrA co-reactant have shown that the conditions of 
some assays heavily favor one ECL pathway over others.
4-5, 37
 The requirements can be 
visualized using the graphs shown in Fig. 4.5a-d,
16
 in which the electrochemical potential 
for oxidation and reduction of the metal complex is plotted against the excited state energy 
(shown as the max from low temperature emission spectra). Overlaid on these graphs are the 
redox potential requirements of the two ECL pathways. Line (i) is the oxidation potential of 
TPrA. For complexes with an oxidation potential above this line, reaction 1 is favorable. 
This ‗catalytic route‘
4




 but it is not 
essential for ECL, because TPrA is also electrochemically oxidized. 
Line (ii) represents the oxidation potential that the metal complex requires to attain its 
electronically excited state via reaction 2 (from Scheme 4.1a). As can be seen in the curve of 
this line, the energy demands become greater as the emission wavelength becomes shorter 
(i.e., blue-shifted luminophores must possess higher oxidation potentials to generate ECL 
via Scheme 4.1a). This requirement for Scheme 4.1a, which we referred to in our previous 
work as the ‗ECL wall of energy sufficiency‘,
39
 was met by all of the metal complexes 
under investigation (Fig. 4.5a-c). 
M
+
 + TPrA  M + TPrA
+•





  M* + P    (2) 
To generate ECL via Scheme 1b, the metal complex must first be able to be reduced by 
TPrA

 (reaction 3) and then react with TPrA
+•
 with sufficient excess energy to generate the 
electronically excited luminophore (reaction 4). These requirements are met in complexes 
with a reduction potential above line (iii) and below line (iv) in Fig. 4.5a-c. (i.e., the green 














  M* + TPrA   (4) 
Of the Ir(C^N)2(acac) and [Ir(C^N)2(dm-bpy)]
+
 complexes (Fig 4.5a and 4.5b), only the 
red emitters with piq ligands clearly satisfy the criteria for generating ECL with TPrA via 
Scheme 4.1b. It should be noted, however, that there are numerous sources of error in these 
predictions
16





should be treated with caution. Of the [Ir(C^N)2(ptb)]
+















, and (d) [Ir(C^N)2(pt-TEG)]
+
, overlaid on graphs 
depicting the redox potential requirements of key steps of the ECL mechanisms shown in Schemes 1a and 1b, 


































































































































































































requirements for reactions 1-4, respectively. (e-f) Normalized ECL intensity during an applied potential sweep 
from 0 V to 1.8 V and back to 0 V (vs Ag|AgCl) for (e) [Ir(bt)2(pt-TEG)]
+
 and (f) [Ir(df-ppy)2(pt-TEG)]
+
 at 1 





 are shown in Supporting Information), providing experimental 
confirmation of the predictions made in Fig. 4.5d under the aqueous conditions commonly used in ECL assays. 
4.3.2 Water soluble [Ir(C^N)2(pt-TEG)]
+
 complexes 
The click chemistry synthesis of pyridyltriazole ligands provides an exceedingly simple 
approach to introduce functional groups that improve the solubility of the Ir(III) complex.
17a, 
20, 24, 40
 Using this approach, we prepared [Ir(C^N)2(pt-TEG)]
+
 (Fig. 4.2c, C^N = piq, bt, ppy, 
df-ppy; R = TEG), with chloride counter ions instead of hexafluorophosphate, for evaluation 
under conditions akin to those of typical ECL assays. The electrochemical properties of 
iridium metal complexes Ir(C^N)2(acac), Ir(C^N)2(ptb), Ir(C^N)2(dm-bpy) and [Ir(C^N)2(pt-
TEG)]
+
 in acetonitrile were investigated by cyclic volatmmetrey using 
ferrocene/ferrocenium as the internal standard. Peak positions were determined using the 
peak picking algorithm in the Nova software package, or, under some conditions, by 
drawing a manual baseline (where automatic picking was difficult or inaccurate). Unless 
otherwise specified, the potential specified is the formal potential (E1/2), calculated from the 
average of the oxidation and reduction peaks of the specified couple. The oxidation 
potentials of the complexes in phosphate buffer were determined by square-wave 
volammetry. The datas were summarized in Table 4.2. 
 The electrochemical potentials of the [Ir(C^N)2(pt-TEG)]
+





 in acetonitrile (Fig. S4.6) and the oxidation potentials of the 
[Ir(C^N)2(pt-TEG)]
+
 complexes in buffered aqueous solution (vs Ag|AgCl) exhibited a 
similar trend (Table 4.2). The luminescence max of [Ir(C^N)2(pt-TEG)]
+
 in water and 
[Ir(C^N)2(ptb)]
+





at low temperature in 4:1 ethanol:methanol (Fig. S4.4 and S4.5, Tables 4.1 and 4.2). The 
ECL intensities of the [Ir(C^N)2(pt-TEG)]
+
 complexes in buffered aqueous solution, 
however, were greater than those of [Ir(C^N)2(ptb)]
+
 in acetonitrile, relative to that of 
[Ru(bpy)3]
2+
 under each set of conditions. 





complexes, the same predictions (Fig. 4.5d) were made for the feasibility of the two ECL 










 are limited to Scheme 4.1a. We sought 
validation for these predictions using the ‗two-wave‘ ECL experiment that was utilized by 
Bard and co-workers
4
 in their elucidation of Scheme 4.1b for [Ru(bpy)3]
2+
, in which the 
ECL intensity is monitored during a voltammetric sweep from low to high anodic potentials. 
Scheme 1b is initiated at the oxidation potential for TPrA, whereas Scheme 4.1a also 
requires electrochemical oxidation of the metal complex, which in the case of the 
[Ir(C^N)2(pt-TEG)]
+
 complexes, occurs at considerably higher potentials (Fig. 4.5d). The 
two ‗waves‘ of ECL intensity corresponding to the oxidation of TPrA and the metal 
complex (Table 4.2) for [Ir(bt)2(pt-TEG)]
+
 (Fig. 4.5e) and [Ir(piq)2(pt-TEG)]
+
 (Fig. S4.8b), 
and the single wave of ECL associated with the oxidation of [Ir(df-ppy)2(pt-TEG)]
+
 
(Fig. 4.5f) and [Ir(ppy)2(pt-TEG)]
+
 (Fig. S4.8a) in aqueous buffered solution support the 
prediction made for each complex based on electrochemical potentials and emission 
energies. Bard and co-workers observed that a lower concentration of [Ru(bpy)3]
2+
 favored 
the first wave of ECL (via Scheme 4.1b), which we also observed for [Ir(bt)2(pt-TEG)]
+
 (Fig. 
4.5e) adding further evidence of the competing ECL pathways of this complex. We note 
here that interpretation of ECL intensity profiles during voltammetric experiments without 





4.5a-d) can be misleading, as other factors can contribute. The ECL of Ir(ppy)3 with TPrA, 
for example, is strongly inhibited at high over-potentials,
13d, e
 which has been attributed to 
oxidative quenching of the excited state Ir(ppy)3* by TPrA
+
. Moreover, De Cola and 
co-workers
14a
 observed more than two maxima in the ECL of Ir(pph)2(pic) (where pph = 
phenylphenanthridine; pic = picolinate) and TPrA, which is yet to be understood. 
 
 
Table 4.2. Selected spectroscopic and electrochemical properties of [Ir(C^N)2(pt-TEG)]
+
 complexes. 
 Photoluminescence Electrochemical potentials  
 max/nm




















+ 596, 628 580, 629, 684 2.14 9 1.15 0.86 2.01, 2.23 0.86 
[Ir(bt)2(pt-TEG)]
+ 526, 562 515, 557, 604, 
659 
2.41 23 1.28 1.01 2.08 2.76 
[Ir(ppy)2(pt-TEG)]
+ 475, 505 471, 506, 536 2.63 14 1.08 0.86 2.20 1.57 
[Ir(df-ppy)2(pt-
TEG)]+ 
452, 481 448, 480, 507 2.77 19 1.44 1.20 2.13 0.26 
aMetal complexes at 10 M in water at ambient temperature. bCorrected for the change in instrument sensitivity over the 
wavelength range. cMetal complexes at 5 M in ethanol:methanol (4:1) at 85 K. dEnergy gap between the zeroth vibrational levels 
of the ground and excited states, estimated from the highest energy peak of the low-temperature emission spectrum. 
ePhotoluminescence quantum yield in ‗ProCell‘ phosphate buffer used in commercial ECL instruments. fMetal complexes at 0.5 
mM in 0.1 M phosphate buffer solution (pH 7.5); squarewave voltammetry; 5 mV step, 0.02 amplitude, 25 Hz. gMetal complexes at 
0.25 mM in acetonitrile with 0.1 TBAPF6; cyclic voltammetry; scan rate: 0.1 V/s. 
hECL intensities relative to [Ru(bpy)3]
2+ (10 M 
metal complex in acetonitrile, 10 mM TPrA phosphate buffer (pH 7.5); 10 s pulse, 10 Hz). 
4.3.3 New ECL labels 
Using the synthetic strategies outlined in our preparation of [Ir(ppy)2(pt-TEG-Sq)]
+
 for live 
cell photoluminescence imaging
27
 (details in Supporting Information), we adapted the 
promising [Ir(C^N)2(pt-TEG)]
+
 electrochemiluminophores (Fig 4.2c, R = TEG) for ECL 





4.2d) for attachment to amine groups require initial conversion to the NHS esters, which can 
only be stored for short periods of time at low temperature. In contrast, the squarate ethyl 
ester functionality of the novel [Ir(C^N)2(pt-TEG-Sq)]
+
 ECL labels (Fig. 4.2f) does not 
require further activation, and the labels can be stored at room temperature for extended 
periods of time. The emission spectra and electrochemical properties of the [Ir(C^N)2(pt-
TEG-Sq)]
+
 and commercial [Ir(C^N)2(mbpy-COOH)]
+
 labels (Table 4.3 and Fig. S4.9) were 
closely aligned to those of their parent luminophores, [Ir(C^N)2(pt-TEG)]
+
 (Table 4. 2) and 
[Ir(C^N)2(dm-bpy)]
+
 (Table 4.1), respectively. Similar to water-soluble complexes 





 labels in acetonitrile solution were investigated by 
cyclic volatmmertry using ferrocene/ferrocenium as the internal standard at a scan rate of 
0.1 V/s. The values of the formal oxidation potential Eox/V (vs Fc
+/0
) and formal reduction 
potential Ered/V (vs Fc
+/0
) were summarized in Table 4.3. Peak positions were determined 
using the peak picking algorithm in the Nova software package, or, under some conditions, 
by drawing a manual baseline (where automatic picking was difficult or inaccurate). Unless 
otherwise specified, the potential specified is the formal potential (E1/2), calculated from the 
average of the oxidation and reduction peaks of the specified couple. Potentials that are 
from one peak only (irreversible redox processes) are highlighted. All the complexes 
showed one oxidation wave at the potential range between 1.16 V and 0.84 V with reduction 
wave at the potential range between -2.56 V and -1.78 V. Comparing the potentials of 
[Ir(C^N)2(pt-TEG-Sq)]
+
 and commercial [Ir(C^N)2(mbpy-COOH)]
+
 labels, we found that 
the ancillary ligand does not have significant effects on the potentials. For example, 
[Ir(piq)2(bpy-COOH)]
+
 can be oxidized at the potential of 0.85 V, which was nealy the same 
as  [Ir(piq)2(pt-TEG-Sq)]
+
, where the oxidation potential was 0.87 V. The 
photoluminescence quantum yields (PL) and emission lifetimes () for the [Ir(C^N)2(pt-
TEG-Sq)]
+





To complete our examination of the influence of the electrochemical and spectroscopic 
properties on the ECL of Ir(III) complexes in the context of the reaction pathways available 





 labels in two different of modes of 
bioassay. The first was a sandwich hybridization RNA assay on magnetic bead support, and 
the second was a C-reactive protein (CRP) sandwich immunoassay with the capture 
monoclonal antibody (mAb) immobilized onto a gold electrode. 
Table 4.3. Selected spectroscopic and electrochemical properties of ECL labels. 
 Photoluminescence Electrochemical potentials 
ECL labela max/nm
b,c PL (%)





2+ 632 4.9 311 0.84 1.78, 1.96, 2.24 
[Ir(piq)2(bpy-COOH)]
+ 592(sh), 640 10.4 378 0.85 1.90, 2.17 
[Ir(bt)2(mbpy-COOH)]
+ 530(sh), 572, 615(sh) 5.9 174 1.04 1.87, 2.28 
[Ir(ppy)2(mbpy-COOH)]
+ 606 2.0 398 0.84 1.87 
[Ir(df-ppy)2(mbpy-COOH)]
+ 533 2.7 392 1.16 1.84, 2.49 
[Ir(piq)2(pt-TEG-Sq)]
+ 590(sh), 632 11.8 927 0.87 2.01, 2.22, 2.56 
[Ir(bt)2(pt-TEG-Sq)]
+ 526, 564 26.7 1051 1.01 2.11, 2.35, 2.56 
[Ir(ppy)2(pt-TEG-Sq)]
+ 476, 503 8.8 308 0.86 2.22 
[Ir(df-ppy)2(pt-TEG-Sq)]
+ 453, 483, 515 15.7 559 1.16 2.14 
aThe chemical structure of [Ru(bpy)2(mbpy-COOH)]
2+ is shown in Fig. 4.1c; the [Ir(C^N)2(mbpy-COOH)]
+ labels are depicted by 
Fig. 4.2d, except that the piq complex does not contain the 4-methyl group, and the bt complex contains a 4′-carboxy instead of 4′-
carboxypropyl group on the bpy-based ligand (due to the availability of the different commercial labels at the time of the study); 
and the [Ir(C^N)2(pt-TEG-Sq)]
+ labels are depicted by Fig. 4.2f. bThe ECL labels were dissolved in DMF (1 mM) and diluted to 10 
M in a 0.1 M PBS solution (pH 7.4). cCorrected for the change in instrument sensitivity over the wavelength range. 
dPhotoluminescence quantum yield. eEmission lifetime. fECL labels at 0.25 mM in acetonitrile with 0.1 TBAPF6; cyclic 
voltammetry; scan rate: 0.1 V/s. Peaks associated with the counter ion or labelling functional group not listed.  
In the sandwich RNA hybridization assay, the target was mixed with a capture probe bound 





label, and heated to 45°C for 15 min. The beads were then washed, resuspended in ProCell 
solution (a phosphate buffer enriched with TPrA and various surfactants with a confidential 
specific chemical composition, which has specially designed and optimized for ECL assays 
in commercial systems), and dispersed above a screen-printed electrode in an in-house-
fabricated holder (Fig. S4.10) containing a magnet to move the beads to the electrode 
surface. The ECL was initiated by applying 1.4 V vs Ag|AgCl at the working electrode for 
10 s and measured using a silicon photomultiplier (Fig. S4.11). 
Bard and co-workers‘ elucidation of an alternative ECL reaction pathway of the 
[Ru(bpy)3]
2+
 luminophore with TPrA co-reactant
4
 revealed Scheme 1b as the dominant 
light-producing pathway of the magnetic bead-supported assays of the commercial ECL 
instruments. In these assays, only an infinitesimal fraction of ECL-labels are held with the 
nanometric electron tunneling distance from the electrode surface required for their direct 
oxidation (required for Scheme 4.1a).
4, 5b, 41
 Diffusion of the TPrA radicals, however, allows 
chemi-excitation of the [Ru(bpy)3]
2+
 luminophores (Scheme 4.1b) at much greater 
(micrometric) distances from the electrode surface.  
Based on the above considerations of the parent luminophores of the ECL labels (Fig. 
4.5), the reaction pathway depicted in Scheme 4.1b should only be feasible for the novel red 




) and the commercial 
red emitter ([Ir(piq)2(bpy-COOH)]
+
). As shown in Fig. 4.6a, comparison of the ECL signal-
to-blank (S/B) ratios for the different labels for the same target RNA concentration and 
assay conditions shows that these labels gave the greatest response. The commercial bt 
analogue, for which the parent luminophore was considered a borderline case (Fig. 4.5b), 
also showed a minor response. The two [Ir(C^N)2(pt-TEG-Sq)]
+
 labels gave superior S/B 
ratios than their commercial counterparts, but the response with [Ir(piq)2(pt-TEG-Sq)]
+
 was 









Fig. 4.6. ECL signal/blank ratio for (a) the detection of target RNA by sandwich hybridization assay on a 
magnetic bead support, and (b) the detection of C-reactive protein by sandwich immunoassay with the capture 
monoclonal antibody immobilized on a gold electrode, using [Ir(C^N)2(pt-TEG-Sq)]
+
 (black columns) or 
[Ir(C^N)2(mbpy-COOH)]
+










 labels, the reactions depicted in Scheme 1b are exergonic, but 
considerable variation in ECL responses were observed in the RNA assay due to differences 
in the efficiencies of (i) excitation (dependent on the relative rate of reactions leading to the 
excited state in addition to various ‗dark‘ reactions), and (ii) emission (which can be 
estimated from the photoluminescence quantum yield, although the excited state may also 
be vulnerable to quenching from reactive oxidation products of the co-reactant in some 
cases
13d









 (Table 4.3), 
the excitation efficiency appears to be the dominant factor. It is therefore not surprising that 










































exhibited red luminescence and reduction potentials that would place them in the same 
regions of Fig. 4.5 as the [Ru(bpy)3]
2+
 complex, even though they were not evaluated under 
bead-based assay conditions that would limit the ECL pathway to that depicted Scheme 4.1b. 
Examples include Ir(pq)2(acac) (em = 609 nm, E
0





Ir(pph)2(pic) (em = 649 nm, E
0







 (em = 590 nm, E
0




 where dmpq = 3,5-
dimethylphenyl)quinoline. 
For assays in which the Ru(II)/Ir(III) complex luminophore can diffuse to the electrode 
or is immobilized in very close proximity to the electrode surface, co-reactant ECL with 
TPrA is feasible via Scheme 4.1a (with possible involvement of Scheme 4.S1a), but only if 
a sufficient potential is applied to oxidize the metal complex, and the reaction between the 
oxidized complex and TPrA

 is sufficiently exergonic to populate the excited state 
responsible for the emission (reaction 2). As illustrated by Fig. 4.5a-d, all metal complexes 
examined in this study meet this requirement. The potentials required to oxidize these metal 
complexes are generally greater than that for TPrA, and so the pathway depicted in Scheme 
4.1b (and Scheme 4.S1b) may also contribute to the overall ECL intensity for complexes 
meeting its requirements (described above). 
In our second assay, the capture antibody was covalently immobilized on a monolayer 
of 16-mercaptohexadecanoic acid on a gold electrode, which was incubated with the target 
CRP and then the detection antibody. The electrode was then introduced to an 
electrochemical cell containing ProCell solution and the ECL was initiated using a 
voltammetric sweep (0.05 V/s) from +0.5 V to +1.5/1.6 V (vs Ag|AgCl) and measured using 
photomultiplier tube (S20 multi-alkali photocathode) module. The ECL labels in this assay 
are much closer to the electrode than the vast majority of those in the bead-based approach, 
but still outside the electron tunneling region.
4, 41
 O‘Reilly et al.,
42





similar assay (CRP by sandwich immunoassay; capture antibody absorbed on a Pt electrode; 
detection antibody with [Ru(bpy)2(N^N)]
2+
-type ECL label) and found evidence that the 
dominant reaction pathway involved oxidation of the label (Scheme 4.1a) and the catalytic 
oxidation of TPrA (Scheme 4.S1a). Electron hopping
37, 41
 between redox active sites was 
noted as a possibility, but the authors favored an explanation based on the fast rate of charge 
transfer for the metal complex label.
42
  
As shown in Fig. 4.6b, comparison of the ECL signal-to-blank (S/B) ratios for the 





, which both require oxidation 
to generate ECL, gave the greatest response. Moreover, the S/B ratio for the novel ([Ir(df-
ppy)2(pt-TEG-Sq)]
+
















 complexes has provided a new 
understanding of the translation of promising Ir(III) complexes to ECL labelling, whilst at 
the same time introducing a new class of ECL label. As the possibility of multi-colored or 
potential-resolved ECL systems has been the main driver for the exploration of Ir(III) ECL 
systems, we selected a group of common C^N ligands (df-ppy, ppy, bt and piq) that would 
impart a wide range of properties. This highlighted the effects of modifying the ancillary 
ligand for ECL labeling purposes, the availability of ECL reaction pathways, and the 
implications on the performance of ECL labels in different assay formats. 
Adaption of promising Ir(C^N)2(acac) complexes for ECL labelling through the 





introduces a low-lying * LUMO that contracts the spread of emission colors over a series 
of complexes, which will be detrimental for multi-color applications. The change is most 
prominent in complexes with the furthest negative reduction potentials (i.e., the highest 
LUMO energies). Of the Ir(C^N)2(acac) complexes examined in this study, this was the ppy 
complex, and the change in ancillary ligand to dm-bpy visibly switched the order of 
emission energies with the Ir(bt)2(acac) complex. These effects can be largely ameliorated 
with alternative ancillary ligands such as pyridyltriazole ligands, which can be prepared by 
simple click chemistry procedures to access more water-soluble analogues and functionality 
suitable for labelling, without significant modification to the properties of the luminophore. 
Graphical representations of the key energy requirements of the competing ECL 
reactions elucidated for the [Ru(bpy)3]
2+
 complex with TPrA as a co-reactant show 
fundamental limits on the redox potentials and emission wavelengths of complexes that can 
generate ECL through a mechanism involving oxidation of only the TPrA co-reactant 
(Scheme 4.1b). Most importantly in the context of developing multi-color ECL systems, the 
‗window‘ of reduction potentials enabling this pathway becomes narrower as emission 
energy increases, and it does not extend across the entire visible region. Plotting the redox 
potentials and (low-temperature) emissions of the Ir(III) complexes on these graphs enables 
simple prediction of the feasible ECL pathways, which for the [Ir(C^N)2(pt-TEG)]
+
 
complexes was supported by the relative ECL intensity at different applied potentials under 
aqueous conditions relevant to bioassay. 
The practical outcome of this limitation is seen in the bead-based assay, in which only 
some of the Ir(III) complexes (those for which Scheme 4.1b is feasible) result in a 
significant ECL signal for the target analyte. This provides the simplest experimental 
verification of Bard and co-workers‘ reasoning
4
 (supported by a range of experiments and 
simulations by other groups
5b, 41, 43





pathway for bead-based assays using [Ru(bpy)3]
2+
 with TPrA as co-reactant. Examination of 
a greater range of electrochemiluminophores with this approach will enable the energy 
boundaries (carrying considerable error due to the difficulty in establishing the redox 
potentials of TPrA and TPrA

) to be clarified. Moreover, this approach will be valuable for 
the evaluation of alternative co-reactants in conjunction with various metal complexes 
(which may extend the reduction potential window further into the blue region of spectrum), 
as previous studies
44
 have predominantly focused on [Ru(bpy)3]
2+
, and not under 
bioconjugated assay conditions. Assays in which the metal complex can diffuse to the 
electrode surface, or is immobilized within a few nanometers of the electrode, or where 
electrons can be transferred over greater distances from the metal complex to the electrode, 
are not subject to the above limitations. In these cases, the effectiveness of the label is 
defined only by the efficiency of its excitation and emission under the specific assay 
conditions, and the relative sensitivity of the photodetector towards that luminophore. 
The novel [Ir(C^N)2(pt-TEG-Sq)]
+
 ECL labels were obtained through a more 
convenient and versatile synthetic approach and provided superior ECL responses to the 
commercial [Ir(C^N)2(mbpy-COOH)]
+
 analogues in both assays. In both assays, the ECL 
was less intense than that of the conventional [Ru(bpy)2(mbpy-COOH)]
2+
 label, but assay 
conditions have been optimized specifically for the [Ru(bpy)3]
2+
-based labels since the 
inception of the technique, and there is considerable scope to improve the relative 
performance of the Ir(III) complex labels, in areas such as TPrA concentration and 
electrochemical pulse time.
14b
 Despite a few alternative co-reactants providing greater ECL 
intensities with [Ru(bpy)3]
2+
 under specific conditions, TPrA remains the ‗gold standard‘ 
co-reactant for ECL assays. Other co-reactants, however, may provide superior ECL 
performance from various Ir(III) complexes. Finally, the ability through DFT calculations to 





of the complex, and consider these changes with respect to the energy requirements of 
various ECL pathways, will enable the design of superior Ir(III) complex ECL labels with 
specific emission colors and targeting different reaction pathways. 
4.5 Experimental 
4.5.1 Chemicals 
 Tris(2,2′-bipyridine)ruthenium(II) hexafluorophosphate ([Ru(bpy)3](PF6)2), 
tetrabutylammonium hexafluorophosphate (TBAPF6; electrochemical grade) was purchased 
from Sigma-Aldrich (NSW, Australia). Tris(2,2′-bipyridine)ruthenium(II) chloride 
hexahydrate ([Ru(bpy)3]Cl2.6H2O), and bis(cyclopentadienyl)iron (ferrocene; Fc) was 
purchased from Strem Chemicals (MA, USA). The four Ir(C^N)(acac) complexes and five 








bipyridyl)iridium(III) hexafluorophosphate ([Ir(ppy)2(mbpy-COOH)](PF6)), bis(2-
phenylbenzothiazole-C
2
,N)(4-methyl-4′-carboxy-2,2′-bipyridyl) iridium(III) chloride 
([Ir(bt)2(mbpy-COOH)]Cl), bis(1-phenylisoquinoline)(4-methyl-4‘-carboxypropyl-2,2′-
bipyridyl)iridium(III) chloride ([Ir(piq)2(bpy-COOH)]Cl)) were purchased from SunaTech 
(Jiangsu, China). Acetonitrile (Scharlau, Spain) and was distilled over calcium hydride 
under a nitrogen atmosphere and collected as needed. Syntheses of the pt-TEG and pt-TEG-
Sq ligands, the [Ir(C^N)2(dm-bpy)](PF6), [Ir(C^N)2(ptb)](PF6) and [Ir(C^N)2(pt-TEG)]Cl 
complexes, and the [Ir(C^N)2(pt-TEG-Sq)]
+
 ECL labels (where C^N = piq, bt, ppy, or df-
ppy) are described in the Supporting Information. The solubility of the [Ir(C^N)2(pt-TEG)]
+
 











 in water, and 0.1 mM [Ir(piq)2(pt-TEG)]
+
 in water with 10% 
acetonitrile. Stock [Ir(C^N)2(pt-TEG)]
+
 solutions were subsequently prepared at 0.1 mM. 
4.5.2 Photophysical measurements  
For the characterization of Ir(C^N)2(acac), [Ir(C^N)2(dm-bpy)](PF6), [Ir(C^N)2(ptb)](PF6) 
and [Ir(C^N)2(pt-TEG)]Cl complexes, absorption spectra were obtained with a Cary 300 
Bio UV/Vis spectrophotometer (Varian Australia, Vic., Australia) with 1 cm pathlength 
quartz cuvettes. Emission spectra were measured on a Cary Eclipse fluorescence 
spectrometer (Varian Australia; 5 nm band pass, 1 nm data interval, PMT voltage: 800 V). 
Metal complexes were prepared at a concentration of 10 μM in deionized water or freshly 
distilled acetonitrile. For the low temperature emission spectra, the complexes were 
prepared at 0.5M in ethanol:methanol (4:1) and cooled to 85 K using an OptistatDN 
Variable Temperature Liquid Nitrogen Cryostat equipped with custom-made quartz sample 
holder. The low temperature spectra were collected at 85 K to avoid damage to the 
spectroscopic cuvettes near 77 K observed during our previous study
14b
 and by others.
45
 No 
significant difference in the max for metal complexes such as [Ru(bpy)3]
2+
 and Ir(ppy)3 
between 77 K and 85 K was observed under these instrumental conditions.
22b
 All emission 
spectra were corrected by standard correction curves established using a quartz halogen 
tungsten lamp.  
For the characterization of [Ir(C^N)2(pt-TEG-Sq)]
+
 and other ECL labels, the 
complexes were dissolved in DMF (1 mM) and diluted to 10 M in a 0.1 M PBS solution 
(pH = 7.4). Steady-state emission spectra were collected on a Nanolog (HORIBA Jobin 
Yvon IBH) spectrofluorometer. A 450 W xenon-arc lamp was used to excite the complexes 
using a 1200 g/mm grating blazed at 330 nm excitation monochromators, a 1200 g/mm 
grating blazed at a 500 nm emission monochromator, and a thermoelectrically cooled TBX 





source intensity, gratings, and detector response. Lifetimes were measured using the time 
correlated single photon counting (TCSPC) option on the spectrometer and correlated by a 
time-to-amplitude converter (TAC) in forward TAC mode. A nanoled laser (ex = 344 nm or 
451 nm) was pulsed at a 100 kHz, signals were collected using a FluoroHub counter and the 
data was analyzed using DAS6 software (HORIBA Jobin Yvon IBH). Spectra for absolute 
quantum yields were measured at room temperature (22 ± 2°C) with a Quanta-phi HORIBA 
Scientific 6 in. diameter integrating sphere connected to the Nanolog via optical fibers. The 
complexes were excited using a 450 W xenon lamp and detected with a liquid nitrogen 
cooled Symphony II (Model SII-1LS-256−06) CCD. 
4.5.3 Electrochemistry 
An Autolab PGSTAT204 potentiostat (Metrohm Autolab B.V., Netherlands) with a 
conventional three-electrode system housed in a custom-made light-tight faraday cage was 
used. The electrochemical cell contained a glassy carbon working electrode (3 mm 
diameter), platinum counter electrode, and a low leakage Ag|AgCl (3.4 M) (Innovative 
Instruments, Fl, USA) or silver wire reference electrode. Cyclic voltammograms were 
performed at a scan rate of 0.1 V/s and metal complex concentration of 0.25 mM with a 
supporting electrolyte of 0.1 M TBAPF6 in freshly distilled acetonitrile. The glassy carbon 
electrode was polished using 0.3 and 0.05 µm alumina powder, sonicated in water and then 
distilled acetonitrile, and dried before use. Prior to analysis, solutions were deoxygenated 
for 15 min (using Argon). Potentials were referenced to the ferrocenium/ferrocene redox 
couple. All electrochemical experiments were carried out at room temperature. Square wave 
voltammetric measurements were performed using 0.5 mM metal complex in 0.1 M 
phosphate buffer (pH 7.5), with 5 mV step, 25 Hz frequency, 0.02 V amplitude and 100 







ECL experiments were performed using the same electrochemical cell configuration as 
described above, and the light emitted near the working electrode surface was detected using 
a photomultiplier tube (PMT; Electron Tubes model 9124B; ETP, NSW, Australia) 
positioned under the cell, or a CCD spectrometer (QE65Pro, Ocean Optics, FL, USA) 
interfaced with the cell using a collimating lens (74-UV, Ocean Optics) and optic fiber (1.0 
m, 1.0 mm core diameter; Ocean Optics). Acquisition was synchronized with the 
electrochemical experiment by sending a trigger from the potentiostat to the HR4000 
(Ocean Optics) break out box. Comparisons of co-reactant ECL intensities (integrated peak 
area) between Ir(III) complexes and [Ru(bpy)3]
2+
 were performed using chronoamperometry 
(potential of Epa + 0.1 V, 10 s pulse time, 10 Hz), with the CCD spectrometer, and metal 
complex concentration of 10 M. The ‗two-wave‘ ECL experiments involved a 
voltammetric sweep from 0 V to 1.8 V vs Ag|AgCl followed by the reverse sweep back to 0 
V, with the resulting ECL measured by PMT. The ECL detection for each bioassay is 
described in later sections. 
4.5.5 Conversion of carboxylic acid ECL labels to N-hydroxysuccinimide (NHS) esters 
N,N′-dicyclohexylcarbodiimide (DCC, 146 mmol; Sigma Aldrich, >99%) and NHS 
(146 mmol; Sigma Aldrich, 98%) were dissolved in 1.5 mL chilled (water ice-bath), dried 
(molecular sieves) DMF (Sigma Aldrich, molecular biology grade) with stirring. To this 
solution, 28 mmol of [Ru(bpy)2(mbpy-COOH)]
2+
 (Fig. 4.1c) or [Ir(C^N)2(mbpy-COOH)]
+
 
(Fig. 4.2d) dissolved in 0.5 mL dry, chilled DMF was added. The mixture was stirred on ice 
for 30 min, before returning to room temperature (22°C) and stirring was continued for 5 h. 





 solutions were stored at -20°C 
in a desiccator. The [Ir(C^N)2(pt-TEG-Sq)]
+





4.5.6 Assay 1: Sandwich hybridization RNA assay on magnetic bead support 
NASBA and purification of target RNA amplicon. The RNA fragment used in the 
sandwich hybridization assay was the amplicon that resulted from the Nucleic Acid 
Sequence Based Amplification (NASBA) of viral-like particles (VLP) RNA. We packaged 
an artificial sequence into MS2 capsid, which created the VLPs to serve as a model for 
carrying target sequence of interest in this study. The VLPs were prepared as previously 
described.
46
 VLP RNA purification was performed using spin column based Qiagen RNeasy 
RNA isolation kit as per the manufacturer‘s protocol. The amplification process was 
performed using commercial NASBA reagent from Life Science Advance Technologies (St. 
Petersburg, FL, USA). Briefly, the final 20 L reaction buffer mixture (LRB) consists of 40 
mM Tris HCl (pH 8.5), 70 mM KCl, 12 mM MgCl2, 15% dimethyl sulfoxide, 5 mM 
dithiothreitol (DTT), 1 mM dNTP mixture, 2 mM ATP, CTP and UTP mixture, 1.5 mM 
GTP, 0.5 mM ITP, 0.2 µM of P1 and P2 primers (Integrated DNA Technologies, IL, USA) 
and purified VLP RNA (10 ng/µL). The NASBA reaction was initiated by addition of 
enzyme cocktail (LEM) containing three enzymes, namely 6.4 U AMV Reverse 
Transcriptase (AMV-RT), 32 U T7 RNA polymerase, and 0.1 U ribonuclease H, and the 
NASBA mixture was incubated at 41°C for 60 min. To obtain purified NASBA RNA 
amplicon, the NASBA reaction mixture was subjected to lithium chloride-cold ethanol RNA 
precipitation method by as per the manufacturers recommendation (AM9480; Thermo 
Fisher, Mulgrave, VIC, Australia) and standardized using UV spectroscopy (Nanodrop 2000; 
Thermo Fisher) to give 1 pmol/µL concentration in 10 mM Tris EDTA (pH 7.5). The RNA 
samples were stored at –80°C until required. Primers and NASBA amplicon fragment 
sequences are detailed in Table S4.7. 
Attachment of the capture probe to the magnetic beads. 40 L (400 g) of Dynabeads M-





NaCl) by vortexing and magnetic separation, then resuspended in 100 L of binding buffer 
at 4 mg/mL, the capture probe (CP) was bound to the MB by adding 20 L of CP solution 
(10 M) to the bead solution and incubating for 20 min at room temperature with gentle 
mixing. Excess CP was removed by washing the beads three times in binding buffer, 
followed by resuspension in 200 µL binding buffer (2 mg/mL). The CP@MB solution was 
stored at 4°C and was stable for several weeks. 
Conjugation of ECL labels with the detection probe. The detection probe (as purchased) 
was resuspended to a concentration of 500 M in 100 mM sodium borate buffer (pH 8). 100 
L (50 nmol) of this solution was combined with 1000 nmol of the complex (20-fold 




 in DMF 
and 620 L 100 mM borate buffer. The solution was shielded from ambient light with 
aluminum foil, and reacted at room temperature for 24 h on a rotating mixer. The labelled 
oligo was washed and purified as described by Zhou et al.,
8c
 before being resuspended in 
nuclease free water at 20 M. The concentration of the labelled oligo was measured using a 
Nanodrop 2000 UV-Vis spectrophotometer and the purity was checked by RP-HPLC. When 
necessary, the labelled oligo was further purified by collecting the appropriate fraction 
eluted from the column and precipitating the labelled oligo by solvent evaporation and salt 
precipitation before re-suspension. The [Ir(C^N)2(pt-TEG-Sq)]
+
 labels were attached to the 
oligo and purified in a similar manner, except the complex concentration was 10 mM in 
acetonitrile, and 800 µL additional borate buffer was added. If the solution turned cloudy on 
the combination of the complex and oligo or borate buffer, acetonitrile (<100 L) was added 
dropwise until the solution turned clear. The analytical and semi-preparative HPLC was 
performed using an Agilent Technologies 1260 Infinity LC system (CA, USA) with a 
Phenomenex Luna 5 C18(2) 100Å column (150 × 4.6 mm) (CA, USA). The mobile phase 





solvent B (acetonitrile) at a total flow rate of 1 mL/min. The oligo labeled with the Ru 
complex was examined and purified using a gradient of 5%100% solvent B over 40 min. 
The oligos labelled with iridium complexes were examined and purified using a gradient of 
5%100% solvent B over 20 min. For semi-preparative RP-HPLC, samples were made up 
to approximately 20 M in acetonitrile and loaded onto the column at a maximum injection 
volume of 100 L. 
Assay procedure. 7 L of CP@MB (2 mg/mL), 1 L of detection probe (20 M, 20 pmol) 
and differing amounts of target RNA solution were mixed in a PCR tube and made up to 20 
L final volume using binding buffer. The sample was heated to 45°C for 15 min to allow 
RNA hybridisation to occur. The beads were then washed two times using binding buffer 
with 5% T-20 and 0.1% T-100 detergent, removing excess detection probe. The beads were 
then resuspended in ProCell solution (Roche Diagnostics Australia), before dispersing 
above the working electrode of a Zensor screen printed electrode, mounted in a custom-
made holder (Fig. S4.10) pre-filled with 80 µL ProCell solution. The magnet (3 × 4 mm 
diameter rod shaped N42 rare earth; Aussie Magnets, Australia) positioned behind the 
electrode ensured the beads were rapidly collected at the surface of the working electrode 
for analysis. The ECL was detected using an 3 × 3 mm silicon photon multiplier (SiPM; 
ASD-RGB3S-P; AdvanSiD, Italy) interfaced with an ASD-EP-EB-N amplifier board 
(AdvanSiD; Fig. S4.11). The SPE holder and photodetector were housed in a light-tight 
Faraday cage. An Autolab PGSTAT 101 (Metrohm Autolab B.V.) potentiostat with NOVA 
software was used to apply a single-step chronoamperometry experiment (1.4 V vs Ag|AgCl 
for 10 s) and record the electrochemical signals. Data from the SiPM was recorded and 
processed using an eDAQ401 (eDAQ, Australia) data recording unit using the supplied 





4.5.7 Assay 2: C-reactive protein sandwich immunoassay on a gold electrode 
Attachment of the capture antibody to the electrode. Fabrication of the immunosensor was 
adapted from a previously described procedure.
42, 47
 A gold electrode (Au) was polished 
with a 0.03 m alumina/water slurry on a polishing cloth to a mirror finish, followed by 
sonicating and rinsing with distilled water. A self-assembled monolayer (SAM) was formed 
by dipping the electrode for 48 h in an ethanol solution containing 1 mM 16-
mercaptohexadecanoic acid (MHDA). The Au/MHDA electrode was then treated in a 
mixture of 5 mM 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) 
and 15 mM sulfo-N-hydroxy succinimide in Dulbecco‘s phosphate buffered saline (DPBS) 
solution for 20 min at room temperature, to activate the carboxylic acids groups of the 
MHDA. The custom capture monoclonal antibody (mAb) mAbTJ229, was covalently 
immobilized on the Au/MHA electrode by incubating the modified electrode in a 0.1 M 
PBS solution (pH 7.4) containing 100 μg/mL stock for approximately 1 h at 37°C. After 
coating with the capture mAb, individual, independently prepared Au/MHA/mAb electrodes 
were incubated with Fetal Bovine Serum for 1 h at 4°C to block the non-specific binding 
sites. 
Conjugation of ECL labels with the detection antibody. The Ir(III) complex was dissolved 
in DMF (0.01 M) and 10 L was added to an Eppendorf tube containing 1 mL 0.1 M PBS 
solution (pH = 7.4) of the monoclonal antibody mAbTJ330 (100 μg/mL) and slowly stirred 
at 4°C for 4 h. The reaction mixture was purified by different cycles of centrifugation using 
an ultra-centrifugal tube with a cut-off of 30K. 
Assay procedure. The Au/MHA electrodes with immobilized capture antibody were 
incubated with 10 ng/mL CRP solution for 1 h at 37°C. The functionalized electrodes were 
then immersed in a PBS solution containing the soluble labelled detection antibody (100 





characterization, consisting in an electrochemical cell based on modified gold-disk working 
electrode shrouded in Teflon (CH Instruments, Austin, TX, USA, 3 mm diameter), which 
were closely facing (a few millimeters) the photomultiplier tube (PMT) module (Sens-Tech 
model P30A-05, ETP, NSW, Australia). The PMT signal was amplified by TA-GI-74 Ames 
Photonics Inc. amplifier (Model D7280) and controlled by a CHI660C Electrochemical 
Workstation (CH Instruments, Inc., Austin, TX, USA). The RE employed was an Ag|AgCl 
(1M KCl) from CHI-Instruments and was separated from the catholyte by a glass frit. A 
platinum wire served as the CE. ProCell solution (Roche Diagnostics Australia) was used as 
the aqueous solvent and source of TPrA. The solutions were scanned at 0.05 V/s from +0.5 
V to +1.5/+1.6 V (according to the oxidation potential of the different complexes). 
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Chapter 5: Conclusions and future work 
In Chapter 2, a series of iridium complexes that have been reported by researchers in the 
past with a wide range of reported ECL intensities relative to Ru(bpy)3
2+
 were re-examined. 
Experiments were carried out under a range of conditions to reconcile the factors that can 
contribute to ECL intensity and highlight the variability that can be introduced from the 
experimental method used to determine the ECL performance of a complex. This study 
revealed several sources for the large discrepancies in reported ECL intensity of the 
complexes relative to Ru(bpy)3
2+
, including possible decomposition of the complex, changes 
to the electrode surface, the influence of solvent and reactant concentration, as well as the 
instrumental setup and experimental approach. This work has shown the importance of 
considering all of these parameters in the evaluation of ECL luminophores.  
In Chapter 3, a set of novel highly water-soluble iridium complexes containing 
polyethylene glycol (TEG) functionalized bipyridine (bpy) ligands were synthesized and 
their co-reactant ECL evaluated in aqueous solution. The introduction of one or two the 
TEG groups to the bpy ligand of iridium(III) complexes was shown to be a viable strategy to 
enhance the solubility of these complexes in aqueous solution while retaining the 
electrochemical and spectroscopic properties of the parent luminophore, and providing a 
convenient attachment point for the future development of ECL labels for bioconjugation in 
affinity based assays. The novel [Ir(C^N)2(Me-bpy-TEG)]Cl and [Ir(C^N)2(TEG-bpy-
TEG)]Cl complexes exhibited ECL intensities close to those of [Ru(bpy)3]
2+
, indicating that 
these iridium complexes could be excellent ECL labels. Although iridium complex ECL 
labels with different emission colors have previously been generated by modification of the 
cyclometallating (C^N) ligands, this study showed a viable strategy to create two ECL-
labels with similar ECL intensities and distinctly different emission colors from the same 





In Chapter 4, a new approach to the development of iridium complex ECL labels 
incorporating a bioconjugatable squarate group was presented. This strategy provided not 
only a more convenient synthetic approach but also superior ECL intensities and a wider 
range of emission colors from red to blue. This study provided new insight into the key 
energy requirements of the competing ECL reactions with iridium complexes, which 
showed the fundamental limits on the redox potentials and emission wavelengths of 
complexes that can generate ECL through a mechanism involving oxidation of only the 
TPrA co-reactant. Most importantly in the context of developing multi-colour ECL systems, 
the ‗window‘ of reduction potentials enabling this pathway becomes narrower as emission 
energy increases, and it does not extend across the entire visible region. This limitation is 
particularly important for bead-based assays, in which the generation of ECL is only 
feasible for certain iridium complexes meeting the energy requirements. Examination of a 
greater range of metal complexes with this approach will enable these energy boundaries to 
be clarified. The approaches outlined in this study should also be exploited to evaluate 
alternative co-reactants in conjunction with various metal complex luminophores, as 
previous studies have focused on [Ru(bpy)3]
2+
, and not under bioconjugated assay 
conditions. 
The research presented in this thesis provides a new platform for the translation of 
iridium complexes showing promising ECL properties into real-world analytical 
applications. This work will continue with the application of the new ECL labels described 
in Chapters 3 and 4 in innovative highly sensitive, multi-color and/or potential-resolved 








Supporting Information: Co-reactant electrogenerated chemiluminescence of 
iridium(III) complexes containing an acetylacetonate ligand 
 
Figure S2.1. Photoluminescence emission spectra of Ir(ppy)3. Solid lines: low temperature (77 K); Dashed 
lines: room temperature. Grey lines: uncorrected; Coloured lines: corrected for the difference in instrumental 
sensitivity over the wavelength range. Details (r.t.): ex = 350 nm; filters: Ex: 250-395 nm, Em: 430-1100 nm; 
concentration: 10 M in acetonitrile. (77 K): ex = 378 nm; filters: Ex: 250-395 nm, Em: 430-1100 nm; 









Figure S2.2. Photoluminescence emission spectra of Ir(ppy)2(acac) in acetonitrile. Solid lines: low 
temperature (77 K); Dashed lines: room temperature. Grey lines: uncorrected; Coloured lines: corrected for the 
difference in instrumental sensitivity over the wavelength range. Details (r.t.): ex = 350 nm; filters: Ex: 250-
395 nm, Em: 430-1100 nm; concentration: 10 M in acetonitrile. (77 K): ex = 300 nm; filters: Ex: 250-395 



















Figure S2.3. Photoluminescence emission spectra of Ir(bt)2(acac) in acetonitrile. Solid lines: low 
temperature (77 K); Dashed lines: room temperature. Grey lines: uncorrected; Coloured lines: corrected 
for the difference in instrumental sensitivity over the wavelength range. Details (r.t.): ex = 350 nm; filters: 
Ex: 250-395 nm, Em: 430-1100 nm; concentration: 10 M in acetonitrile. (77 K): ex = 329 nm; filters: Ex: 

















Figure S2.4. Photoluminescence emission spectra of Ir(pq)2(acac) in acetonitrile. Solid lines: low 
temperature (77 K); Dashed lines: room temperature. Grey lines: uncorrected; Coloured lines: corrected 
for the difference in instrumental sensitivity over the wavelength range. Details (r.t.): ex = 350 nm; filters: 
Ex: 250-395 nm, Em: 430-1100 nm; concentration: 10 M in acetonitrile. (77 K): ex = 345 nm; filters: Ex: 
















Figure S2.5. Photoluminescence emission spectra of [Ru(bpy)3](PF6)2 in acetonitrile. Solid lines: low 
temperature (77 K); Dashed lines: room temperature. Grey lines: uncorrected; Coloured lines: corrected 
for the difference in instrumental sensitivity over the wavelength range. Details (r.t.): ex = 450 nm; filters: 
Ex: 335-620 nm, Em: 430-1100 nm; concentration: 10 M in acetonitrile (500-800 nm shown). (77 K): ex 


















Figure S2.6. BP86/def2-TZVP ground-state singlet molecular orbital surfaces. 
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Figure S2.7. BP86/def2-TZVP calculated triplet spin density surfaces. 
Ir(ppy)3 Ir(ppy)2(acac) Ir(bt)2(acac) Ir(pq)2(acac) [Ru(bpy)3]
2+ 







Figure S2.8. Contribution of metal centre to LUMO in: (1) Ir(ppy)3; (2) Ir(ppy)2(acac); (3) Ir(bt)2(acac); 
(4) Ir(pq)2(acac); and (5) [Ru(bpy)3]
2+
. 
           
Figure S2.9. Comparison of energies of: HOMO-LUMO gap; room temperature ECL (at max); low 
temperature photoluminescence  (at max); and electrochemical E (oxidation-reduction potentials); for 
(1) Ir(ppy)3; (2) Ir(ppy)2(acac); (3) Ir(bt)2(acac); (4) Ir(pq)2(acac); and (5) [Ru(bpy)3]
2+
. The HOMO-
LUMO gaps were found to be strongly dependent on the proportion of Hartree-Fock exchange in the 
functional. As a result, the BP86 results (pure exchange-correlation functional without Hartree-Fock 
exchange) shown here represent a lower bound of DFT calculated values. 


































Supporting Information: A conceptual framework for the development of iridium(III) 
complex-based electrogenerated chemiluminescence labels 
Scheme 1. Additional ECL pathways 
Synthesis and characterization 





 ECL labels 








Figure S4.1. UV-Vis absorption spectra 
Figures S4.2-S4.5. Ambient and low temperature photoluminescence emission spectra 
Figure S4.6. Cyclic voltammograms 
Tables S4.1-S4.4. Calculated MO energies 
Figure S4.7. Contribution to the respective MOs 
Table S4.5-S4.6. Contour plots 
Figure S4.8. ECL intensity during potential sweeps
 
Figure S4.9. Photoluminescence emission spectra of ECL labels 
Table S4.7. Primers and NASBA amplicon fragment sequences 
Figure S4.10. 3D drawing and photograph of the custom screen-printed electrode (SPE) 
holder 







Scheme S4.1. (a) The ‗catalytic route‘ of co-reactant ECL involving oxidation of TPrA by M
+
, and (b) an 
alternative ECL pathway
1





contribution of these pathways to the overall emission intensity is expected to be small when low 






Synthesis of [Ir(C^N)2(dm-bpy)](PF6) and [Ir(C^N)2(ptb)](PF6) complexes 
Reagents and solvents were purchased from commercial sources and used without further 
purification. The iridium(III) dimer precursors were purchased from SunaTech (China). 
NMR spectra were acquired on a Bruker Biospin AV400 spectrometer. 
1
H NMR spectra 




H} NMR spectra were acquired at 100 MHz. All NMR 
spectra were recorded at 298 K. Chemical shifts were referenced to residual solvent peaks 
and are quoted in terms of parts per million (ppm), relative to tetramethylsilane (Si(CH3)4). 
Electrospray ionization mass spectra (ESI-MS) were acquired using a Thermo Scientific 
Exactive Plus Orbitrap Mass Spectrometer. 
[Ir(piq)2(dm-bpy)](PF6): The dimer [Ir(piq)2(μ-Cl)]2 (150 mg, 118 μmol) and 4,4′-
dimethyl-2,2′-bipyridine (50 mg, 271 μmol) were suspended in a 3:1 mixture of 
dichloromethane and methanol and heated at reflux whilst stirred in darkness under an inert 
atmosphere for 16 h. The solution was cooled to ambient temperature and a large excess of 
KPF6 was added and the mixture stirred for a further 24 h. The mixture was filtered to 
remove solid KPF6 and the filtrate was concentrated under reduced pressure. The residue 
was redissolved in a minimum amount of acetonitrile and filtered through filter aid (Celite). 
To this solution was added a saturated aqueous solution of ammonium hexafluorophosphate 
until precipitation of a brightly colored solid began to occur. The mixture was allowed to stir 
in darkness for 16 h, and the product then collected by filtration and washed with water, 
cold ethanol and diethyl ether to yield the product as a dark brown precipitate (114 mg, 
52%). 
1
H NMR (400 MHz; CD2Cl2): δ 8.98 (m, 1H), 8.32 (m, 2H), 7.92 (m, 1H), 7.80 (m, 
2H), 7.68 (d, J = 5.8 Hz, 1H ), 7.41 (d, J = 6.4 Hz, 1H), 7.34 (d, J = 6.4 Hz, 1H), 7.20 (1H, J 
= 5.1 Hz, d), 7.14 (t, J = 7.6 Hz 1H), 6.90 (t, J = 7.4 Hz, 1H), 6.34 (d, J = 8.1 Hz, 1H), 2.57 
(s, 3H). ESI-MS (positive ion). Calcd for C42H32IrN4 ([M]
+






[Ir(bt)2(dm-bpy)](PF6): The dimer [Ir(bt)2(μ-Cl)]2 (150 mg, 116 μmol) and 4,4′-dimethyl-
2,2′-bipyridine (47 mg, 255 μmol) were suspended in a 3:1 mixture of dichloromethane and 
methanol and heated at reflux whilst stirred in darkness under an inert atmosphere for 16 h. 
The solution was cooled to ambient temperature and a large excess of KPF6 was added and 
the mixture stirred for a further 24 h. The mixture was filtered to remove solid KPF6 and the 
filtrate was concentrated under reduced pressure. The crude product was then recrystallized 
from ethanol to yield the product as an orange solid (119 mg, 54%). 
1
H NMR (400 MHz; 
CD2Cl2): δ 8.23 (s, 1H), 7.95 (d, J = 5.6 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 7.85 (d, J = 7.6 
Hz, 1H), 7.37 (t, J = 7.4 Hz, 1H), 7.30 (d, J = 5.6 Hz, 1H), 7.09-7.14 (m, 2H), 6.88 (td, J = 





NMR (100 MHz; CD2Cl2): δ 181.8, 156.8, 153, 150.9, 150.7, 149.8, 140.8, 133.9, 132.6, 





): m/z 797.139. Found m/z 757.1393.  
[Ir(ppy)2(dm-bpy)](PF6): The dimer [Ir(ppy)2(μ-Cl)]2 (150 mg, 140 μmol) and 4,4′-
dimethyl-2,2′-bipyridine (57 mg, 309 μmol) were suspended in a 3:1 mixture of 
dichloromethane and methanol and heated at reflux whilst stirred in darkness under an inert 
atmosphere for 16 h. The solution was cooled to ambient temperature and a large excess of 
KPF6 was added and the mixture stirred for a further 24 h. The mixture was filtered to 
remove solid KPF6 and the filtrate was concentrated under reduced pressure. The crude 
product was then recrystallized from isopropanol to yield the product as a pale yellow solid 
(181 mg, 78%). 
1
H NMR (400 MHz; CD2Cl2): δ 8.31 (s, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.82 
(d, J = 5.6 Hz, 1H), 7.78 (td, J = 7.8, 1.5 Hz, 1H), 7.73 (dd, J = 7.8, 0.9 Hz, 1H), 7.51 (d, J = 
5.7 Hz, 1H), 7.23 (d, J = 5.5 Hz, 1H), 7.06 (td, J = 7.5, 1.1 Hz, 1H), 7.00 (ddd, J = 7.4, 5.9, 
1.4 Hz, 1H), 6.92 (td, J = 7.5, 1.4 Hz, 1H), 6.32 (d, J = 7.6 Hz, 1H), 2.58 (s, 3H). ESI-MS 
(positive ion). Calcd for C34H28IrN4 ([M]
+





[Ir(df-ppy)2(dm-bpy)](PF6): The dimer [Ir(df-ppy)2(μ-Cl)]2 (150 mg, 123 μmol) and 4,4′-
dimethyl-2,2′-bipyridine (50 mg, 271 μmol) were suspended in a 3:1 mixture of 
dichloromethane and methanol and heated at reflux whilst stirred in darkness under an inert 
atmosphere for 16 h. The solution was cooled to ambient temperature and a large excess of 
KPF6 was added and the mixture stirred for a further 24 h. The mixture was filtered to 
remove solid KPF6 and the filtrate was concentrated under reduced pressure. The crude 
product was then recrystallized from isopropanol to yield the product as a pale yellow solid 
(165 mg, 74%). 
1
H NMR (400 MHz; CD2Cl2): δ 8.37 (s, 1H), 8.32 (d, J = 8.4 Hz, 1H), 7.82 
(m, 2H), 7.50 (d, J = 5.7 Hz, 1H), 7.29 (d, J = 5.7 Hz, 1H), 7.05 (m, 1H), 6.62 (ddd, J = 12.5, 





): m/z 757.157. Found m/z 757.1575. 
[Ir(piq)2(ptb)](PF6): This complex was synthesized according to the previously published 
procedure.
2
 The dimer [Ir(piq)2(μ-Cl)]2 (150 mg, 118 μmol) and 2-(1-(benzyl)-1H-1,2,3-
triazol-4-yl)pyridine (56 mg, 236 μmol) were suspended in a 3:1 mixture of 
dichloromethane and methanol. Starting materials typically solubilized within 1 h. Reactions 
were stirred in darkness under an inert atmosphere for 16 h. The solvents were then removed, 
and the residue dissolved in acetonitrile and filtered through a filter aid (Celite). The solvent 
was then removed by evaporation under reduced pressure and the residue redissolved in a 
minimum amount of ethanol and filtered through filter aid (Celite). To this solution was 
added a saturated aqueous solution of ammonium hexafluorophosphate until precipitation of 
a brightly colored solid began to occur. The mixture was allowed to stir in darkness for 16 h, 
and the product was then collected by filtration and washed with water, cold ethanol, ether, 
and lastly pentane, and then dried in vacuo to yield the product as an orange solid (153 mg, 
66 %). 
1
H NMR spectra was consistent with the literature values. 
1
H NMR (400 MHz; 





3H), 7.84-7.99 (m, 4H), 7.69 (d, J = 5.6 Hz, 1H), 7.60 (d, J = 6.4 Hz, 1H), 7.39 (t, J = 6.9 
Hz, 2H), 7.09-7.33 (m, 9H), 6.93 (t, J = 7.4 Hz, 1H), 6.84 (t, J = 7.4 Hz, 1H), 6.51 (d, J = 





): m/z 837.231. Found m/z 837.2410. 
[Ir(bt)2(ptb)](PF6): The dimer [Ir(bt)2(μ-Cl)]2 (150 mg, 116 μmol) and 2-(1-(benzyl)-1H-
1,2,3-triazol-4-yl)pyridine (55 mg, 232 μmol) were suspended in a 3:1 mixture of 
dichloromethane and methanol. Starting materials typically solubilized within 1 h. Reactions 
were stirred in darkness under an inert atmosphere for 16 h. The solvents were then removed 
and the residue dissolved in acetonitrile and filtered through a filter aid (Celite). The solvent 
was then removed by evaporation under reduced pressure and the residue redissolved in a 
minimum amount of ethanol and filtered through filter aid (Celite). To this solution was 
added a saturated aqueous solution of ammonium hexafluorophosphate until precipitation of 
a brightly colored solid began to occur. The mixture was allowed to stir in darkness for 16 h, 
and the product was then collected by filtration and washed with water, cold ethanol, ether, 
and lastly pentane, and then dried in vacuo to yield the product as a dark yellow solid (191 
mg, 83%). 
1
H NMR (400 MHz; CD2Cl2): δ 8.67 (s, 1H), 8.06 (dq, J = 8.0, 0.8 Hz, 1H), 8.00 
(td, J = 7.8, 1.6 Hz, 1H), 7.94 (dq, J = 5.5, 0.8 Hz, 1H), 7.90 (dq, J = 8.1, 0.6 Hz, 1H), 7.87 
(dq, J = 8.1, 0.6 Hz, 1H), 7.84 (m, 1H), 7.80 (m, 1H), 7.32-7.43 (m, 6H), 7.25-7.29 (m, 2H), 
7.11 (td, J = 7.6, 1.2 Hz, 1H), 7.03-7.08 (m, 2H), 6.95 (ddd, J = 8.5, 7.3, 1.3 Hz, 1H), 6.88 
(td, J = 7.6, 1.5 Hz, 1H), 6.82 (td, J = 7.6, 1.5 Hz, 1H), 6.48 (d, J = 7.7 Hz, 1H), 6.40 (d, J = 
8.4 Hz, 1H), 6.37 (d, J = 7.8 Hz, 1H), 6.08 (d, J = 8.3 Hz, 1H), 5.65 (d, J = 14.8 Hz, 1H), 





 NMR (100 MHz; CD2Cl2): δ 182.2, 181.3, 151.1, 150.6, 150.2, 150.0, 149.7 (2C), 146.4, 
141.3, 140.9, 140.6, 134.2, 134.0 (2C), 132.5, 132.0 (2C), 131.9, 129.9 (2C), 129.8, 128.6 









): m/z 849.144. Found m/z 
849.1458. 
[Ir(ppy)2(ptb)](PF6): This complex was synthesized according to the previously published 
procedure.
2
 The dimer [Ir(ppy)2(μ-Cl)]2 (150 mg, 140 μmol) and 2-(1-(benzyl)-1H-1,2,3-
triazol-4-yl)pyridine (66 mg, 280 μmol) were suspended in a 3:1 mixture of 
dichloromethane and methanol. Starting materials typically solubilized within 1 h. Reactions 
were stirred in darkness under an inert atmosphere for 16 h. The solvents were then removed 
and the residue dissolved in acetonitrile and filtered through a filter aid (Celite). The solvent 
was then removed by evaporation under reduced pressure and the residue redissolved in a 
minimum amount of ethanol and filtered through filter aid (Celite). To this solution was 
added a saturated aqueous solution of ammonium hexafluorophosphate until precipitation of 
a brightly colored solid began to occur. The mixture was allowed to stir in darkness for 16 h, 
and the product was then collected by filtration and washed with water, cold ethanol, ether, 
and lastly pentane, and then dried in vacuo to yield the product as a yellow solid (197 mg, 
80%). 
1
H NMR spectra was consistent with the literature values. 
1
H NMR (400 MHz; 
CD2Cl2): δ 8.62 (s, 1H), 8.11 (d, J = 7.9 Hz, 1H), 7.99 (dt, J = 7.9, 1.6 Hz, 1H), 7.95 (t, 8.8 
Hz, 2H), 7.76-7.84 (m, 3H), 7.69-7.74 (m, 2H), 7.67 (d, J = 5.8 Hz, 1H), 7.49 (d, J = 5.8 Hz, 
1H), 7.38-7.42 (m, 3H), 7.26-7.34 (m, 3H), 7.00-7.09 (m, 3H), 6.98 (ddd, J = 7.5, 5.8, 1.4 
Hz, 1H), 6.93 (td, J = 7.5, 1.3 Hz, 1H), 6.88 (td, J = 7.5, 1.3 Hz, 1H), 6.32 (dd, J = 7.7, 0.6 





): m/z 737.200. Found m/z 737.2012. 
[Ir(df-ppy)2(ptb)](PF6): This complex was synthesized according to the previously 
published procedure.
2
 The dimer [Ir(df-ppy)2(μ-Cl)]2 (100 mg, 82 μmol) and 2-(1-(benzyl)-
1H-1,2,3-triazol-4-yl)pyridine (39 mg, 165 μmol) were suspended in a 3:1 mixture of 





were stirred in darkness under an inert atmosphere for 16 h. The solvents were then removed 
and the residue dissolved in acetonitrile and filtered through a filter aid (Celite). The solvent 
was then removed by evaporation under reduced pressure and the residue redissolved in a 
minimum amount of ethanol and filtered through filter aid (Celite). To this solution was 
added a saturated aqueous solution of ammonium hexafluorophosphate until precipitation of 
a brightly colored solid began to occur. The mixture was allowed to stir in darkness for 16 h, 
and the product was then collected by filtration and washed with water, cold ethanol, ether, 
and lastly pentane, and then dried in vacuo to yield the product as a yellow solid (126 mg, 
80%). 
1
H NMR spectra was consistent with the literature values. 
1
H NMR (400 MHz; 
CDCl3): δ 8.80 (s, 1H), 8.30 (t, J = 10.5 Hz, 2H), 8.22 (d, J = 7.9 Hz, 1H), 8.00 (td, J = 7.9, 
1.5 Hz, 1H), 7.79-7.83 (m, 3H), 7.61 (d, J = 5.8 Hz, 1H), 7.45 (d, J = 5.8 Hz, 1H), 7.36 (s, 
5H), 7.32 (m, 1H), 7.11 (ddd, J = 7.3, 5.9, 1.3 Hz, 1H), 7.01 (ddd, J = 7.3, 5.9, 1.3 Hz, 1H), 
6.55 (m, 2H), 5.73 (dd, J = 8.5, 2.5 Hz, 1H), 5.68 (dd, J = 8.5, 2.3 Hz, 1H), 5.58 (s, 2H). 




): m/z 808.162. Found m/z 808.1638. 
Synthesis of pt-TEG ligand and [Ir(C^N)2(pt-TEG)]Cl complexes 
The iridium(III) dimer precursors were purchased from SunaTech (China). The ligand pt-
TEG was synthesized according to the previously reported procedure.
3
 Nuclear magnetic 
resonance (NMR) spectra were acquired on a Jeol 400 spectrometer or a Bruker Ascend 500 
spectrometer. 
1





spectra were acquired at 101 MHz or 126 MHz, and 
19
F NMR acquired at 471 MHz. All 






H} chemical shifts are referenced to 
residual solvent peaks and quoted in ppm relative to TMS. 
19
F NMR signals are quoted 
relative to an internal standard of trifluoroacetic acid. HRMS spectra were recorded on an 







A solution of sodium hydroxide (0.70 g, 17.5 mmol) in H2O (4 mL) was added to a solution 
of tetraethylene glycol (20 mL, 116 mmol) in THF (4 mL, 0°C). A mixture of tosyl chloride 
(2.12 g, 11.1 mmol) in THF (4 mL) was added dropwise over 1 h to the mixture and was 
stirred for a further 3.5 h at 0°C. The mixture was added to iced water (100 mL) and 
extracted with DCM (3 × 50 mL). The combined organic extracts were washed (H2O, 2 × 30 
mL) then dried (MgSO4) and the solvent was removed under reduced pressure to afford a 
slightly yellow oil (3.66g, 91%), 
1
H NMR (400 MHz; CDCl3): δ 7.81-7.79 (m, 2H, ArH), 





H} NMR (101 MHz; CDCl3): δ 144.9, 133.0, 129.9, 128.1, 72.5, 70.8, 70.7, 70.6, 
70.4, 69.3, 68.8, 61.8, 21.7. 
2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethan-1-ol: 
  
A mixture of the product above (3.56 g, 9.83 mmol) and sodium azide (1.47 g, 22.6 mmol) 
in ethanol (60 mL) was stirred at 70°C for 16 h. The solution was let cool to ambient 
temperature before H2O (50 mL) was added and the solvent volume was reduced under 
reduced pressure. The aqueous mixture was extracted with ethyl acetate (3 × 50 mL) and the 
combined organic extracts were dried (MgSO4). The solvent was removed under reduced 
pressure and the residue purified by column chromatography (SiO2, 100% DCM  5% 
MeOH) to afford a slightly yellow oil (1.30g, 60%). 
1
H NMR (400 MHz; CDCl3): δ 3.68 (t, 














To a solution of the azide (0.57 g, 2.6 mmol) in a 2:1 mixture of DMSO/H2O (3 mL) was 
added 2-ethynylpyridine (0.33 g, 3.23 mmol), CuSO4.5H2O (15 mg, 2 mol%) and sodium 
ascorbate (0.10 g, 20 mol%). The mixture was stirred at ambient temperature for 20 h before 
the reaction was quenched by addition of 1M EDTA in NH4OH (50 mL). The mixture was 
extracted with DCM (3 × 50 mL) and the combined organic extracts were dried (MgSO4) 
and the solvent was removed under reduced pressure. The residue was purified by column 
chromatography (SiO2, 100% DCM  5% MeOH) to afford a yellow oil (0.50 g, 60%). 
1
H 
NMR (400 MHz; CDCl3) δ 8.56 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 8.41 (s, 1H), 8.18 (dt, J = 
8.0, 1.1 Hz, 1H), 7.81 – 7.75 (m, 1H), 7.23 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 4.64 – 4.59 (m, 




H} NMR (101 MHz, CDCl3) δ 150.3, 149.1, 147.8, 137.5, 123.8, 123.0, 120.6, 72.7, 
70.8, 70.7, 70.6, 70.4, 69.6, 61.8, 50.6. 
[Ir(piq)2(pt-TEG)]Cl: The dimer [Ir(piq)2(μ-Cl)]2 (229 mg, 0.2 mmol) and the ligand pt-
TEG (117 mg, 0.4 mmol) were suspended in a stirred solution of dichloromethane and 
methanol (3:1 v/v, 10 mL). Full dissolution occurred within 1 h and the solution was 
allowed to stir in the dark for 14 h. The solution was concentrated under reduced pressure 
and the residue was taken up in a minimum of dichloromethane then diethyl ether was 
added until the mixture became cloudy. The mixture was stored at -20°C overnight to afford 
an orange powder. The solid was isolated by filtration, washed with diethyl ether and dried 
in vacuo to afford an orange powder (189 mg, 56%). 
1
H NMR (400 MHz; CDCl3): δ 10.38 
(s, 1H), 9.02 (d, J = 7.9 Hz, 1H), 8.95 (ddd, J = 10.5, 6.9, 3.4 Hz, 2H), 8.24 (dd, J = 10.4, 





(m, 2H), 7.41-7.37 (m, 2H), 7.32-7.28 (m, 1H), 7.18-7.14 (m, 1H), 7.12-7.08 (m, 1H), 7.06-
7.02 (m, 1H), 6.90-6.86 (m, 1H), 6.83-6.79 (m, 1H), 6.39 (dd, J = 7.7, 1.1 Hz, 1H), 6.30-
6.28 (m, 1H), 4.70-4.61 (m, 2H), 3.94 (ddd, J = 13.0, 6.4, 4.2 Hz, 1H), 3.71 (dd, J = 6.0, 3.0 




H} NMR (101 MHz; CDCl3): δ 169.6, 168.8, 153.7, 
150.2, 150.1, 149.6, 148.4, 145.8, 145.6, 141.4, 140.5, 139.9, 137.2, 137.1, 132.6, 132.5, 
131.7, 131.7, 130.8, 130.6, 130.3, 130.1, 129.3, 128.7, 128.6, 127.7, 127.5, 127.2, 126.9, 
126.4, 125.9, 124.9, 122.3, 122.0, 121.0, 121.5, 77.4, 72.8, 70.6, 70.6, 70.4, 70.2, 68.4, 61.5, 




): m/z 923.29. Found m/z 
923.2500. 
[Ir(bt)2(pt-TEG)]Cl: The dimer [Ir(bt)2(μ-Cl)]2 (247 mg, 0.2 mmol) and the ligand pt-TEG 
(124 mg, 0.4 mmol) were stirred in a mixture of dichloromethane and methanol (3:1 v/v, 
10 mL) and the solution was allowed to stir in the dark for 14 h. Some solid was still present 
and was removed by centrifugation and the supernatant was decanted off and retained. The 
supernatant was concentrated under reduced pressure and the residue was taken up in a 
minimum of dichloromethane then PET spirits (bp 40-60°C) was added until the mixture 
became cloudy. The mixture was stored at -20°C overnight to afford a yellow crystalline 
solid. The solid was isolated by filtration, washed with PET spirits and dried in vacuo to 
afford a yellow crystalline powder (154 mg, 42%). 
1
H NMR (400 MHz; DMSO-d6): δ 9.40 
(s, 1H), 8.44 (d, J = 8.0 Hz, 1H), 8.25 (m, 3H,), 8.01 (d, J = 7.7 Hz, 1H), 7.91 (d, J = 7.6 Hz, 
1H,), 7.87 (d, J = 5.5 Hz, 1H), 7.66 (m, 1H), 7.46 (m, 1H), 7.42 (m, 1H), 7.29 (m, 1H), 7.14 
(m, 2H), 7.02 (m, 1H), 6.93 (m, 1H), 6.83 (m, 1H), 6.35 (m, 2H), 6.28 (d, J = 7.7 Hz, 1H), 




H} NMR (101 
MHz; DMSO-d6): δ 181.5, 180.8, 150.0, 149.7, 148.7, 148.5, 148.4, 146.6, 140.8, 140.4, 
140.2, 132.9, 132.8, 132.0, 131.3, 131.2 (2C), 131.2, 128.3, 128.0, 127.6, 127.3, 127.0, 









): m/z 935.20. 
Found m/z 935.1620. 
[Ir(ppy)2(pt-TEG)]Cl: The chlorido-bridged dimer [Ir(ppy)2(μ-Cl)]2 (132 mg, 123 μmol) 
and the ligand pt-TEG (80 mg, 247 μmol) were suspended in a stirred solution of 
dichloromethane and methanol (3:1 v/v, 5 mL). Full dissolution occurred within 1 h and the 
solution was allowed to stir in the dark for 14 h. The solvent was removed under reduced 
pressure and the residue redissolved in acetonitrile (3 mL) and filtered through Celite filter 
aid. The filtrate was evaporated under reduced pressure to dryness and diethyl ether (20 mL) 
added. The suspension was sonicated for 15 min and the precipitate collected by filtration 
and copiously washed with diethyl ether and pentane. The crude solid was purified via silica 
gel chromatography with a gradient of methanol (0-10%) in dichloromethane. The collated 
fractions were evaporated under reduced pressure and to yield the product as a yellow 
powder (188 mg, 89%). 
1
H NMR (500 MHz; CDCl3): δ 10.46 (s, 1H), 9.04 (d, J = 8.0 Hz, 
1H), 8.04 (td, J = 7.8, 1.5 Hz, 1H), 7.90 (m, 2H), 7.78-7.74 (m, 3H), 7.70 (dd, J = 5.8, 
0.7 Hz, 1H), 7.67-7.64 (m, 2H), 7.50 (dd, J = 5.8, 0.7 Hz, 1H), 7.22 (ddd, J = 7.6, 5.6, 
1.3 Hz, 1H), 7.07 (ddd, J = 7.3, 5.9, 1.4 Hz, 1H), 7.03 (td, J = 7.5, 1.0 Hz, 1H), 7.00-6.97 (m, 
2H), 6.91 (td, J = 7.4, 1.2 Hz, 1H), 6.87 (td, J = 7.4, 1.2 Hz, 1H), 4.77-4.68 (m, 2H), 4.05-
3.99 (m, 2H), 3.76-3.66 (m, 4H), 3.68-3.57 (m, 8H). 
13
C NMR (126 MHz; CDCl3): δ 168.4, 
167.6, 150.3, 150.1, 149.5, 149.4, 148.5, 148.4, 146.6, 143.8, 143.6, 139.8, 137.8, 137.7, 
131.9, 131.7, 130.6, 130, 129.3, 125.8, 124.7, 124.6, 124.2, 123.3, 122.8, 122.6, 122.1, 





): m/z 823.258. Found m/z 823.2571. 
[Ir(df-ppy)2(pt-TEG)]Cl: The chlorido-bridged dimer [Ir(df-ppy)2(μ-Cl)]2 (340 mg, 
280 μmol) and the ligand pt-TEG (182 mg, 564 μmol) were suspended in a stirred solution 





the solution was allowed to stir in the dark for 14 h. The solvent was removed under reduced 
pressure and the residue redissolved in acetonitrile (3 mL) and filtered through Celite filter 
aid. The filtrate was evaporated under reduced pressure to dryness and diethyl ether (20 mL) 
added. The suspension was sonicated for 15 min and the precipitate collected by filtration 
and copiously washed with diethyl ether and pentane. The solid was dried in vacuo to give 
the complex as a light-yellow powder (380 mg, 73%). 
1
H NMR (500 MHz; CDCl3): δ 9.16 
(s, 1H), 8.40 (d, J = 8.0 Hz, 1H), 8.28 (t, J = 10.0 Hz, 2H), 8.01 (t, J = 7.8 Hz, 1H), 7.80 (m, 
3H), 7.65 (d, J = 5.7 Hz, 1H), 7.50 (d, J = 5.7 Hz, 1H), 7.31 (t, J = 6.6 Hz, 1H), 7.15 (t, J 
= 6.7 Hz, 1H), 7.05 (t, J = 6.7 Hz, 1H), 6.55 (m, 1H), 6.48 (m, 1H), 5.71 (d, J = 7.7 Hz, 1H), 
5.66 (d, J = 8.0 Hz, 1H), 4.69‑4.58 (m, 2H), 3.95‑3.89 (m, 2H), 2.69 (broad s, 1H). 
13
C 
NMR (101 MHz; CDCl3
162.0 (m), 160.0 (m), 153.9 (d), 150.2, 150.0 (d), 149.7, 149.4, 148.7, 148.4, 140.7, 139.1, 
139.0, 129.7, 127.9 (m, 2C), 126.4, 125.2, 123.9, 123.7 (d), 123.5 (d), 123.3, 114.2 (m, 2C), 
99.1 (m, 2C), 77.4, 72.8, 70.6, 70.5, 70.2, 68.4, 61.4, 52.2. 
19
F NMR (376 MHz; CDCl3




): m/z 895.221. Found m/z 895.2184. 
Synthesis of the pt-TOxT-Sq ligand 
General  
Reagents and solvents were purchased from various commercial sources and used without 
further purification. NMR spectra were acquired on a Jeol 400 spectrometer or a Bruker 
Ascend 500 spectrometer. 
1





NMR spectra were acquired at 101 MHz or 126 MHz, and 
19
F NMR acquired at 471 MHz. 
All NMR spectra were recorded at 298 K. Chemical shifts were referenced to residual 
solvent peaks and are quoted in terms of parts per million (ppm), relative to 
tetramethylsilane (Si(CH3)4); 
19





trifluoroacetic acid. Electrospray ionization mass spectra (ESI-MS) were acquired using a 





To a solution of 4,7,10-trioxa-1,13-tridecanediamine (18.2 g, 82.5 mmol) in 1,4-dioxane 
(150 mL) a solution of Boc2-O (3.00 g, 13.8 mmol) in 1,4-dioxane (80 mL) was added 
dropwise at ambient temperature over 16 h. The solution was stirred for a further 30 h 
before the solvent was removed under reduced pressure and the residue taken up in H2O. 
The aqueous mixture was extracted with dichloromethane (8 × 80 mL) and the combined 
organic extracts were washed with brine (2 × 200 mL). The organic phase was then dried 
(MgSO4), filtered and the solvent removed under reduced and the product isolated as a 
yellow oil after the residue was purified by silica gel chromatography using a solvent 
gradient of 100% dichloromethane  10% methanol/2% aq. ammonia/88% 
dichloromethane (2.96 g, 9.23 mmol, 67%). 
1
H NMR (400 MHz; CDCl3): δ 5.17 (s, 1H), 





A flask containing sodium azide (6.04 g, 93.0 mmol), H2O (30 mL) and dichloromethane 
(75 mL) was cooled to 0°C and triflic anhydride (3 mL, 18.0 mmol) was added dropwise. 
After 15 min the mixture was stirred vigorously at ambient temperature for 3.5 h. The 
organic layer was separated and the aqueous layer was back extracted with dichloromethane 





phase was then added dropwise to 1-amino,13-(Boc-amino)-4,7,10-trioxatridecane (2.92 g, 
9.12 mmol), K2CO3 (2.59 g, 18.7 mmol) and CuSO4.5H2O (cat.) in a methanol/water (90 
mL/60mL) solvent mixture. The mixture was stirred vigorously for 3 days before the 
organic phase was separated, washed with H2O (2×40 mL) and the aqueous phases were 
back extracted with dichloromethane (2×40 mL). The combined organic extracts were dried 
(MgSO4), filtered and the solvent removed under reduced pressure. The residue was loaded 
onto a silica column and eluted with a gradient of 100% dichloromethane4%methanol/96% 
dichloromethane to afford a slightly yellow oil (1.99 g, 5.74 mmol, 63%). 
1
H NMR (400 
MHz; CDCl3): δ 4.98 (s, 1H), 3.65-3.51 (m, 12H), 3.38 (t, J = 6.7 Hz, 2H), 3.21 (m, 2H), 




C NMR (101 MHz; CDCl3): δ 156.1, 79.0, 





A mixture of 1-azido,13-(Boc-amino)-4,7,10-trioxatridecane (1.95 g, 5.62 mmol), 2-
ethynylpyridine (0.65 g, 6.26 mmol) and sodium ascorbate (20 mol%) was set stirring in 
DMSO/H2O (2:1, 3 mL) then CuSO4.5H2O (2 mol%) was added. After 5 days H2O was 
added (40 mL) and the mixture was extracted with dichloromethane (3×30 mL). The organic 
phase was washed with brine, dried (MgSO4) and filtered then the solvent was removed 
under reduced pressure and any remaining DMSO was removed in vacuo. The residue was 
purified by silica gel chromatography using ethyl acetate as the eluent to afford a yellow oil 
(2.36 g, 5.44 mmol, 97%). 
1
H NMR (400 MHz; CDCl3): δ 8.57 (ddd, J = 4.9, 1.8, 1.0 Hz, 
1H), 8.18 (s, 1H), 8.16 (t, J = 1.0 Hz, 1H), 7.77 (td, J = 7.8, 1.8 Hz, 1H), 7.22 (ddd, J = 7.5, 










C NMR (101 MHz; CDCl3): δ 156.1, 150.5, 149.5, 148.3, 137.0, 122.9, 122.6, 120.3, 
70.7, 70.6, 70.5, 70.3, 69.7, 67.2, 47.4, 38.6, 30.3, 29.8, 29.7, 28.5. 
pt-TOxT-Sq: 
 
A mixture of 2-(1-(13-(Boc-amino)-4,7,10-trioxatridecyl)-1H-1,2,3-triazol-4-yl)pyridine 
(0.656 g, 1.44 mmol) and trifluoroacetic acid (2 mL) in acetonitrile (10 mL) was set stirring 
at 50°C. After 2.5 h the reaction was cooled to ambient temperature and potassium 
carbonate was cautiously added to adjust the reaction mixture to pH 7. The reaction mixture 
was added dropwise to a round bottom flask containing 3,4-diethoxy-3-cyclobutene-1,2-
dione (0.737 g, 4.33 mmol) and potassium carbonate (3.43 g, 24.8 mmol) in acetonitrile (25 
mL). The reaction mixture was then stirred for 18 h before being filtered through celite and 
the solvent was removed affording a yellow residue. The residue was washed with 
dichloromethane, the washings were retained, and the solvent volume reduced before 
purification by column chromatography (SiO2, DCM10%MeOH/DCM) to afford a light-
yellow oil (0.625 g, 1.32 mmol, 92%). 
1
H NMR (500 MHz; CD3CN): δ 8.56 (d, J = 4.6 Hz, 
1H), 8.27 (s, 1H), 8.07 (d, J = 7.9 Hz, 1H), 7.82 (td, J = 7.7, 1.7 Hz, 1H), 7.27 (ddd, J = 7.5, 
4.9, 1.0 Hz, 1H), 4.65 (m, 2H), 4.50 (t, J = 6.9 Hz, 2H), 3.54 (m, 14H), 2.15 (dq, J = 13.4, 




H} NMR (126 MHz; 
CD3CN): δ 190.2, 151.5, 150.6, 148.8, 137.9, 123.9, 123.8, 123.7, 120.5, 71.1, 70.9, 70.9, 
70.1, 69.2, 69.0, 68.0, 48.2, 43.0, 31.0, 16.1. 
Synthesis of the [Ir(C^N)2(pt-TOxT-Sq)]
+








A mixture of the appropriate iridium precursor and pt-TOxT-Sq was set stirring in a solvent 
mixture of methanol/dichloromethane (3:1). The reaction was stirred overnight at ambient 
temperature and the solvent was removed after TLC confirmed the reaction was complete. 
The solvent was removed under reduced pressure. The residue was taken up in a minimum 
of dichloromethane and diethyl ether was layered on top. A residue settled at the bottom of 
the flask after storing at -20°C for 72 h. The supernatant was decanted off and the residue 
was washed with diethyl ether (×3). A solid was isolated by filtration after trituration of the 
residue with diethyl ether. 
[Ir(ppy)2(pt-TOxT-Sq)]Cl. The chlorido-bridged dimer [Ir(ppy)2(μ-Cl)]2 was reacted as 
detailed in the general procedure affording a yellow powder (0.473 g, 0.47 mmol, 75%). 
1
H 
NMR (500 MHz; CD3CN): δ 9.40 (m, 1H), 8.41-8.37 (m, 1H), 8.05 (m, 3H), 7.86-7.74 (m, 
6H), 7.63 (d, J=5.3 Hz, 1H), 7.34 (ddd, J =7.4, 5.8, 1.3 Hz, 1H), 7.10 (ddd, J = 7.3, 6.0, 1.3, 
1H), 7.04 (m, 2H), 6.92 (m, 2H), 6.81 (td, J = 7.4, 1.1 Hz, 1H), 6.26 (m, 2H), 4.64 (m, 2H), 





H} NMR (126 MHz; CD3CN): δ 168.6, 168.2, 151.1, 150.8, 150.7, 150.2, 149.4, 
147.7, 145.3, 145.3, 140.7, 139.5, 139.4, 132.8, 132.4, 131.2, 130.6, 128.3, 127.5, 125.8, 
125.3, 124.6, 124.3, 124.0, 123.5, 123.1, 120.7, 120.6, 71.0, 70.9, 70.8, 70.8, 70 .0, 69.1, 




): m/z 974.322. 
Found m/z 974.3229. 
[Ir(bt)2(pt-TOXT-Sq)]Cl. The chlorido-bridged dimer [Ir(bt)2(μ-Cl)]2 was reacted as 
detailed in the general procedure affording a yellow powder (0.320 g, 0.29 mmol, 52%). 
1
H 
NMR (400 MHz; CD3CN): δ 9.16 (s, 1H), 8.26 (d, J = 7.9 Hz, 1H), 8.06 (m, 3H), 7.95 (m, 
2H), 7.84 (m, 1H), 7.40 (m, 3H), 7.27 (m, 1H), 7.11 (m, 2H), 7.03 (td, J= 7.5,
 
1.0 Hz, 1H), 





J = 7.6 Hz, 1H), 6.36 (d, J = 7.6 Hz, 1H), 6.16 (d, J = 8.4 Hz, 1H), 4.62 (d, J = 6.3 Hz, 2H), 
4.54 (t, J = 6.5 Hz, 2H), 3.37 (m, 14H), 3.02 (s, 1H), 2.03 (q, J = 6.1 Hz, 2H), 1.71 (q, J = 




H} NMR (101 MHz; CD3CN): δ 182.7, 182.1, 
151.7, 151.2, 150.9, 150.1, 150.1, 149.8, 147.5, 141.9, 141.5, 141.3, 134.4, 134.4, 132.8, 
132.6, 132.6, 132.2, 129.2, 128.9, 128.6, 128.0, 127.7, 127.2, 126.9, 124.9, 124.8, 124.3, 
123.9, 123.8, 119.1, 118.3, 70.9, 70.9, 70.8, 70.0, 69.1, 67.2, 50.5, 42.9, 42.6, 31.6, 31.0, 




): m/z 1086.266. 
Found m/z 1086.2673. 
[Ir(piq)2(pt-TOxT-Sq)]Cl. The chlorido-bridged dimer [Ir(piq)2(μ-Cl)]2 was reacted as 
detailed in the general procedure affording an orange powder (0.547 g, 0.49 mmol, 93%). 
1
H NMR (400 MHz; [CD3CN]): δ 9.14 (s, 1H), 9.01 (m, 2H), 8.38 (d, J = 8.0 Hz, 1H), 8.31 
(m, 2H), 8.02 (m, 3H,), 7.83 (m, 4H), 7.70 (m, 1H), 7.67 (d, J = 6.4 Hz), 7.54 (d, J = 6.4 Hz, 
1H), 7.49 (d, J = 6.4 Hz, 1H), 7.43 (d, J = 6.4 Hz, 1H), 7.31 (ddd, J = 7.7, 5.6, 1.3 Hz, 1H), 
7.13 (ddd, J = 8.2, 7.2, 1.2 Hz, 1H), 7.04 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 6.89 (td, J = 7.4, 
1.2 Hz, 1H), 6.77 (td, J = 7.4, 1.2 Hz, 1H), 6.42 (d, J = 7.5 Hz, 1H), 6.28 (dd, J = 7.7, 1.1 
Hz, 1H), 4.62 (m, 2H), 4.46 (t, J = 6.8 Hz, 2H), 3.32 (m, 15H), 1.98 (dd, J = 6.5, 5.2 Hz, 




H} NMR (101 MHz; [CD3CN]): 
δ 169.5, 169.2, 154.3, 151.2, 151.0, 150.4, 149.2, 146.8, 146.7, 142.4, 141.8, 140.7, 138.1, 
138.0, 133.3, 133.1, 132.8, 132.8, 131.7, 131.3, 131.2, 130.6, 129.9, 129.8, 128.6, 128.5, 
128.1, 127.7, 127.6, 127.1, 127.0, 123.9, 123.3, 122.9, 122.8, 122.6, 70.9, 70.8, 70.7, 70.0, 





1074.353. Found m/z 1074.3534. 
[Ir(df-ppy)2(pt-TOXT-Sq)]Cl. The chlorido-bridged dimer [Ir(df-ppy)2(μ-Cl)]2 was reacted 
as detailed in the general procedure affording a yellow powder (0.276 g, 0.25 mmol, 61%). 
1





7.89 (m, 3H), 7.76 (m, 1H), 7.66 (m, 1H), 7.39 (m, 1H), 7.13 (m, 2H), 6.66 (m, 2H), 5.73 
(ddd, J = 24.1, 8.7, 2.3 Hz, 2H), 4.63 (m, 2H), 4.54 (m, 2H), 3.45 (m, 15H), 2.09 (q, J = 6.2 




H} NMR (126 MHz; CD3CN): δ 
164.7 (m, CF), 163.4 (m, CF), 162.8 (m, CF), 161.0 (m, CF), 154.9 (m, CF), 151.9 (m, CF), 
151.6, 151.0, 150.7, 150.3, 141.3, 140.5, 140.5, 128.4, 128.0, 125.1, 124.8, 124.7, 124.54, 
124.5, 124.3, 124.2, 114.8 (m, CF), 99.6 (m, CF), 71.0, 70.9, 70.8, 70.79, 70.0, 69.2, 67.6, 
57.9, 50.6, 30.4, 18.8, 16.2. 
19
F NMR (471 MHz; CD3CN): δ -106.18 (d, J = 10.6, 1F), -
107.06 (d, J = 9.6, 1F), -108.07 (d, J = 10.5, 1F), -108.87 (d, J = 10.2, 1F). ESI-MS 



















, where C^N = piq (red lines), bt (orange lines), ppy (green lines) or df-ppy (blue 
lines). The metal complexes were prepared at a concentration of 10 M in acetonitrile (a-c) or water (d). The 




























































































































































Figure S4.2. Normalized photoluminescence emission spectra of (a) Ir(piq)2(acac), (b) Ir(bt)2(acac), (c) 
Ir(ppy)2(acac), and (d) Ir(df-ppy)2(acac). Black lines: corrected spectra at 85 K (solid) and room temperature 
(dashed). Grey lines: uncorrected spectra at 85 K (solid) and room temperature (dashed). Conditions: 85 K 
spectra: 5 M in 4:1 (v/v) ethanol:methanol; excitation wavelengths (ex) were between 300 and 342 nm. 


































































































, and (d) [Ir(df-ppy)2(dm-bpy)]
+
. Black lines: corrected spectra at 85 K (solid) 
and room temperature (dashed). Grey lines: uncorrected spectra at 85 K (solid) and room temperature (dashed). 
Conditions: 85 K spectra: 5 M in 4:1 (v/v) ethanol:methanol; ex = 295-374 nm. Room temperature spectra: 


































































































, and (d) [Ir(df-ppy)2(ptb)]
+
. Black lines: corrected spectra at 85 K (solid) and room 
temperature (dashed). Grey lines: uncorrected spectra at 85 K (solid) and room temperature (dashed). 
Conditions: 85 K spectra: 5 M in 4:1 (v/v) ethanol:methanol; ex = 290-324 nm. Room temperature spectra: 


































































































, and (d) [Ir(df-ppy)2(pt-TEG)]
+
. Black lines: corrected spectra at 85 K (solid) and room 
temperature (dashed). Grey lines: uncorrected spectra at 85 K (solid) and room temperature (dashed). 
Conditions: 85 K spectra: 5 M in 4:1 (v/v) ethanol:methanol; ex = 267-324 nm. Room temperature spectra: 



































































































 (blue lines) overlaid on those for [Ir(C^N)2(ptb)]
+
 (black lines). The grey plots show 
selected further reduction peaks. Metal complexes were prepared at a concentration of 0.25 mM in acetonitrile 
with 0.1 M TBAPF6 supporting electrolyte. The additional peaks at ~0.65 V in the CVs for the [Ir(C^N)2(pt-
TEG)]
+
 complexes are due to their chloride counter ions. 
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Table S4.1. Calculated MO energies (eV; BP86/def2-TZVP) for Ir(C^N)2(acac) complexes in acetonitrile. 
 Ir(piq)2(acac) Ir(bt)2(acac) Ir(ppy)2(acac) Ir(df-ppy)2(acac) 
LUMO+3 -1.92 -1.56 -1.97 -1.99 
LUMO+2 -2.01 -2.04 -1.98 -2.05 
LUMO+1 -2.78 -2.73 -2.40 -2.48 
LUMO -2.87 -2.73 -2.41 -2.49 
HOMO -4.63 -4.80 -4.63 -4.88 
HOMO-1 -4.91 -4.99 -4.91 -5.06 
HOMO-2 -5.22 -5.37 -5.26 -5.45 
HOMO-3 -5.50 -5.61 -5.69 -5.76 
HOMO-LUMO 
GAP 
1.76 2.07 2.22 2.39 
 
Table S4.2. Calculated MO energies (eV; BP86/def2-TZVP) for [Ir(C^N)2(dm-bpy)]
+













LUMO+3 -2.29 -2.22 -2.30 -2.34 
LUMO+2 -2.86 -2.85 -2.47 -2.55 
LUMO+1 -2.98 -2.92 -2.56 -2.63 
LUMO -3.06 -3.04 -3.06 -3.12 
HOMO -5.06 -5.13 -5.09 -5.31 
HOMO-1 -5.29 -5.53 -5.31 -5.52 
HOMO-2 -5.48 -5.62 -5.56 -5.72 
HOMO-3 -5.75 -5.97 -5.95 -5.94 
HOMO-LUMO 
GAP 






Table S4.3. Calculated MO energies (eV; BP86/def2-TZVP) for [Ir(C^N)2(ptb)]
+










LUMO+3 -2.27 -2.23 -2.31 -2.34 
LUMO+2 -2.74 -2.77 -2.53 -2.62 
LUMO+1 -2.91 -2.87 -2.60 -2.66 
LUMO -3.06 -2.92 -2.76 -2.82 
HOMO -5.04 -5.18 -5.07 -5.31 
HOMO-1 -5.50 -5.58 -5.57 -5.75 
HOMO-2 -5.51 -5.69 -5.63 -5.78 
HOMO-3 -5.85 -6.00 -5.90 -6.01 
HOMO-LUMO 
GAP 
1.98 2.26 2.31 2.49 
 
Table S4.4. Calculated MO energies (BP86/def2-TZVP) for [Ir(C^N)2(pt-TEG)]
+













LUMO+3 -2.20 -2.17 -2.25 -2.27 
LUMO+2 -2.70 -2.72 -2.51 -2.58 
LUMO+1 -2.94 -2.84 -2.57 -2.63 
LUMO -2.98 -2.90 -2.71 -2.76 
HOMO -5.03 -5.15 -5.04 -5.26 
HOMO-1 -5.40 -5.53 -5.54 -5.70 
HOMO-2 -5.52 -5.65 -5.58 -5.71 
HOMO-3 -5.80 -5.97 -5.88 -5.95 
HOMO-LUMO 
GAP 















 complexes, where C^N = piq, 

















































































































Table S4.6. Contour plots for [Ru(bpy)3]
2+




in water. The hydrogen 
atoms and TEG chain have been omitted for clarity. 































Figure S4.8. Normalized ECL intensity during an applied potential sweep from 0 V to 1.8 V and back to 0 V 
(vs Ag/AgCl) for (a) [Ir(piq)2(pt-TEG)]
+
 and (b) [Ir(ppy)2(pt-TEG)]
+
 at 1 M (blue lines) and 0.1 M (red lines) 
in (ProCell) phosphate buffer solution containing TPrA as a co-reactant. 
 
 
Figure S4.9. Photoluminescence emission spectra (corrected) of (a) [Ir(C^N)2(mbpy-COOH)]
+
, and (b) 
[Ir(C^N)2(pt-TOxT-Sq)]
+
 labels, where C^N = df-ppy (blue lines), ppy (green lines), bt (yellow lines), or piq 
(red lines), at a concentration of 10
 













































Potential / V (vs Ag/AgCl)
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Table S4.7. Primers and NASBA amplicon fragment sequences. 
 
a
Primer 1 consists of a 3‘ terminal sequence that is target specific (underlined) and a 5‘ terminal T7 promoter 
sequence (bold) that can be recognized by T7 RNA polymerase. 
b
Primer 2 consists of a 3‘ terminal target 




Sequences (5' - 3' orientation) 
P1a AAT TTC TAA TAC GAC TCA CTA TAG GGA AGT GCC ATC CGA TAA CAG 
P2b GAT GCA AGG TCG CAT ATG AGA GCC TTA CCG TAG TGT ACT A 
Detection 
probe 
Amino-C6-GAT GCA AGG TCG CAT ATG AG 




GGGAAGUGCC AUCCGAUAAC AGGACGAUCG CACGGAACCC ACCCGAAAUU 
GUCGGUGGUACUUAUCGUCC AGGUGUAUCG AAAGUGCGUG AAUAAAUACG 
CUUUUGCUAG CGAGGGAGCUAAUGCUGCCC UGGAGUUAGU ACACUACGGU 





                       
Figure S4.10. 3D drawing and photograph of the custom screen-printed electrode (SPE) holder, which was 
designed using SolidWorks 2015 CAD package (Dassault Systems, France). G-code CNC toolpaths were 
created using Siemens NX 10 CAD/CAM package (Siemens, Germany). The holders were machined from 10 
mm thick cast poly(methylmethacrylate) (PMMA) sheets (Resi-Plex, Australia) using a Datron M7HP CNC 
mill (Datron AG, Germany). They were designed to house Zensor TE-100 SPE (eDAQ, Australia) which 
consist of carbon ink working (3 mm diameter) and counter electrodes, and an Ag|AgCl based ink reference 
electrode. These electrodes have been shown to have characteristics well suited for ECL-based analytical 
methods.
5
 To perform ECL assays using paramagnetic particles, the holders incorporated a 3 × 4 mm diameter 









Figure S4.11. Photograph of the cell holder containing magnet and Zensor SPE, coupled with the silicon 






NMR spectra of [Ir(C^N)2(dm-bpy)](PF6) and [Ir(C^N)2(ptb)](PF6) complexes 
1
H NMR spectrum of [Ir(bt)2(dm-bpy)](PF6) 
 
1
H NMR (400 MHz; CD2Cl2): δ 8.23 (s, 1H), 7.95 (d, J = 5.6 Hz, 1H), 7.90 (d, J = 8.0 Hz, 
1H), 7.85 (d, J = 7.6 Hz, 1H), 7.37 (t, J = 7.4 Hz, 1H), 7.30 (d, J = 5.6 Hz, 1H), 7.09-7.14 
(m, 2H), 6.88 (td, J = 7.5, 1.2 Hz, 1H), 6.41 (d, J = 7.6 Hz, 1H), 6.24 (d, J = 8.4 Hz, 1H), 














H} NMR (100 MHz; CD2Cl2): δ 181.8, 156.8, 153.0, 150.9, 150.7, 149.8, 140.8, 133.9, 







H NMR spectrum of [Ir(piq)2(dm-bpy)](PF6) 
 
1
H NMR (400 MHz; CD2Cl2): δ 8.98 (m, 1H), 8.32 (m, 2H), 7.92 (m, 1H), 7.80 (m, 2H), 
7.68 (d, J = 5.8 Hz, 1H ), 7.41 (d, J = 6.4 Hz, 1H), 7.34 (d, J = 6.4 Hz, 1H), 7.20 (1H, J = 









H NMR spectrum of [Ir(ppy)2(dm-bpy)](PF6) 
 
1
H NMR (400 MHz; CD2Cl2): δ 8.31 (s, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.82 (d, J = 5.6 Hz, 
1H), 7.78 (td, J = 7.8, 1.5 Hz, 1H), 7.73 (dd, J = 7.8, 0.9 Hz, 1H), 7.51 (d, J = 5.7 Hz, 1H), 
7.23 (d, J = 5.5 Hz, 1H), 7.06 (td, J = 7.5, 1.1 Hz, 1H), 7.00 (ddd, J = 7.4, 5.9, 1.4 Hz, 1H), 






H NMR spectrum of [Ir(df-ppy)2(dm-bpy)](PF6) 
 
1
H NMR (400 MHz; CD2Cl2): δ 8.37 (s, 1H), 8.32 (d, J = 8.4 Hz, 1H), 7.82 (m, 2H), 7.50 (d, 
J = 5.7 Hz, 1H), 7.29 (d, J = 5.7 Hz, 1H), 7.05 (m, 1H), 6.62 (ddd, J = 12.5, 9.2, 2.4 Hz, 1H), 







H NMR spectrum of [Ir(bt)2(ptb)](PF6) 
 
1
H NMR (400 MHz; CD2Cl2): δ 8.67 (s, 1H), 8.06 (dq, J = 8.0, 0.8 Hz, 1H), 8.00 (td, J = 7.8, 
1.6 Hz, 1H), 7.94 (dq, J = 5.5, 0.8 Hz, 1H), 7.90 (dq, J = 8.1, 0.6 Hz, 1H), 7.87 (dq, J = 8.1, 
0.6 Hz, 1H), 7.84 (m, 1H), 7.80 (m, 1H), 7.32-7.43 (m, 6H), 7.25-7.29 (m, 2H), 7.11 (td, J = 
7.6, 1.2 Hz, 1H), 7.03-7.08 (m, 2H), 6.95 (ddd, J = 8.5, 7.3, 1.3 Hz, 1H), 6.88 (td, J = 7.6, 
1.5 Hz, 1H), 6.82 (td, J = 7.6, 1.5 Hz, 1H), 6.48 (d, J = 7.7 Hz, 1H), 6.40 (d, J = 8.4 Hz, 1H), 
6.37 (d, J = 7.8 Hz, 1H), 6.08 (d, J = 8.3 Hz, 1H), 5.65 (d, J = 14.8 Hz, 1H), 5.55 (d, J = 














H} NMR (100 MHz; CD2Cl2): δ 182.2, 181.3, 151.1, 150.6, 150.2, 150, 149.7 (2C), 
146.4, 141.3, 140.9, 140.6, 134.2, 134.0 (2C), 132.5, 132.0 (2C), 131.9, 129.9 (2C), 129.8, 










H NMR spectrum of [Ir(piq)2(ptb)](PF6) 
 
1
H NMR spectra was consistent with the literature values. 
1
H NMR (400 MHz; CD2Cl2): δ 
9.00 (m, 2H), 8.62 (s, 1H), 8.33 (m, 2H), 8.12 (d, J = 7.9 Hz, 1H), 7.91-8.00 (m, 3H), 7.84-
7.99 (m, 4H), 7.69 (d, J = 5.6 Hz, 1H), 7.60 (d, J = 6.4 Hz, 1H), 7.39 (t, J = 6.9 Hz, 2H), 
7.09-7.33 (m, 9H), 6.93 (t, J = 7.4 Hz, 1H), 6.84 (t, J = 7.4 Hz, 1H), 6.51 (d, J = 7.6 Hz, 1H), 







H NMR spectrum of [Ir(ppy)2(ptb)](PF6) 
 
1
H NMR (400 MHz; CD2Cl2): δ 8.62 (s, 1H), 8.11 (d, J = 7.9 Hz, 1H), 7.99 (dt, J = 7.9, 1.6 
Hz, 1H), 7.95 (t, 8.8 Hz, 2H), 7.76-7.84 (m, 3H), 7.69-7.74 (m, 2H), 7.67 (d, J = 5.8 Hz, 
1H), 7.49 (d, J = 5.8 Hz, 1H), 7.38-7.42 (m, 3H), 7.26-7.34 (m, 3H), 7.00-7.09 (m, 3H), 
6.98 (ddd, J = 7.5, 5.8, 1.4 Hz, 1H), 6.93 (td, J = 7.5, 1.3 Hz, 1H), 6.88 (td, J = 7.5, 1.3 Hz, 






H NMR spectrum of [Ir(df-ppy)2(ptb)](PF6) 
 
1
H NMR (400 MHz; CDCl3): δ 8.80 (s, 1H), 8.30 (t, J = 10.5 Hz, 2H), 8.22 (d, J = 7.9 Hz, 
1H), 8.00 (td, J = 7.9, 1.5 Hz, 1H), 7.79-7.83 (m, 3H), 7.61 (d, J = 5.8 Hz, 1H), 7.45 (d, J = 
5.8 Hz, 1H), 7.36 (s, 5H), 7.32 (m, 1H), 7.11 (ddd, J = 7.3, 5.9, 1.3 Hz, 1H), 7.01 (ddd, J = 
7.3, 5.9, 1.3 Hz, 1H), 6.55 (m, 2H), 5.73 (dd, J = 8.5, 2.5 Hz, 1H), 5.68 (dd, J = 8.5, 2.3 Hz, 






NMR spectra of [Ir(C^N)2(pt-TEG)]Cl complexes 
[Ir(ppy)2(pt-TEG)]Cl, CDCl3. Residual solvent marked with an asterisk. 
 
1
H NMR (500 MHz; CDCl3): δ 10.46 (s, 1H), 9.04 (d, J = 8.0 Hz, 1H), 8.04 (td, J = 7.8, 
1.5 Hz, 1H), 7.90 (m, 2H), 7.78-7.74 (m, 3H), 7.70 (dd, J = 5.8, 0.7 Hz, 1H), 7.67-7.64 (m, 
2H), 7.50 (dd, J = 5.8, 0.7 Hz, 1H), 7.22 (ddd, J = 7.6, 5.6, 1.3 Hz, 1H), 7.07 (ddd, J = 7.3, 
5.9, 1.4 Hz, 1H), 7.03 (td, J = 7.5, 1.0 Hz, 1H), 7.00-6.97 (m, 2H), 6.91 (td, J = 7.4, 1.2 Hz, 
1H), 6.87 (td, J = 7.4, 1.2 Hz, 1H), 4.77-4.68 (m, 2H), 4.05-3.99 (m, 2H), 3.76-3.66 (m, 4H), 










C NMR (126 MHz; CDCl3): δ 168.4, 167.6, 150.3, 150.1, 149.5, 149.4, 148.5, 148.4, 
146.6, 143.8, 143.6, 139.8, 137.8, 137.7, 131.9, 131.7, 130.6, 130, 129.3, 125.8, 124.7, 













H NMR (500 MHz; CDCl3): δ 9.16 (s, 1H), 8.40 (d, J = 8.0 Hz, 1H), 8.28 (t, J = 10.0 Hz, 
2H), 8.01 (t, J = 7.8 Hz, 1H), 7.80 (m, 3H), 7.65 (d, J = 5.7 Hz, 1H), 7.50 (d, J = 5.7 Hz, 
1H), 7.31 (t, J = 6.6 Hz, 1H), 7.15 (t, J = 6.7 Hz, 1H), 7.05 (t, J = 6.7 Hz, 1H), 6.55 (m, 1H), 
6.48 (m, 1H), 5.71 (d, J = 7.7 Hz, 1H), 5.66 (d, J = 8.0 Hz, 1H), 4.69‑4.58 (m, 2H), 













C NMR (101 MHz; CDCl3): δ 165.1 (m, CF), 164.5 (m, CF), 164.2 (m, CF), 162.6 (m, 
CF), 162.0 (m), 160.0 (m), 153.9 (d), 150.2, 150.0 (d), 149.7, 149.4, 148.7, 148.4, 140.7, 
139.1, 139.0, 129.7, 127.9 (m, 2C), 126.4, 125.2, 123.9, 123.7 (d), 123.5 (d), 123.3, 114.2 


















[Ir(bt)2(pt-TEG)]Cl, d6-DMSO. Residual solvent marked with an asterisk. 
 
1
H NMR (400 MHz; DMSO-d6): δ 9.40 (s, 1H), 8.44 (d, J = 8.0, 1H), 8.25 (m, 3H,), 8.01 (d, 
J = 7.7 Hz, 1H), 7.91 (d, J = 7.6 Hz, 1H,), 7.87 (d, J = 5.5 Hz, 1H), 7.66 (m, 1H), 7.46 (m, 
1H), 7.42 (m, 1H), 7.29 (m, 1H), 7.14 (m, 2H), 7.02 (m, 1H), 6.93 (m, 1H), 6.83 (m, 1H), 
6.35 (m, 2H), 6.28 (d, J = 7.7, 1H), 6.08 (d, J = 8.4, 1H), 4.73 (m, 2H), 3.82 (m, 2H), 3.45 












H} NMR (101 MHz; DMSO-d6): δ 181.5, 180.8, 150.0, 149.7, 148.7, 148.5, 148.4, 
146.6, 140.8, 140.4, 140.2, 132.9, 132.8, 132.0, 131.3, 131.2 (2C), 131.2, 128.3, 128.0, 
127.6, 127.3, 127.0, 126.4, 126.1, 125.9, 124.7, 124.6, 123.2, 122.8, 122.7, 117.5, 116.6, 







Ir(piq)2(pt-TEG)]Cl, CDCl3. Residual solvent marked with an asterisk. 
 
1
H NMR (400 MHz; CDCl3): δ 10.38 (s, 1H), 9.02 (d, J = 7.9, 1H), 8.95 (ddd, J = 10.5, 6.9, 
3.4, 2H), 8.24 (dd, J = 10.4, 5.9, 2H), 8.01 (td, J = 7.8, 1.5, 1H), 7.93-7.87 (m, 2H), 7.79-
7.72 (m, 4H), 7.58-7.53 (m, 2H), 7.41-7.37 (m, 2H), 7.32-7.28 (m, 1H), 7.18-7.14 (m, 1H), 
7.12-7.08 (m, 1H), 7.06-7.02 (m, 1H), 6.90-6.86 (m, 1H), 6.83-6.79 (m, 1H), 6.39 (dd, J = 
7.7, 1.1, 1H), 6.30-6.28 (m, 1H), 4.70-4.61 (m, 2H), 3.94 (ddd, J = 13.0, 6.4, 4.2, 1H), 3.71 










H} NMR (101 MHz; CDCl3): δ 169.6, 168.8, 153.7, 150.2, 150.1, 149.6, 148.4, 145.8, 
145.6, 141.4, 140.5, 139.9, 137.2, 137.1, 132.6, 132.5, 131.7, 131.7, 130.8, 130.6, 130.3, 
130.1, 129.3, 128.7, 128.6, 127.7, 127.5, 127.2, 126.9, 126.4, 125.9, 124.9, 122.3, 122.0, 







NMR spectra of [Ir(C^N)2(pt-TOxT-Sq)]Cl ECL labels 







H NMR (500 MHz; CD3CN): δ 9.40 (m, 1H), 8.41-8.37 (m, 1H), 8.05 (m, 3H), 7.86-7.74 
(m, 6H), 7.63 (d, J=5.3 Hz, 1H), 7.34 (ddd, J =7.4, 5.8, 1.3 Hz, 1H), 7.10 (ddd, J = 7.3, 6.0, 
1.3, 1H), 7.04 (m, 2H), 6.92 (m, 2H), 6.81 (td, J = 7.4, 1.1 Hz, 1H), 6.26 (m, 2H), 4.64 (m, 















H} NMR (126 MHz; CD3CN): δ 168.6, 168.2, 151.1, 150.8, 150.7, 150.2, 149.4, 147.7, 
145.3, 145.3, 140.7, 139.5, 139.4, 132.8, 132.4, 131.2, 130.6, 128.3, 127.5, 125.8, 125.3, 













H NMR (400 MHz; CD3CN): δ 9.16 (s, 1H), 8.26 (d, J = 7.9 Hz, 1H), 8.06 (m, 3H), 7.95 
(m, 2H), 7.84 (m, 1H), 7.40 (m, 3H), 7.27 (m, 1H), 7.11 (m, 2H), 7.03 (td, J= 7.5,
 
1.0 Hz, 
1H), 6.89 (td, J = 7.5, 1.3 Hz, 1H), 6.80 (td, J = 7.5, 1.3 Hz, 1H), 6.55 (d, J= 8.3 Hz, 1H), 
6.47 (d, J = 7.6 Hz, 1H), 6.36 (d, J = 7.6 Hz, 1H), 6.16 (d, J = 8.4 Hz, 1H), 4.62 (d, J = 6.3 
Hz, 2H), 4.54 (t, J = 6.5 Hz, 2H), 3.37 (m, 14H), 3.02 (s, 1H), 2.03 (q, J = 6.1, 2H), 1.71 (q, 





















H} NMR (101 MHz; CD3CN): δ 182.7, 182.1, 151.7, 151.2, 150.9, 150.1, 150.1, 149.8, 
147.5, 141.9, 141.5, 141.3, 134.4, 134.4, 132.8, 132.6, 132.6, 132.2, 129.2, 128.9, 128.6, 
128.0, 127.7, 127.2, 126.9, 124.9, 124.8, 124.3, 123.9, 123.8, 119.1, 118.3, 70.9, 70.9, 70.8, 














H NMR (400 MHz; [CD3CN]): δ 9.14 (s, 1H), 9.01 (m, 2H), 8.38 (d, J = 8.0 Hz, 1H), 8.31 
(m, 2H), 8.02 (m, 3H,), 7.83 (m, 4H), 7.70 (m, 1H), 7.67 (d, J = 6.4 Hz), 7.54 (d, J = 6.4 Hz, 
1H), 7.49 (d, J = 6.4, 1H), 7.43 (d, J = 6.4 Hz, 1H), 7.31 (ddd, J = 7.7, 5.6, 1.3 Hz, 1H), 7.13 
(ddd, J = 8.2, 7.2, 1.2 Hz, 1H), 7.04 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 6.89 (td, J = 7.4, 1.2 Hz, 
1H), 6.77 (td, J = 7.4, 1.2 Hz, 1H), 6.42 (d, J = 7.5 Hz, 1H), 6.28 (dd, J = 7.7, 1.1 Hz, 1H), 
4.62 (m, 2H), 4.46 (t, J = 6.8 Hz, 2H), 3.32 (m, 15H), 1.98 (dd, J = 6.5, 5.2 Hz, 2H), 1.73 (q, 















H} NMR (101 MHz; [CD3CN]): δ 169.5, 169.2, 154.3, 151.2, 151.0, 150.4, 149.2, 
146.8, 146.7, 142.4, 141.8, 140.7, 138.1, 138.0, 133.3, 133.1, 132.8, 132.8, 131.7, 131.3, 
131.2, 130.6, 129.9, 129.8, 128.6, 128.5, 128.1, 127.7, 127.6, 127.1, 127.0, 123.9, 123.3, 










H NMR (500 MHz; CD3CN): δ 9.50 (m, 1H), 8.44 (m, 1H), 8.30 (m, 2H), 8.10 (m, 1H), 
7.89 (m, 3H), 7.76 (m, 1H), 7.66 (m, 1H), 7.39 (m, 1H), 7.13 (m, 2H), 6.66 (m, 2H), 5.73 
(ddd, J = 24.1, 8.7, 2.3 Hz, 2H), 4.63 (m, 2H), 4.54 (m, 2H), 3.45 (m, 15H), 2.09 (q, J = 6.2 















H} NMR (126 MHz; CD3CN): δ 164.7 (m, CF), 163.4 (m, CF), 162.8 (m,CF), 161.0 
(m, CF), 154.9 (m, CF), 151.9 (m, CF), 151.6, 151.0, 150.7, 150.3, 141.3, 140.5, 140.5, 
128.4, 128.0, 125.1, 124.8, 124.7, 124.54, 124.5, 124.3, 124.2, 114.8 (m, CF), 99.6 (m, CF), 





F NMR (471 MHz; CD3CN): δ -106.18 (d, J = 10.6, 1F), -107.06 (d, J = 9.6, 1F), -108.07 
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